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General introduction
Dementia is a neurodegenerative disorder affecting white matter (WM) and grey 
matter (GM) in different regions of the brain. Dementia generally occurs over 
the age of 65 years, but may also occur before the age of 65 years, i.e. presenile 
dementia [1]. In 2010 it was estimated that 35.6 million people worldwide suf-
fered from dementia, and it was predicted that this number will nearly double 
every 20 years [1,2]. Few studies have investigated the prevalence of presenile 
dementia specifically [3], but the World Health Organization estimated in 2012 
that presenile dementia may account for 6-9% of all dementia cases [1]. The two 
most common underlying diseases of presenile dementia are Alzheimer’s disease 
(AD) and frontotemporal dementia (FTD) [4].
FTD is the umbrella term for several dementia subtypes affecting the frontal and/
or temporal lobes. The two main variants of FTD are behavioural variant FTD 
(bvFTD) and semantic dementia (SD) [5].
BvFTD is mainly characterised by behavioural symptoms:  disinhibition, 
apathy, loss of sympathy or empathy, stereotypical behaviour and hyperorality 
[6], but may also present with  cognitive deficits in executive functioning [6] and 
memory [7,8]. Of note is that this clinical profile may not be as apparent in early 
stages of bvFTD when symptoms may still be unspecific. Brain abnormalities on 
conventional (structural) magnetic resonance imaging (MRI) are predominantly 
observed as GM atrophy of the right or bilateral frontal lobe(s) and the anterior 
temporal lobes [9–11]. Again, these abnormalities may only be evident in later 
disease stages. GM atrophy patterns such as these are likely underlying bvFTD 
behavioural symptomatology, as the bilateral frontal lobes are important for be-
haviour [12,13]. 
 A syndrome controversially related to bvFTD is phenocopy FTD (phFTD). 
PhFTD is a rare and poorly understood syndrome with symptomatology very 
similar to that of bvFTD, but some aspects of phFTD are essentially different. In 
phFTD, core bvFTD symptoms, such as apathy, behavioural disinhibition, and loss 
of insight [14], are usually not accompanied by cognitive and brain abnormalities 
as is the case in bvFTD. PhFTD patients show a cognitive profile that ranges from 
normal to suggesting bvFTD [15–18] and have a relatively intact performance of 
daily living activities (ADL) [14,18]. These clinical features in phFTD appear sta-
ble over time, whereas in bvFTD patients progression of cognitive deficits is evi-
dent [18–21]. On conventional (structural) MRI, phFTD patients show no or only 
borderline abnormalities [19,21] in the frontal - and temporal - regions, which 
are typically affected in bvFTD [22]. As bvFTD patients may initially also present 
without structural MRI abnormalities, early-stage distinction between phFTD and 
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1bvFTD may be difficult. Patients often remain undiagnosed or receive an alterna-
tive psychiatric diagnosis. A pathophysiological explanation for phFTD symptom-
atology is currently not available. 
In contrast with this bvFTD spectrum, the SD variant of FTD is characterised by 
a language disorder affecting mainly the left hemisphere of the brain. SD presents 
with impaired confrontation naming and impaired single-word comprehension as 
core features, and may additionally present with impaired object knowledge and 
surface dyslexia [23]. On conventional (structural) MRI, SD predominantly shows 
anterior temporal lobe atrophy in the left hemisphere [10,11,23]. This likely un-
derlies the specific language symptomatology as the left hemisphere is important 
for language functioning [24]. Language deficits seen in SD and other language 
variants of FTD may complicate differential diagnosis with atypical cases of AD 
presenting with early-stage language symptomatology [25,26].
AD is the most common disease underlying (presenile) dementia. It is mainly 
characterised by memory deficits, specifically by difficulties in learning and re-
membering new information. AD may also present with other cognitive deficits 
such as impaired reasoning and handling of complex tasks, visuospatial deficits 
and impaired language functioning [25]. In early stages however, symptoms may 
still be mild and unspecific, and AD may present with early-stage changes in so-
cial behaviour or executive functioning [27–29]. This may complicate differential 
diagnosis of AD and bvFTD, especially as early-stage symptoms in bvFTD may also 
be unspecific and memory deficits can occur [29,30]. Additionally, although in 
later stages of AD GM atrophy of the temporo-parietal lobes is usually observed 
on conventional (structural) MRI [25], in early stages this atrophy pattern may still 
be unclear. 
Overall, early (differential) diagnosis of diseases underlying dementia may 
be difficult. Correct early diagnosis is important for several reasons. First, existing 
medication that may slow down progression in dementia (e.g. acetylcholinester-
ase inhibitors) will be most beneficial in a specific dementia subtype. Second, 
being aware of the nature of a patient’s dementia will help both the patient and 
the family develop coping strategies and prepare for the future. Third, it will allow 
medication trials to target defined patient groups. Fourth, it is likely that future 
medication will be most beneficial when administered in the early stages - or 
even presymptomatically. In conclusion, it is of great importance to improve early 
(differential) diagnosis in dementia. In this thesis I investigate the potential use 
of advanced MRI for the differential diagnosis of diseases underlying dementia in 
the presenile dementia population.
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General introduction
As mentioned above, MRI is used to support diagnosis of dementia subtypes by 
means of brain imaging. However, in early disease stages, such as in AD and bvFTD, 
conventional (structural) MRI may still appear normal or show diffuse brain ab-
normalities unspecific for a dementia subtype [21,31,32]. More advanced MRI 
techniques, such as diffusion tensor imaging (DTI), resting state functional MRI 
(rs-fMRI) and arterial spin labelling (ASL) may aid (differential) diagnosis by detect-
ing more subtle abnormalities that remain unrevealed using structural MRI [33]. 
The first and second techniques, DTI and rs-fMRI, can be used to assess brain 
connectivity, in terms of WM microstructure (Figure 1a) and functional connec-
tivity (Figure 1b) respectively. Changes in WM microstructure are approximated 
by looking at diffusion of water molecules in the brain. For this purpose, several 
diffusion measures are used: fractional anisotropy (FA, i.e. directionality of diffu-
sion), mean diffusivity (MD), radial diffusivity (RD, i.e. diffusion perpendicular to 
the axis) and axial diffusivity (AxD, i.e. diffusion along the axis). A decrease in FA 
suggests loss of directionality of diffusion, which has been suggested to indicate 
abnormal microstructure of the WM. Likewise, an increase in mean diffusivity 
indicates increased diffusion in all directions of a WM tract, i.e. less restricted 
movement of water molecules, is also thought to represent changes of WM mi-
crostructure. An increase in RD and AxD has been suggested to reflect respec-
tively myelin [34] and axonal changes [35]. As both FA and MD are combination 
measures of RD and AxD, abnormalities of FA and MD may be induced by changes 
in either. Resting state functional connectivity changes are investigated in terms 
of patterns of brain activity that co-vary between different regions of the brain, 
so called resting state networks. A widely studied and well-defined resting state 
network is the default mode network (DMN), consisting of the precuneus, poste-
rior cingulate cortex, inferior parietal lobule, lateral temporal cortex and medial 
prefrontal cortex [36] (Figure 1b). In this network, increased functional connectiv-
ity reflects neuronal activity changes that have become more congruent between 
regions. This may point to a brain mechanism compensating for early diminished 
neuronal functioning [37,38]. The degree of increased connectivity may reflect 
the brain’s remaining ability of compensation, ultimately reversing to decreased 
connectivity as neuronal dysfunctioning progresses. 
The third technique, ASL, can be used to assess GM perfusion in the whole-
brain or in regions of interest (Figure 1c). Additionally, advanced post-processing 
tools may improve the use of conventional MRI enabling detection of smaller GM 
volume changes and combination of GM volumes with other MRI measures. 
Taken together, these advanced MRI techniques detect subtle brain abnor-
malities in structure and function, which may aid clinical diagnosis in dementia. 
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1Clinical differential diagnosis may especially benefit from objective quantitative 
advanced MRI measures, such as diffusion values. This allows us to identify de-
mentia patients by comparing them to reference values of the healthy popula-
tion. Additionally, advanced MRI techniques also allow us to combine WM and 
GM measures and to investigate relationships between subtle changes of WM 
and GM in dementia.
In section 2 of this thesis I investigate subtle brain abnormalities in early-stage 
presenile AD and bvFTD. In chapter 2.1 I explore the diagnostic utility of quantita-
tive measures of tract-specific WM microstructure and functional connectivity of 
the DMN for early-stage and long-term differentiation of AD and bvFTD. Chapter 
2.2 investigates whether there is coherence between regional abnormalities of 
WM microstructure and GM volume and perfusion in AD and in bvFTD. 
In section 3 I investigate associations between subtle brain abnormalities 
and clinical symptomatology in AD, bvFTD and SD. In chapter 3.1 I address func-
tional associations between early-stage symptomatology and abnormalities of 
WM microstructure in both bvFTD and AD. In chapter 3.2 I explore lateraliza-
tion of WM microstructure and functional connectivity abnormalities in SD and 
bvFTD, which may be underlying their differential symptomatology. 
Section 4 investigates whether phFTD and bvFTD may belong to the same 
Figure 1. Axial images of (A) a white matter skeleton created by post-processing of diffusion tensor 
imaging, (B) resting state functional magnetic resonance imaging, and (C) arterial spin labelling 
in healthy participants. The white matter skeleton is depicted in blue (A). Default mode network 
functional connectivity of the inferior parietal lobules, posterior cingulate cortex/precuneus, and 
medial prefrontal cortex is shown in red (B). Grey matter regions with the highest perfusion are 
shown in red (C).
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General introduction
disease spectrum by exploring whether there are subtle brain abnormalities in 
phFTD that are similar to those seen in bvFTD.  Functional DMN connectivity and 
microstructural WM abnormalities will be discussed in chapter 4.1, and quan-
tified perfusion and GM volumes in chapter 4.2. In chapter 4.3 I will address 
longitudinal changes in individual phFTD patients by looking at cognition, WM 
microstructure, GM volumes and perfusion. 
In chapter 5 I will provide an overview of the main findings and discuss the 
methodological considerations, clinical implications and future perspective of this 
research. 
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abstract
This study investigated quantitative measures of tract-specific white matter 
(WM) microstructure and functional default mode network (DMN) connectivity 
to explore clinical applicability for early-stage and long-term differential diagno-
sis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia 
(bvFTD).
Eleven AD and 12 bvFTD early-stage patients, and 18 controls underwent dif-
fusion tensor imaging and resting state functional magnetic resonance imaging at 
3T. All AD and 6 bvFTD patients underwent the same protocol at 1-year follow-up. 
Functional connectivity measures of the DMN and WM tract-specific diffusivity 
measures (fractional anisotropy, mean, radial and axial diffusivity) were deter-
mined for all groups. All measures were compared between the three groups at 
baseline, and between patients at follow-up. Additionally, the difference between 
baseline and follow-up diffusivity measures in AD and bvFTD patients were com-
pared.
Functional connectivity of the DMN was not different between groups nei-
ther at baseline nor at follow-up. Diffusion abnormalities were observed widely 
in bvFTD and regionally in the hippocampal cingulum in AD. The extent of the dif-
ferences between bvFTD and AD were diminished at follow-up yet abnormalities 
were still more pronounced in bvFTD, specifically in the cingulate cingulum and 
inferior fronto-occipital fasciculus. The rate of change was very similar in bvFTD 
and AD. 
Quantitative tract-specific microstructural WM abnormalities, but not quan-
titative functional connectivity of the DMN, may aid early-stage and long-term 
differential diagnosis of bvFTD and AD. Specifically, pronounced microstructural 
WM changes in anterior WM tracts characterise bvFTD, whereas microstructural 
WM abnormalities of the hippocampal cingulum characterise AD.
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2.1
1. IntroDUCtIon 
Presenile dementia is dementia with an onset before the age of 65 years. The two 
most common underlying disorders are Alzheimer’s disease (AD) and behavioural 
variant frontotemporal dementia (bvFTD) [1]. AD is characterised by an episodic 
memory disturbance for recently learned as well as for learning new material, 
together with at least one other cognitive disturbance [2]. In contrast, bvFTD is 
mainly characterised by behavioural problems such as disinhibition, apathy and 
loss of empathy [3]. In later stages of AD and bvFTD, predominance of cognitive 
impairment in AD and social/executive impairment in bvFTD [4,5] aid differential 
diagnosis. However, differential diagnosis can be difficult in early stages of AD 
and bvFTD, as symptoms may still be mild and unspecific. BvFTD patients may 
present with memory deficits [6,7] and AD patients with changes in social behav-
iour or executive functioning [5,7,8]. Magnetic resonance imaging (MRI) supports 
diagnosis, but in early disease stages conventional (structural) MRI may still ap-
pear normal or show diffuse brain abnormalities unspecific for a dementia sub-
type [9–11]. More advanced  MRI techniques, such as diffusion tensor imaging 
(DTI) and resting state functional MRI (rs-fMRI) may aid differential diagnosis by 
detecting more subtle abnormalities that remain unrevealed using structural MRI 
[12]. 
DTI is used to assess white matter (WM) microstructure of the brain. Previ-
ous studies have observed more pronounced microstructural WM abnormalities 
in bvFTD than in AD [13,14] and have suggested an anterior-posterior division 
of WM abnormalities in bvFTD and AD. Microstructural WM abnormalities are 
observed in anterior brain regions in bvFTD, such as the cingulate cingulum, genu 
of the corpus callosum (or forceps minor) and uncinate fasciculus, whereas mi-
crostructural WM changes in AD are localised in more posterior brain regions, 
such as the splenium (or forceps major) and the hippocampal cingulum [15–17]. 
Rs-fMRI is used to assess functional connectivity between grey matter (GM) re-
gions that together form functional brain networks. A widely studied network is 
the default mode network (DMN), known to be affected in both AD and bvFTD 
[18]. Previous research has shown DMN differences between AD and bvFTD  - 
mostly in the posterior DMN -, specifically decreased DMN connectivity in AD and 
increased DMN connectivity in bvFTD.
Clinical diagnosis may especially benefit from objective quantitative mea-
sures derived from DTI and rs-fMRI in differentiating subtypes of dementia pa-
tients, and patients from healthy persons, using group-specific reference values. 
In this study we explore the diagnostic utility of quantitative measures of tract-
Quantitative differentiation of AD en bvFTD
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specific WM microstructure and functional connectivity of the DMN for early-
stage and long-term differentiation of AD and bvFTD.
2. MethoDS
2.1 Participants
Patients were recruited in the Alzheimer Centre Southwest Netherlands. Inclu-
sion criteria were an age between 40 and 70 years; suspected diagnosis of early 
AD [2] or bvFTD [3]; a Mini-Mental State Examination [19] (MMSE) score of ≥ 
20. Exclusion criteria were contraindications for MRI; an expected loss to follow-
up within one year; other neurological disorders; a different cause of dementia; 
alternative psychiatric diagnosis; past or current substance abuse. Diagnosis of 
either AD or bvFTD was confirmed after at least one year follow-up. Patients un-
derwent the MMSE as part of their routine clinical diagnostic work-up.
Healthy controls, matched for age and gender, and without neurological or psy-
chiatric history, were recruited through advertisement. Controls underwent neuro-
psychological testing and the MMSE as part of this study to rule out cognitive impair-
ment.
The study was approved by the local medical ethics committee. All partici-
pants gave written informed consent.
2.2 Image acquisition
MRI was performed on a 3T GE Discovery MR750 system (GE Healthcare, Milwau-
kee, WI, US). See Table 1 for acquisition parameters. Patients underwent identical 
MRI protocols at baseline (T0) and at one year follow-up (T1). Controls underwent 
MRI at T0 only.
For anatomical reference, a high-resolution three-dimensional (3D) inver-
sion recovery (IR) fast spoiled gradient echo (FSPGR) T1-weighted (T1w) image 
was acquired. DTI scans were acquired with spin-echo echo planar imaging (EPI) 
sequence and functional scans with a gradient echo EPI sequence with full cover-
age of the supratentorial brain. For functional scans participants were instructed 
to think of nothing in particular, to focus on a fixation cross and to remain awake.
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2.3 Demographical analysis
Between-group differences in age were tested using a one-way ANOVA. Between-
group differences in MMSE score were tested using a Welch-ANOVA and post-hoc 
Games-Howell t-tests, due to unequal variance across groups. Gender was com-
pared across groups using chi-square tests. Analyses were done using IBM SPSS 
Statistics (version 21.0, New York, USA) with a significance threshold of p<0.05.
T1w = T1-weighted, DTI = diffusion tensor imaging, fMRI = functional magnetic resonance 
imaging, FOV= field of view,  TE = echo time, TR = repetition time,  ASSET = array spatial  sensitivity 
encoding technique, TI = inversion time.
*TE for DTI was set to minimum. This number represents the  average TE. The range  of TE was 
81.9-90.8 ms.
t1w DtI fmrI
foV (mm) 240 240 240
te (ms) 3.06 84.5* 30
tr (ms) 7.90 7930 3000
ASSet factor 2 2 2
flip angle 12° 90° 90°
Acquisition matrix 240x240 128x128 96x96
Slice thickness (mm) 1 2.5 3
Volumes (slices per volume) 1 (176) 28 (59) 200 (44)
Duration (min) 4.41 3.50 10.00
Diffusion-weighted directions n/a 25 n/a
non-diffusion weighted images n/a 3 n/a
Maximum b-value (s/ mm2) n/a 1000 n/a
tI (ms) 450 n/a n/a
table I. Acquisition parameters.
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2.4 Grey matter (GM) volume analysis
GM volumes were calculated according to the methods described in Bron et al. 
(2014) [20]. GM volumes were obtained from the T1w image using the unified 
tissue segmentation method of SPM8 (Statistical Parametric Mapping, London, 
UK), after which intracranial volume (ICV) was calculated. Then, GM volume 
was divided by ICV to correct for brain size. GM volume (%ICV) was compared 
between all groups at T0 and between bvFTD and AD at T1 using a one-way ANO-
VA and post-hoc Bonferroni tests (IBM SPSS Statistics, version 21.0, New York, 
USA).
2.5 Microstructural white matter (WM) analysis 
Data were analysed using FMRIB Software Library (FSL5, Oxford, UK) [21–23]. 
Data were corrected for motion and eddy currents using Eddy Correct and then 
skull-stripped using BET [24]. 
Tracts known to be associated with cognitive functions such as language, 
executive functioning and memory were selected for tractography: anterior 
thalamic radiation [25,26], cingulum [27], forceps major [25,28], forceps minor 
[25,29,30], inferior fronto-occipital fasciculus [31–33] , inferior longitudinal fas-
ciculus [31,34], superior longitudinal fasciculus [34,35] and uncinate fasciculus 
[27,29,33]. The genu and splenium of the corpus callosum were represented by 
respectively the forceps minor and major.
Automated probabilistic tractography (AutoPtx) [36] was used to apply 
a tensor fit with DTIFIT [37], followed by a FNIRT registration and a BEDPOSTX 
probabilistic model fit for each participant. PROBTRACKX [37,38] was then run for 
all selected WM tracts using default space seed, target, stop and exclusion masks 
available in AutoPtx [36], resulting in a participant-specific tract density image. 
Tract density images were normalised by dividing them by the number of fibres 
included in the tract-image and then binarised for WM tract segmentation, based 
on the best-fit segmentation thresholds established by De Groot et al. (2015) [84] 
(see supplemental (suppl) Table 1 for thresholds). 
Diffusivity images were masked with thresholded tract images using FSL-
stats, to acquire median fractional anisotropy (FA), mean diffusivity (MD), radial 
diffusivity (RD) and axial diffusivity (AxD) for each tract. 
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Further WM analyses were done using IBM SPSS Statistics (version 21.0, New 
York, USA). First, WM microstructure values at T0 were compared between AD, 
bvFTD and controls using an ANOVA and post-hoc Bonferroni t-tests, unless an 
age effect was present.  Age effects were investigated using linear regression and, 
if necessary, taken into account using an ANCOVA. TE variation - induced by the 
minimum setting during scanning - could not be accounted for by means of re-
gression analysis as ANOVA revealed higher TE for AD than for bvFTD and con-
trols. The effect of varying TE is expected to be small, however a possible bias 
may have been introduced. In case of unequal variances across groups, between-
group differences were investigated using a Welch-ANOVA and post-hoc Games-
Howell t-tests. Second, WM microstructure values at T1 were compared between 
AD and bvFTD, following the same approach as for the baseline analyses. Two 
diffusion measures for separate WM tracts with both unequal variance across 
groups and age effect were excluded from the analysis. Third, AD and bvFTD WM 
microstructure values at T0 were subtracted from WM microstructure values at 
T1 to establish the difference score per diffusion metric per tract. These differ-
ence scores (rate of change) were then compared between AD and bvFTD using 
the same approach as for baseline WM metrics.
2.6 Functional connectivity analysis
Using regions of interest (ROIs) of the Hammers atlas (30 atlases with 83 ROIs; 
http://brain-development.org/brain-atlases) [39], GM regions making up the de-
fault mode network (DMN) were selected for functional analysis: bilateral medial 
prefrontal cortex (mPFC), bilateral lateral temporal cortex (LTC), bilateral inferi-
or parietal lobule (IPL), bilateral precuneus, bilateral posterior cingulate cortex 
(PCC). All ROIs were normalised to Montreal Neurological Institute (MNI) space.
Functional and structural data were first preprocessed using Statistical Para-
metrical Mapping (SPM8, Wellcome department, London, UK).  Spatial prepro-
cessing consisted of manual realignment of functional and structural data to the 
anterior commissure, realignment of functional data, coregistration of functional 
and structural data, segmentation of structural data into grey matter and white 
matter with a light clean, and normalisation to MNI space with a resampling size 
of 3mm3  for functional and 1mm3  for structural data. Further preprocessing and 
analysis were performed using the connectivity toolbox by Mantini [40,41]. Func-
tional data were scrubbed, smoothed with a Gaussian kernel of 5mm3 and cor-
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rected for motion, WM and cerebrospinal fluid signals. Additionally, band-pass 
filtering (0.009-0.08 Hz) was applied. 
For each DMN ROI, the blood-oxygenation-level dependent (BOLD) signal 
was calculated by averaging the BOLD signal of all voxels within the ROI. Subse-
quently, the average BOLD signal of each DMN ROI was correlated with all DMN 
ROI separately to assess functional connectivity. A Fisher’s r-to-z transformation 
was then applied to allow for analysis of between-group functional connectivity 
differences. For both T0 (AD, bvFTD, controls) and T1 (AD, bvFTD) data, functional 
connectivity between ROIs was established for each group using a random-effect 
analysis corrected for multiple comparisons (false discovery rate (FDR)<0.001). 
Functional connectivity differences at T0 between AD, bvFTD and control 
and differences between AD and bvFTD at T1 were assessed using an ANCOVA 
(p<0.05) with GM volume (%ICV) as covariate and post-hoc two-sample t-tests 
corrected for multiple comparisons (FDR<0.05). 
3. reSULtS
3.1 Participant and disease characteristics 
Eleven AD patients, 12 bvFTD patients and 21 controls were included in the study 
(see Table 2). Patients underwent MRI at T0 and at T1 one year later (mean 378 
days); controls underwent MRI at T0 only. Three controls were excluded due to 
incidental structural imaging findings. Three bvFTD patients were excluded from 
the functional connectivity analysis due to missing rs-fMRI data. Six bvFTD pa-
tients did not undergo MRI at T1 and hence were excluded from T1 data analysis. 
BvFTD = behavioural variant frontotemporal dementia, AD = Alzheimer’s disease, N = sample size. 
Values given as Mean (standard deviation). MMSE = Mini-Mental State Examination.
table 2. Demographic characteristics.
Group n mean age mean mmse
BvFtD 12 (6 male) 60.3 (7.7) 26.6 (2.8)
BvFtD t1 6 (3 male) 64.0 (3.6) -
AD 11 (8 male) 62.8 (5.0) 25.3 (2.0)
AD t1 11 (8 male) 63.3 (5.0) -
Controls 18 (8 male) 59.8 (6.7) 29.1 (1.0)
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Data from 11 AD patients at T0 and T1, 12 bvFTD patients at T0 (9 for the rs-fMRI 
analysis) and 6 bvFTD patients at T1, and 18 controls at T0 were used for the 
analysis.  
Participants did not differ in age at T0 (F(2,38) = .498, p>0.05), age at T1(t(15) 
= 0.311, p>0.05), gender at T0 (χ2(2,38) = 2.288, p>0.05), or gender at T1 (χ2(1,15) 
= 0.88, p>0.05). MMSE score was different between groups (F(2, 17.1) = 20.213, 
p<0.001), and was lower in both patient groups compared with controls. MMSE 
score did not differ between AD and bvFTD.
3.2 Grey matter (GM) volume (%ICV)
Total GM volume (%ICV) was significantly lower in bvFTD (0.30%ICV, standard 
deviation (SD) 0.04) compared with both AD (0.33%ICV, SD 0.03) and controls 
(0.36%ICV, SD 0.03) at T0 (F(2,38) = 13.837, p<0.001), but not different between 
AD and controls. At T1, total GM volume (%ICV) was different between AD and 
bvFTD (t(15) = -2.266, p<0.039), and was significantly lower in bvFTD (0.27%ICV, 
SD 0.05) than in AD (0.32%ICV, SD 0.04).
3.3 White matter (WM) microstructure
3.3.1 Baseline (T0)
AD in comparison with controls (Table 3) showed higher MD only in the right hip-
pocampal cingulum.
BvFTD in comparison with controls (Table 3) showed lower FA and higher 
MD, RD and AxD in the bilateral  hippocampal cingulum, inferior fronto-occipi-
tal fasciculus, uncinate fasciculus, and forceps minor. Higher MD, RD and AxD in 
bvFTD compared with controls were additionally observed in the bilateral an-
terior thalamic radiation and superior longitudinal fasciculus. Further, lower FA 
and higher MD and RD in bvFTD compared with controls were observed in the 
bilateral cingulate cingulum. 
BvFTD in comparison with AD (Table 3) showed lower FA and higher MD, RD 
and AxD in the bilateral inferior fronto-occipital fasciculus and uncinate fascicu-
lus, and forceps minor. Higher MD, RD and AxD in bvFTD compared with AD was 
additionally observed in the bilateral anterior thalamic radiation, superior longi-
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tudinal fasciculus, and right hippocampal cingulum. Lower FA in bvFTD compared 
with AD was additionally observed in the left hippocampal cingulum. Further, 
bvFTD in comparison with AD showed higher MD and RD in the bilateral cingulate 
cingulum, and higher AxD in the right cingulate cingulum.
3.3.2 Follow-up (T1)
BvFTD in comparison with AD (Table 4) showed lower FA and higher MD and RD 
in the right cingulate cingulum and left inferior fronto-occipital fasciculus. Addi-
tionally, higher MD in bvFTD compared with AD was observed in the left cingulate 
cingulum and lower FA in the left uncinate fasciculus, and forceps minor. No dif-
ferences were observed in AxD.
3.3.3 Rate of change 
The rate of change (Table 5) of FA in the cingulum was different between bvFTD 
and AD. Specifically, the rate of change of FA in the right cingulate cingulum was 
higher in bvFTD compared with a lower change in AD, whereas the rate of change 
of FA in the left hippocampal cingulate was lower in bvFTD compared with a higher 
change in AD. Additionally, the rate of change of AxD in the right inferior fronto-
occipital fasciculus was also different between bvFTD and AD, namely it was lower 
in bvFTD compared with higher in AD.
3.4 Functional connectivity
DMN functional connectivity was not significant for each group at T0 (Figure 1) 
and at T1 (Figure 2). Between-group differences in functional connectivity of the 
DMN at T0 (Figure 1) or at T1 (Figure 2) were also not significant.
As groups did not differ in DMN functional connectivity at both T0 and T1, 
added value and/or sensitivity of the rate of change analysis was not expected and 
consequently it was not performed.
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Figure 1. Non-significant default mode network (DMN) connectivity (p>0.05; FWE
corrected
) at 
baseline (T0). DMN functional connectivity for behavioural variant frontotemporal dementia 
(bvFTD), Alzheimer’s disease (AD) and healthy controls is shown in row one. Between-group 
differences for DMN functional connectivity are shown in row two. Colours represent the t-values 
of between-region functional connectivity.
Figure 2. Non-significant default mode network (DMN) connectivity (p>0.05; FWE
corrected
) at follow-
up (T1). DMN functional connectivity for behavioural variant frontotemporal dementia (bvFTD) 
and Alzheimer’s disease (AD) is shown in column one and two respectively. Between-group 
comparison for DMN functional connectivity is shown in column three. Colours represent the 
t-values of between-region functional connectivity.
Quantitative differentiation of AD en bvFTD
38
4. DISCUSSIon
In this study we observed that quantitative tract-specific microstructural WM 
abnormalities, but not quantitative functional DMN connectivity, may aid dif-
ferential diagnosis  of bvFTD and AD. Tract-specific microstructural WM abnor-
malities were observed in several WM tracts in bvFTD, whereas they were only 
seen regionally in AD. At follow-up, differences in tract-specific microstructural 
WM abnormalities between bvFTD and AD became less pronounced , although 
they were still stronger in bvFTD. Despite the diminished differences, the rate of 
changes was very similar between bvFTD and AD.
Quantitative microstructural WM abnormalities were seen in bvFTD and AD in dif-
ferent WM tracts, suggesting a differential diagnostic role for assessing diffusion 
values in a clinical context. Tract-specific WM microstructural abnormalities were 
evident in bvFTD in all WM tracts investigated, but most pronounced in the forceps 
minor, hippocampal cingulum, cingulate cingulum, inferior fronto-occipital and un-
cinate fasciculus. These WM tracts have been associated with cognitive domains 
characteristically affected in bvFTD [42], namely the forceps minor with disinhibi-
tion  and executive functioning [29,43], the hippocampal cingulum with memory 
and executive functioning [44–46], the cingulate cingulum with cognitive control 
[47], the inferior fronto-occipital fasciculus with social cognition  and emotional 
functioning [48–51], and the uncinate fasciculus with apathy, disinhibition and 
behavioural dyscontrol [29,52–54]. Unsurprisingly, WM abnormalities were not 
observed in the forceps major, a posterior WM tract associated with visuospatial 
functioning, such as perceptual speed  and topographical orientation [55,56], a 
domain generally preserved in bvFTD [57,58].
Microstructural WM abnormalities in bvFTD were evident in comparison 
with both AD and healthy participants, but even more pronounced in compari-
son with the latter. This smaller difference between bvFTD and AD suggests that 
microstructural WM abnormalities, although to a much lesser extent, are also 
present in AD. The subtle microstructural WM abnormalities observed in the 
hippocampal cingulum only in AD compared to controls suggests an important 
implication of this WM structure in AD. The hippocampal cingulum has been as-
sociated with memory functioning [45,59], which is characteristically impaired in 
AD [60].
Thus, for the differentiation between early-stage AD and bvFTD, microstruc-
tural WM abnormalities of the hippocampal cingulum in absence of other WM 
tract changes is indicative of AD, whereas widespread, mostly anterior, WM mi-
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crostructure abnormalities (e.g. uncinate fasciculus, hippocampal and cingulate 
cingulum, forceps minor) is indicative of bvFTD.
At follow-up, microstructural WM abnormalities were also more pronounced in 
bvFTD than in AD, mainly in the left inferior fronto-occipital fasciculus and right 
cingulate cingulum, and also in the left uncinate fasciculus and the forceps minor. 
These specific WM tracts may be important for differentiating between bvFTD 
and AD in later stages, as microstructural WM abnormalities of other WM tracts 
were no longer different between bvFTD and AD upon follow-up. 
Cingulum involvement is in line with previous literature showing classifica-
tion of bvFTD and controls to be best achieved using FA in the cingulum bundle 
[61]. Why it is the right cingulum that seems to be differentially affected is not 
entirely clear. Functional differentiation between the left and right cingulate cin-
gulum has not been extensively investigated. One study has associated the right 
cingulate cingulum with visual working memory in bvFTD [27], but this finding 
should be interpreted with caution as previous research [62] has pointed out 
methodological issues concerning the task used to measure visual working mem-
ory, and consequently this task has been discarded by the manufacturer (http://
www.pearsonclinical.com/psychology/products/100000281/wechsler-memory-
scale--fourth-edition-wms-iv.html#tab-details). Another study has associated the 
right cingulate cingulum with cognitive control (e.g. problem solving, reasoning, 
behavioural flexibility) in MCI [47]. A possible explanation may be that cognitive 
control in bvFTD is more affected than in AD. 
The inferior fronto-occipital fasciculus has been associated with a variety 
of cognitive domains, such as visual spatial information processing [63], emo-
tion recognition [51], executive functioning [46,64], and psychiatric symptoms 
[65]. The left inferior fronto-occipital fasciculus has been specifically associated 
with language [66], processing speed and verbal/visual learning [67], and psy-
chosis [68]. Many of these cognitive domains have been associated with bvFTD 
[69–71]. Although to our knowledge a direct association between the inferior 
fronto-occipital fasciculus and cognitive/behavioural performance in bvFTD has 
not been previously reported, our finding suggests there may be a link between 
bvFTD symptomatology and the observed abnormalities in this WM tract. 
The uncinate fasciculus and forceps minor are both known to play an im-
portant role in bvFTD and are associated with characteristic bvFTD symptoms 
[29,43,52,54], such as disinhibition and executive dysfunctioning [3]. However, 
both the uncinate fasciculus and forceps minor have also been implicated in AD 
[45,72], which may explain why the differences in WM microstructure between 
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AD and bvFTD were not as pronounced (decreased FA only) as in the inferior 
fronto-occipital fasciculus. 
Taken together, differences in WM microstructure between bvFTD and AD 
seem to be diminished at one year follow-up. This may be explained by the fact 
that with advancing of the AD disease process, WM microstructure changes more 
rapidly. Some studies have shown longitudinal microstructural WM changes in AD 
[73–75], and in bvFTD [61], but to our knowledge none has compared the rate of 
change of longitudinal abnormalities between AD and bvFTD.  The rate of change in 
this study, in terms of the difference in diffusivity abnormalities between baseline 
and follow-up, showed a faster decline in WM microstructure of the right cingulate 
cingulum in bvFTD, and the left hippocampal cingulum and right inferior fronto-oc-
cipital fasciculus in AD. First, in line with changes at follow-up observed in this study 
and previous literature [61], these rates of changes may suggest a differential in-
volvement of the cingulum, in which the anterior part is more affected in bvFTD and 
the posterior part in AD. This is supported by the macrostructural frontotemporal 
(anterior) and temporoparietal (posterior) involvement in respectively bvFTD and 
AD [76,77]. Second, the left inferior fronto-occipital fasciculus showed more pro-
nounced changes in bvFTD at follow-up, and the right inferior fronto-occipital fas-
ciculus showed a faster rate of change in AD, suggesting a differential hemispheric 
involvement for these two neurodegenerative disorders. However, whether the left 
and right inferior fronto-occipital fasciculus are associated with different, potentially 
disease-specific, symptomatology remains speculative. As described above, the in-
ferior fronto-occipital fasciculus has been associated with many different cognitive 
functions but has as yet not been specifically linked to AD or bvFTD. However, our 
results suggest that  such a link  between the left inferior fronto-occipital fasciculus 
and bvFTD, and the right inferior fronto-occipital fasciculus and AD, may be present.
MD and RD differences between bvFTD and AD were most pronounced and 
thus seem more sensitive for early-stage differentiation of AD and bvFTD than 
FA and AxD. This suggest that myelin abnormalities are more pronounced in the 
early stages of bvFTD, as RD is thought to represent myelin damage [78], AxD ax-
onal loss [79], and MD and FA a combination of these measures. At follow-up, AD 
and bvFTD could be best differentiated by FA, although differences in MD and RD 
were also evident. This again suggests that myelin changes are more pronounced 
in bvFTD than in AD, which is also supported by the absence of AxD differences at 
follow-up. Axonal abnormalities may develop to a similar extent in later stages of 
AD and bvFTD.  Overall, however, differences in FA, MD and RD were diminished 
at follow-up, suggesting that myelin changes may also develop in AD, similar to 
bvFTD. In conclusion - in line with previous literature [16,61] - it is recommended 
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to use FA, MD and RD to differentiate between AD and bvFTD, but not AxD as this 
is less different between groups.
Functional DMN connectivity between AD and bvFTD was not different in our 
quantitative approach. Previous literature comparing AD and bvFTD observed 
differences in regions of the DMN using whole-brain independent component 
analysis [18,80–82], such as increased parietal DMN connectivity in bvFTD and 
decreased parietal DMN connectivity in AD. However, in this study we aimed to 
assess a different approach that may be used clinically, i.e. a quantitative mea-
sure of functional connectivity between DMN regions. The small sample size of 
this study, and thus low power, may have left possible group effects undetected. 
However, clinical use warrants sensitivity of measures at an individual patient lev-
el, hence a low sensitivity of quantitative functional DMN connectivity does not 
seem suitable for individual diagnostics.
This study knows some limitations. First, the small sample size limits interpreta-
tion of results and may particularly lead to underestimation of between-group 
differences. However, the findings of this study are in line with the literature and 
may indicate clinical utility of DTI, but not rs-fMRI, on an individual patient level. 
Second, sample size was smaller at follow-up than at baseline due to patients 
who were too ill to return for follow-up. This may have induced an underapprecia-
tion of long-term abnormality severity and rate of change differences.
In conclusion, quantitative tract-specific microstructural WM abnormalities, but 
not quantitative functional connectivity of the DMN, may aid differential diagnosis 
of bvFTD and AD at early-stage and in the longer-term. Specifically, pronounced 
microstructural WM changes in anterior WM tracts, in particular the right cingu-
late cingulum and left inferior fronto-occipital fasciculus, may differentiate bvFTD 
from AD, and microstructural WM abnormalities of the hippocampal cingulum, in 
absence of other microstructural WM changes, may differentiate AD from bvFTD. 
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SUPPLeMent
Supplemental table 1. Tractography tract thresholds based on De Groot et al. (2015), but 
multiplied with a factor of eight due to the resolution difference.
White matter tract tractography threshold
Anterior thalamic radiation (ATR) 0.016
Cingulum (cingulate gyrus) 0.08
Cingulum (parahippocampal region) 0.16
Forceps major (FMa) 0.04
Forceps minor (FMi) 0.08
Inferior fronto-occipital fasciculus (IFOF) 0.08
Inferior longitudinal fasciculus (ILF) 0.04
Superior longitudinal fasciculus (SLF) 0.008
Uncinate fasciculus (UF) 0.08
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abstract
This study investigates regional coherence between white matter (WM) micro-
structure and grey matter (GM) volume and perfusion measures in Alzheimer’s 
disease (AD) and behavioural variant frontotemporal dementia (bvFTD) using a 
correlational approach.
WM-GM coherence, compared with controls, was stronger between cingu-
lum WM and frontotemporal GM in AD, and temporoparietal GM in bvFTD. Addi-
tionally, in AD compared with controls, coherence was stronger between inferior 
fronto-occipital fasciculus WM microstructure and occipital GM perfusion.
In this first study assessing regional WM-GM coherence in AD and bvFTD 
we show that WM microstructure and GM volume and perfusion measures are 
coherent, particularly in regions implicated in AD and bvFTD pathology. This in-
dicates concurrent degeneration in disease-specific networks. Our methodology 
allows for the detection of incipient abnormalities that go undetected in conven-
tional between-group analyses.
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1. IntroDUCtIon
Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia 
(bvFTD) are two common types of presenile dementia (onset ≤ 65 years) [1]. 
These diseases are characterised by distinct abnormalities in grey matter (GM) 
and white matter (WM), as measured with magnetic resonance imaging (MRI) 
[2–6]. Although regional relationships between GM volume and perfusion have 
been widely studied in AD and bvFTD [7–14], it is still largely unclear whether and 
how WM and GM abnormalities are related. One hypothesis is that WM and GM 
abnormalities develop in a Wallerian-like degenerative manner, in which GM cell 
death leads to degeneration of WM tracts connecting affected GM regions. An-
other possible mechanism is that WM degeneration occurs independently from 
GM volume loss and/or hypoperfusion [15]. However, since both diseases are 
characterised by specific WM and GM abnormalities, it is conceivable that these 
abnormalities do not occur in isolation, but that they co-occur in the context of 
a common disease process. Regionally concurrent degeneration would then be 
reflected in regional coherence of abnormalities in WM and GM.
Thus far, relationships between abnormalities in WM microstructure and GM 
volume have been found to be inconsistent in AD [16–20], whereas in bvFTD WM 
microstructural abnormalities have been consistently found to exceed GM volume 
loss [21–24]. One study looked at the relationship between WM microstructure, GM 
volume, and GM perfusion in AD and bvFTD [25], and confirmed that WM micro-
structure is more severely affected in bvFTD than in AD. Additionally, they confirmed 
that GM volume loss and WM microstructural abnormalities in bvFTD exceed GM 
hypoperfusion, whereas in AD the degree of (micro)structural abnormalities and 
GM hypoperfusion is similar. However, this study did not assess the spatial rela-
tionships between WM microstructure and GM measures. This precludes the dem-
onstration of possible regional relationships between WM and GM abnormalities, 
which is of particular interest given their disease-specific regional distribution.  One 
study [26] investigated the regional relationship between WM and GM abnormali-
ties, but limited their investigation to temporoparietal WM-GM relationships in AD, 
hence leaving whole-brain regional coherence in both AD and bvFTD unexplored. 
In this study we aimed to establish whether there is coherence between regional 
abnormalities of WM microstructure and GM volume and perfusion in AD and in 
bvFTD. First, we assessed abnormalities of WM microstructure, GM volume and GM 
perfusion for each measure separately. Second, we correlated WM measures in af-
fected tracts with volume and perfusion in the GM regions at either end of the tract.
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2. MethoDS
2.1 Participants
Patients were recruited at the Alzheimer Centre Southwest Netherlands and in-
cluded in the analysis if they were clinically diagnosed with AD [27] or bvFTD [28], 
had an age of 45 to 70 years, and a Mini-Mental State Examination (MMSE [29]) 
score of ≥ 20. In our memory clinic it is common practice to screen for genetic 
mutations only in case of a positive family history for dementia. In the clinical 
sample of this study consisting of nine bvFTD patients, three patients were known 
to have a genetic mutation (two MAPT, one C9orf72).
Patient exclusion criteria were other causes of dementia, other neurological 
disorders, psychiatric diagnosis, contraindications for MRI, and expected loss to 
follow up within 1 year.
Healthy age and gender matched controls with an age between 45 and 70 
years, and without psychiatric or neurological history, were recruited from pa-
tient peers and through advertisement. 
Both patients and controls underwent a full neuropsychological assessment 
evaluating attention and concentration, executive functioning, memory, lan-
guage, social cognition, and constructive and visuospatial skills and MMSE. The 
MMSE was assessed in controls after the MRI scan by the researcher.
The study was approved by the local medical ethics committee, and all par-
ticipants gave written informed consent.
2.2 Image acquisition
Scanning was performed on a 3 tesla Discovery MR750 system (GE Healthcare, 
Milwaukee, WI, US). 
2.2.1 Diffusion imaging
DTI was acquired with 25 non-collinear directions using a spin echo echo planar 
imaging (EPI) sequence and with full coverage of the supratentorial brain (echo 
time (TE) set to minimum with range 81.9ms-90.8ms, repetition time (TR) 7.9ms, 
voxel size 1.9x1.9x2.5mm3 with a 240mm2 field of view (FOV), array spatial sensi-
tivity encoding technique (ASSET) acceleration factor 2, flip angle 90°, maximum 
b-value 1000 s/mm2, 3 non-diffusion-weighted volumes, 59 axial slices per vol-
ume, total acquisition time 3:50min).
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2.2.2 Structural imaging
A high-resolution three-dimensional (3D) inversion recovery fast spoiled gradient 
echo T1-weighted (T1w) image was acquired for GM volumetric assessment with 
TE 3.06ms, TR 7.90ms, inversion time 450ms, isotropic voxel size 1mm3 with a 
240mm2 FOV, ASSET acceleration factor 2, flip angle 12°, 176 sagittal slices, total 
acquisition time 4:41min.
2.2.3 Perfusion imaging
Perfusion images were acquired using whole brain 3D pseudo-continuous ASL (p-
CASL), which is currently the recommended sequence for clinical use [30] (inter-
leaved fast spin-echo stack-of-spiral readout of 512 sampling points on 8 spirals, 
TE 10.5ms, TR 4632ms, isotropic voxel size 3.3mm3 with a 240mm2 FOV, 36 axial 
slices, number of excitations (NEX) 3, total acquisition time 4:29min; with back-
ground suppression, post label delay 1525ms, labelling duration 1450ms). The 
labelling plane was positioned 9cm below the anterior commissure – posterior 
commissure line.
2.3 Demographical analysis
Using SPSS Statistics, version 20.0 (IBM, New York, USA), gender differences across 
groups were assessed using chi-square tests and age differences using one-way 
ANOVA, with Bonferroni correction for multiple comparisons. As MMSE was not 
normally distributed across groups (Shapiro-Wilk test p<0.05) a nonparametric 
Kruskal-Wallis test was used to assess differences between groups, with Dunn-
Bonferroni correction for multiple comparisons (p<0.05). 
2.4 DTI processing and analysis
Data were analysed using FMRIB Software Library (FSL5, Oxford, UK) [31–33]. 
Data were corrected for motion and eddy currents using Eddy Correct and then 
skull-stripped using BET [34]. Two analyses were performed. First, Tract-based 
spatial statistics (TBSS) was performed to identify affected WM tracts in AD and 
bvFTD. Second, Tractography was performed to obtain quantitative diffusion met-
rics per WM tract in order to correlate WM measures with GM measures.
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2.4.1 Tract-Based Spatial Statistics (TBSS)
First, diffusion tensors were reconstructed using DTIFIT [35], allowing computa-
tion of an FA image for each participant. Second, using whole brain TBSS [36], 
WM tracts showing fractional anisotropy (FA) abnormalities were identified.
Group differences in FA were tested with Randomise [37], using 5000 non-
parametric permutations, threshold-free cluster enhancement (TFCE) [38], and 
multiple comparison correction. Default settings for skeletonised data were ap-
plied.
Using the General Linear Model toolbox, a one-way ANOVA design with three 
groups (AD≠bvFTD≠controls) was defined. Six post-hoc t-contrasts (AD>controls, 
controls>AD, bvFTD>controls, controls>bvFTD, AD>bvFTD, bvFTD>AD) were con-
structed. 
In order to identify post-hoc t-test results within the boundaries of the f-test 
results, common binary masks were created using FSLmaths. First, for the f-test 
and all t-tests a binary mask was created (p=0.95). Second, each t-test binary 
mask was multiplied with the f-test binary mask, resulting in a common binary 
mask for every t-test. Last, cluster size (voxels (k)≥50) was extracted from all t-test 
common binary masks using the Cluster tool in FSL. 
Using FSLview, results were visualised with the implemented JHU White-
Matter Tractography Atlas and the JHU ICBM-DTI-81 White-Matter labels. WM 
tracts showing lower FA in AD and/or bvFTD in the current study and known to be 
associated with cognition were selected for tractography.
2.4.2 Tractography
From the selected WM tracts, median FA values were extracted. In addition, 
median values of mean diffusivity (MD) were extracted to obtain a more com-
prehensive view on how WM measures relate to GM measures. Both FA and 
mean diffusivity MD are considered as sensitive measures for diffusion changes 
and reflect different aspects of diffusion.  Automated probabilistic tractography 
(AutoPtx [39]) was used to apply a tensor fit with DTIFIT [35], followed by a FNIRT 
registration and a BEDPOSTX probabilistic model fit for each participant. Then 
PROBTRACKX [35,40] was run for all selected WM tracts (Table 1) in each pa-
tient and control individually using default space seed, target, stop and exclusion 
masks available in AutoPtx [39], resulting in a tract density image for each tract 
in each participant. To ensure a fair comparison of diffusivity measures between 
subjects with variable brain size and to account for the size of white matter tracts, 
tract density images were normalised through division by the number of fibres 
included in each tract-image. These were then binarised for WM tract segmenta-
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tion, based on the best-fit segmentation thresholds established by De Groot et al. 
(2015) [41] (see supplemental Table 1 for thresholds). 
Using FSLstats, whole-brain FA and MD images were masked with threshold-
ed tract images to obtain median FA and MD values for each WM tract. Significant 
effects of age and TE on FA and MD were identified using linear regression and 
corrected for if necessary.
2.5 Structural imaging and ASL processing and analysis
GM regions of interest (ROIs) were defined for every participant to obtain quan-
titative values of volume and perfusion to correlate these with WM measures. 
2.5.1 Tissue segmentation 
The unified tissue segmentation method [42] of SPM8 (Statistical Parametric 
Mapping, London, UK) was used to segment the T1w image into GM, WM and 
cerebrospinal fluid maps. Volume and cerebral blood flow (CBF) were derived 
from GM only. 
2.5.2 ASL post-processing
The ASL dataset consisted of a perfusion-weighted and a proton density image. 
The GM map of each participant was rigidly registered with the proton density 
image (Elastix registration software [43]). Subsequently, GM maps were trans-
formed to ASL image space to enable partial volume (PV) correction. The ASL 
images were corrected for PV effects using local linear regression within a 3D 
kernel based on tissue maps [44]. Then, CBF was quantified using the single-com-
partment model recommended in Alsop et al., 2015 [30]. CBF maps were trans-
formed to T1w image space to enable region labelling.
2.5.3 ROI labelling
A multi-atlas approach was used to define ROIs for each participant, as register-
ing multiple atlases to an individual T1w scan provides a much more robust reg-
istration than a single atlas approach [8,45]. The atlas included 30 labelled T1w 
images, each containing 83 ROIs [46,47]. These atlas images were registered to 
the participants’ T1w images using a rigid, affine, and non-rigid B-spline transfor-
mation model consecutively. For this registration, both the participants’ and the 
labelled T1w images were masked (Brain Extraction Tool [34]) and T1w images 
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were non-uniformity corrected [48]. ROI labels were fused using a majority vot-
ing algorithm [45]. Registration of all ROI labels was visually inspected for every 
participant.
2.5.4 Regional GM volume and CBF analysis
GM volume and CBF were analysed in the global supratentorial brain and in ROIs. 
The multi-atlas approach resulted in a parcellation of each participant’s T1w im-
age into 83 ROIs. The cerebellum, brainstem, pallidum, substantia nigra, ventricles 
and WM regions were excluded from analysis. Regions smaller than a single gyrus 
were combined to constitute an entire gyrus (Supplemental Table 2). To correct 
for head size, regional GM volumes were normalised using total intracranial vol-
ume (ICV). These are referred to as normalised GM (nGM) volumes and reported 
as percentage of ICV. To obtain a measure of CBF representative of perfusion in 
remaining grey matter, CBF was then divided by nGM volume, to correct for vol-
ume loss independent of interindividual volume differences. This is referred to as 
cCBF. Significant effects of age on nGM volume and cCBF were identified using 
linear regression and corrected for if necessary.
As nGM volumes and cCBF values were not normally distributed across 
groups (Shapiro-Wilk test p<0.05), a nonparametric Kruskal-Wallis test with Dunn-
Bonferroni correction for multiple comparisons was used to compare measures 
from the global supratentorial cortex and the ROIs between groups. 
2.6 WM and GM correlation analyses
Correlation analyses were performed between FA and MD in WM tracts affected 
in AD and/or bvFTD (Table 1) and volume and perfusion of regional GM.  To de-
termine the GM regions at either end of the tract (ROI1 and ROI2), tracts were 
visualised in FSLview using the JHU White-Matter Tractography Atlas overlaid on 
the MNI152 1mm3 template, and/or the default WM masks available in AutoPtx 
[39]. For WM tracts that projected to multiple cortical regions, GM measures 
(nGM volume, cCBF) were averaged over all cortical regions included in ROI1 or 
ROI2. This resulted in six variables per tract: FA, MD, nGM volume in ROI1 and 
ROI2, and cCBF in ROI1 and ROI2 (Figure 1). Correlations between WM measures 
(FA and MD) and GM measures (nGM and cCBF in ROI1 and ROI2) were assessed 
with Spearman analysis. Correlations exceeding the threshold of -0.6 ≥ rho ≥ 0.6 
are reported. 
59
2.2
Differences between these within-group correlations were subsequently tested 
for significance using a Fisher’s r to z transformation with Bonferroni correction. 
As sample sizes were small, uncorrected significant results are also reported.
WM-GM coherence was considered positive when correlations between 
FA and GM measures were positive, or when correlations between MD and GM 
measures were negative. WM-GM coherence was considered negative when cor-
relations between FA and GM measures were negative, or correlations between 
MD and GM measures were positive. 
3. reSULtS
3.1 Participant and disease characteristics 
Eleven AD patients, 9 bvFTD patients and 18 controls were included in the study. 
Gender (χ2 (2, n=37) = 2.508, p>0.05) and age (F(2,35) = .823, p>0.05) were not 
different between groups. MMSE differed across groups (H(2) = 19.938, p<0.05), 
with post-hoc analyses indicating that both patient groups had lower MMSE 
scores compared to controls, but not to each other (Table 2). One AD patient was 
excluded from the ASL analysis due to low image quality. 
3.2 Separate WM and GM abnormalities 
3.2.1 WM abnormalities
AD and bvFTD patients compared with controls showed lower FA (Figure 2, Sup-
plemental Tables 3-4) in WM of the anterior thalamic radiation, cingulum (cin-
Figure 1. Schematic overview of variables entered into correlation analysis. WM = white matter; 
FA = fractional anisotropy; MD = mean diffusivity; ROI = region of interest; nGM = grey matter; 
cCBF = cerebral blood flow. 
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gulate gyrus and hippocampus), forceps major and minor, 
inferior fronto-occipital fasciculus, inferior and superior lon-
gitudinal fasciculus, and uncinate fasciculus. 
In all these WM tracts (supplemental Table 5), FA was 
lower in bvFTD patients than in AD patients. AD patients did 
not show WM regions of lower FA compared with bvFTD pa-
tients. 
3.2.2 nGM volume loss
In AD patients compared with controls, nGM volume was low-
er in the bilateral parietal cortex, left temporal cortex, right 
occipital regions, right thalamus and left nucleus accumbens. 
In bvFTD patients compared with controls, global supratento-
rial nGM volume was lower as were volumes of the bilateral 
frontal, temporal and parietal cortices and bilateral basal gan-
glia. There was more extensive volume loss in the frontal lobe 
in bvFTD than AD patients (Supplemental Table 6, Figure 3).
3.2.3 GM hypoperfusion
AD patients compared with controls showed lower cCBF in 
the posterior temporal lobe bilaterally, left superior temporal 
gyrus, bilateral precuneus and left posterior cingulate, and in 
the lateral remainder of the right occipital lobe. In bvFTD pa-
tients, cCBF was not different from controls. AD patients com-
pared with bvFTD patients showed lower cCBF in the bilateral 
orbitofrontal gyri, right hippocampal formation, left superior 
and right inferior temporal gyrus, and right fusiform gyrus 
(Supplemental Table 7, Figure 3).
3.3 Correlations between WM 
and GM measures
Only WM tracts found to be affected in AD and/or bvFTD (Sup-
plemental Tables 3-5; Table 1), and associated with cognition, 
were selected for the correlation analysis: anterior thalamic 
radiation [49,50], cingulum [51], forceps major [49,52] and 
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minor [49,53,54](representing respectively the splenium and genu of the corpus 
callosum), inferior fronto-occipital fasciculus [55–57], inferior longitudinal fas-
ciculus [55,58], superior longitudinal fasciculus [58,59] and uncinate fasciculus 
[51,53,56].  
3.3.1 Within-group WM-GM correlations
Within-group correlations (rho ≥ 0.6) between WM and GM measures are shown 
in Supplemental Table 8. Both patient groups showed more correlations between 
WM and GM measures than controls. 
Controls BvFtD AD
n (male) 18 (8) 9 (4) 11 (8)
Mean age ± SD in 
years
59.8 ± 6.73 62.3 ± 5.68 62.3 ± 5.04
Median MMSe (range) 30 (27-30) 28 (24-30) 25 (22-28)
AD = Alzheimer’s disease; bvFTD = behavioural variant frontotemporal dementia; MMSE = Mini-
Mental State Examination; SD = standard deviation
table 2. Participant characteristics
Figure 2. Post-hoc t-test (p<0.05; k=50) white matter FA abnormalities. Lower FA in comparison 
with controls for bvFTD (top row) and AD (middle row) is shown in blue and lower FA in bvFTD in 
comparison with AD (bottom row) is shown in red. 
FA = fractional anisotropy; AD = Alzheimer’s disease; BvFTD = behavioural variant frontotemporal 
dementia; L = left hemisphere.
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3.3.2 Between-group differences in WM-GM correlations 
Group differences detected with Fisher Z testing are shown in Table 3 and visual-
ised in Figure 4. In AD patients compared with controls, strong positive correla-
tions were found between cingulum WM microstructure and frontal GM perfu-
sion and temporal GM volume, and between inferior fronto-occipital fasciculus 
WM microstructure and occipital GM volume and perfusion. 
In bvFTD patients compared with controls, strong positive correlations were 
found between cingulum WM microstructure and parietal GM perfusion and 
temporal GM volume.
In bvFTD compared with AD, a strong positive correlation was observed be-
tween cingulum WM microstructure and parietal GM perfusion (Figure 5). Not 
Figure 3. Overview of grey matter (GM) regions showing group differences between normalised 
GM volume (left) and corrected cerebral blood flow (right). Regions that showed differences 
between bvFTD and controls are depicted in green, regions showing differences between AD and 
controls are depicted in red, and regions showing differences between AD and bvFTD in yellow.
GM = grey matter; AD = Alzheimer’s disease; BvFTD = behavioural variant frontotemporal 
dementia; L = left hemisphere.
Figure 4. White matter (WM) tracts and grey matter (GM) regions that are correlated in AD and 
bvFTD. A: Cingulum microstructure (blue) correlated with frontal and temporal GM in AD (red) and 
temporal and parietal GM in bvFTD (green). B: Inferior fronto-occipital fasciculus microstructure 
(blue) correlated with occipital GM in AD (red).
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a stronger, but negative rather than positive correlation was observed between 
uncinate fasciculus WM microstructure and frontal GM perfusion.
Figure 5. Correlation between median FA of the right hippocampal cingulum and median cCBF in 
the right PCC and precuneus in controls, AD, and bvFTD patients. Correlations were significantly 
different between AD and bvFTD patients (solid line). Dashed lines indicate non-significant 
correlations.
FA = fractional anisotropy; cCBF = cerebral blood flow; PCC = posterior cingulate cortex; AD = 
Alzheimer’s disease; bvFTD = behavioural variant frontotemporal dementia.
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Positive WM-GM coherence in AD versus controls
WM tract GM region
WM-GM correlation coefficient
AD Control p-value
R_CGC FA R ACC/subcallosal cCBF 0.648 -0.077 0.05
L CGH MD L HF/ATL nGM volume -0.645 0.216 0.02
R IFOF FA R occipital cCBF 0.636 -0.104 0.05
L IFOF MD L occipital cCBF -0.748 0.023 0.02
R IFOF MD R occipital nGM volume -0.137 -0.765 0.04
Positive WM-GM coherence in bvFtD versus controls
WM tract GM region
WM-GM correlation coefficient
BvFTD Control p-value
R CGC MD R precuneus/PCC cCBF -0.867 -0.178 0.02
R CGH FA R precuneus/PCC cCBF 0.933 -0.003 <0.01
R CGH MD R precuneus/PCC cCBF -0.650 0.323 0.02
R CGH MD R HF/ATL nGM volume -0.767 -0.001 0.04
Positive WM-GM coherence in bvFtD versus AD
WM tract GM region
WM-GM correlation coefficient
BvFTD AD p-value
R CGH FA R precuneus/PCC cCBF 0.933 -0.382 <0.01
negative WM-GM coherence in bvFtD versus AD
WM tract GM region
WM-GM correlation coefficient
BvFTD AD p-value
L UF MD L OFG/IFG cCBF 0.533 -0.624 0.01
table 3. Between-group differences in regional correlation coefficients for WM tracts and 
associated GM regions and their respective p-values. Correlations that were significantly different 
between groups after correcting for multiple comparisons are printed in bold.
WM-GM coherence was considered positive when correlations between FA and GM measures 
were positive, or when correlations between MD and GM measures were negative. WM-GM 
coherence was considered negative when correlations between FA and GM measures were 
negative, or correlations between MD and GM measures were positive.
CGC = cingulum (cingulate gyrus); CGH = cingulum (hippocampal); IFOF = inferior fronto-occipital 
fasciculus; UF = uncinate fasciculus; OFG = orbitofrontal gyrus; ACC/PCC = anterior/posterior 
cingulate cortex; HF = hippocampal formation; ATL = anterior temporal lobe; L = left; R = right; 
cCBF = corrected cerebral blood flow; nGM = normalised grey matter; WM = white matter; FA 
= fractional anisotropy; MD = mean diffusivity; AD = Alzheimer’s disease; bvFTD = behavioural 
variant frontotemporal dementia.
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4. DISCUSSIon
In this study we observed a disease-specific dissociation between structural and 
perfusion abnormalities, specifically more widespread microstructural WM abnor-
malities and GM atrophy in bvFTD patients, and more widespread hypoperfusion in 
AD patients. More importantly, we observed coherence between WM microstruc-
ture and GM volume and perfusion in both AD and bvFTD, and this coherence was 
strongly increased compared to controls in regions implicated in AD and bvFTD. We 
hypothesise that this is due to concurrent degeneration in disease specific networks.
Our findings of WM and GM abnormalities assessed separately are in line 
with the published literature. Compared to controls, bvFTD showed more exten-
sive structural abnormalities in both WM and GM than AD. In bvFTD, WM abnor-
malities were observed throughout the entire brain, and GM atrophy in the fron-
tal, temporal, parietal and subcortical regions [5,6,22]. In AD, WM abnormalities 
were less extensive and found in frontal, parietal and occipital regions, and GM 
atrophy in temporal, parietal, occipital and subcortical regions [2,5,6]. Only AD 
showed prominent temporal, parietal and occipital hypoperfusion [7,12,60–62], 
while there was no significant hypoperfusion in bvFTD.
In this study, we took these – known – findings a step further by assessing the 
coherence between regional WM and GM measures. In the healthy elderly, only 
a small number of regions showed positive coherence between WM microstruc-
ture and GM volume. Coherence between WM microstructure and GM perfusion 
was even less pronounced. Conversely, patients showed strong coherence of WM 
and GM changes in many disease-specific regions, which may thus reflect concur-
rent degeneration of WM and GM. The strong positive coherence between WM 
and GM measures in patients was particularly prominent between cingulum WM 
microstructure and associated temporal GM volume and frontal GM perfusion 
in AD, and between cingulum WM microstructure and temporal GM volume and 
parietal GM perfusion in bvFTD. 
The cingulum WM is central to the Papez circuit [63], which comprises re-
gions implicated in AD such as the entorhinal cortex, fornix and hippocampal for-
mation. The positive coherence between cingulum WM microstructure and GM 
volume of the hippocampal formation and anterior temporal lobe can thus be 
explained by concurrent anterior medial temporal atrophy and cingulum degen-
eration. Additionally, we observed coherence between the cingulum WM and its 
associated anterior GM regions, which we hypothesise to be related to the pos-
terior to anterior propagation of AD pathology [64]. This propagation is widely 
believed to result from Wallerian degeneration in which WM pathology is pre-
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sumably secondary to GM pathology. However, there also is increasing evidence 
that WM pathology is primary to GM pathology in AD [65]. Our cross-sectional 
correlational study design does not allow for claims on changes over time, but 
rather shows evidence of concurrent changes in WM and GM. Instead of AD be-
ing primarily a WM or GM disease, we speculate that WM microstructural abnor-
malities and GM abnormalities are dependent in pathophysiology, as changes of 
the cingulum WM microstructure and associated GM regions seem to co-occur. 
In support of this, individual WM and GM measures in this study showed a similar 
degree of WM and GM structural abnormalities in AD.    
In bvFTD, positive coherence between cingulum WM microstructure and pa-
rietal GM perfusion was not only evident in comparison with controls, but also 
with AD patients, in whom this regional coherence was absent. On a group level, 
cingulum WM microstructure in bvFTD was abnormal but parietal perfusion was 
not. Nevertheless, the strong positive coherence indicates that as cingulum WM 
deteriorates, perfusion decreases too, implying incipient parietal perfusion ab-
normalities, as previously reported in bvFTD [62]. Additionally, higher coherence 
was observed exclusively in the right hemisphere, consistent with the notion of 
greater right than left hemispheric involvement in bvFTD [66–68]. 
Of note is that recently different abnormality patterns in bvFTD have been as-
sociated with underlying genetic mutations and/or pathology [22,69–71]. The 
presence of patients with different genetic mutations/pathology may therefore 
have a differential effect on brain abnormalities across groups. This may also have 
happened in our study. Importantly, we aimed to investigate coherence in clinical 
samples of AD and bvFTD patients, i.e. with an AD or bvFTD phenotype.  The cor-
relations found here indicate similar brain abnormalities within the bvFTD group 
that are, given the strength of the correlations, likely to be common to these 
patients of the bvFTD phenotype.
It may seem counterintuitive that bvFTD showed high coherence in poste-
rior regions and AD in anterior regions, when relating it to propagation of pathol-
ogy from anterior to posterior in bvFTD [72], and from posterior to anterior in 
AD [64]. Higher coherence may be expected in more severely affected anterior 
regions in bvFTD and posterior regions in AD. Instead, this study shows coherence 
between WM and GM measures in the less rather than the more severely affected 
regions. We postulate that when abnormalities are incipient, WM and GM changes 
are concurrent, whereas this coherence may be lost in a more advanced disease 
stage. This is supported by a recent study reporting correlations between parietal 
hypoperfusion and cingulate WM in mild cognitive impairment converters, but not 
Concurrent WM-GM degeneration in AD and bvFTD
68
in mild AD patients [26]. Additionally, this postulation is in line with previous find-
ings of changes of functional connectivity in the default mode network (DMN). The 
DMN consists of a frontal and parietal component, connected through the cingu-
lum. Parallel with our findings, in bvFTD functional connectivity is generally found 
to be higher in the parietal than in the frontal DMN, whereas in AD functional 
connectivity is found to be lower in the parietal than in the frontal DMN [73]. The 
coherence we found between uncinate fasciculus WM and frontal GM perfusion in 
AD can be similarly interpreted in the context of the salience network (SN), which 
has previously shown increased frontal functional connectivity in AD [73].
Additionally, in AD coherence was observed between inferior fronto-occipital 
fasciculus WM microstructure and occipital GM perfusion, but not occipital GM 
volume. GM abnormalities of the occipital lobe are not consistently implicated in 
AD pathology [12,61,74] and indeed when we assessed GM measures separately, 
we found dissimilar perfusion and GM volume abnormalities.
Surprisingly, in bvFTD we observed negative coherence between uncinate 
fasciculus WM microstructure and frontal GM perfusion, suggesting diverging 
WM and GM changes. This may seem remarkable as both uncinate fasciculus WM 
abnormalities and frontal hypoperfusion have been reported in bvFTD [22,75]. 
In our study we corrected perfusion for GM volume and showed that perfusion 
was slightly increased in the frontal GM in bvFTD, albeit non-significantly. Slightly 
increased perfusion may suggest functional compensation for structural damage 
in the frontal lobe. It was only seen in the frontal lobe, which is indeed the most 
severely affected brain region structurally in bvFTD. As we found rather exten-
sive frontal WM and GM volume abnormalities, we speculate that the slightly 
increased perfusion may be the final stage of a compensatory process, prior to 
the occurrence of hypoperfusion. However, this speculative hypothesis should be 
verified by longitudinal studies.
Overall, our findings demonstrate that the concurrent changes in WM and GM 
adhere to the disease-specific distribution of abnormalities, generally propagating 
from posterior to anterior regions in AD and from anterior to posterior regions in 
bvFTD. It is of interest that the correlational methodology appears to be sensitive 
to incipient abnormalities that are not (yet) evident as differences between groups. 
This study knows some limitations. First, our patient group sizes were small, 
which warrants caution with the interpretation of the contradictory findings we 
observed. Nevertheless, to correct for the sensitivity of small samples to outli-
ers, we used non-parametric testing which is generally more stringent and thus 
reduces the risk of false positive results but carries the risk of false negative re-
sults. A potentially larger problem is the difference in sample size of the patient 
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groups compared with controls. In a large sample, the threshold for significance 
of correlations is lower, i.e. relatively low correlation coefficients were significant 
in our control sample but not in patients. This may have skewed a fair comparison 
between the groups. We accounted for this by reporting all correlations above 
the threshold of rho ≥ 0.6. Second, we attribute our findings to the early disease 
stage of our sample. Measures of disease stage, such as the clinical dementia 
rating (CDR) scale or frontal rating scale (FRS) were not available for our sample. 
Instead, MMSE scores were available, which may also be used as a proxy of dis-
ease stage. The fact that mean MMSE scores were very high, supports the notion 
that our patients are at an early stage of dementia. Third, a single FA and MD 
value was used for each WM tract. In long association fibres this may not be fully 
representative as it may obscure regional differences within the WM tract. An op-
tion would have been to parcellate these tracts into smaller sections. However, as 
we aimed to study coherence as defined by WM anatomy and its associated GM 
projections, we chose to look at anatomical connections as a whole rather than 
at subregions. Similarly, regional heterogeneity may have affected the large GM 
ROIs. For instance, GM within the occipital lobe was not similarly affected, with 
the right medial part showing GM volume loss whereas the right lateral part and 
left occipital ROI did not. Restricting such heterogeneity within an ROI may re-
sult in more consistent coherence patterns with associated WM microstructure. 
Fourth, for acquiring DTI scans we used a number of 25 gradient directions, which 
is relatively low in comparison with the suggested use of approximately 30 gradi-
ent directions [76]. A lower number of gradient directions may bias anisotropy 
estimation and may therefore influence group differences. As this study was a 
clinical study, scan time could not be prolonged due to patient care and associ-
ated imaging time restrictions. Nevertheless, our group results were in line with 
previous literature, suggesting fairly limited anisotropy bias.
In conclusion, we observed a disease-specific dissociation between structur-
al degeneration and hypoperfusion. More importantly, we established a frame-
work for assessing coherence between WM microstructure and GM volume and 
perfusion in AD and bvFTD. Within this framework we showed how that such co-
herence is mostly absent in healthy elderly controls, but present both in AD and 
bvFTD. Coherence is particularly strong in regions implicated in AD and bvFTD pa-
thology, indicating concurrent degeneration in disease-specific networks. Moreo-
ver, the correlational methodology applied in this framework allows for the de-
tection of incipient abnormalities that would go undetected in comparative group 
analyses. Our future research is aimed at further defining these relationships at 
different stages of aging and neurodegeneration. 
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SUPPLeMent
Supplemental table 1. White matter tracts affected in Alzheimer’s disease (AD) and/or 
behavioural variant frontotemporal dementia (bvFTD) based on the tract-based spatial statistics 
(TBSS) (p<0.05) analysis of fractional anisotropy (FA). Tractography tract thresholds based on De 
Groot et al. (2015), multiplied with a factor of eight to correct for the difference in resolution.
White matter tract tractography threshold
Anterior thalamic radiation (ATR) 0.016
Cingulum (cingulate gyrus) 0.08
Cingulum (parahippocampal region) 0.16
Forceps major (FMa) 0.04
Forceps minor (FMi) 0.08
Inferior fronto-occipital fasciculus (IFOF) 0.08
Inferior longitudinal fasciculus (ILF) 0.04
Superior longitudinal fasciculus (SLF) 0.008
Uncinate fasciculus (UF) 0.08
77
2.2
Supplemental table 2. Grey matter regions of interest (ROIs) and their abbreviations.
Regions of interest (ROIs) assessed for grey matter volume and cerebral flood flow. Parcellated gyri 
(according to (Gousias et al., 2008; Hammers et al., 2003), right column) were combined (middle 
column) for analysis.
Lobe Gyrus Abbr. Consisting of:
Frontal
Superior frontal gyrus
SFG Central superior frontal gyrus
Anterior superior frontal gyrus
Middle frontal gyrus MFG
Inferior frontal gyrus IFG
Straight gyrus
Orbitofrontal gyrus
OFG Anterior orbital gyrus
Medial orbital gyrus
Lateral orbital gyrus
Posterior orbital gyrus
Subcallosal area
Anterior cingulate cortex ACC
Insula
Precentral gyrus
Temporal
Anterior temporal lobe
ATL Medial anterior temporal lobe
Lateral anterior temporal lobe
Posterior temporal lobe PTL
Amygdala
Hippocampal formation
HF Hippocampus
Parahippocampal gyrus
Superior temporal gyrus STG
Inferior temporal gyrus ITG
Fusiform gyrus
Parietal
Postcentral gyrus
Posterior cingulate cortex PCC
Precuneus
Remainder of parietal lobe
Occipital
Lingual gyrus
Cuneus
Lateral remainder of occipital lobe
Subcortical
Thalamus
Putamen
Caudate
Nucleus accumbens
Concurrent WM-GM degeneration in AD and bvFTD
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Supplemental table 3. Post-hoc two sample t-test for FA investigating AD < controls (n=29; 
p
corrected
<0.05; k=50). k= voxel; L = left; R = right. 
Cluster size (k) White matter tracts within cluster
8687 L, R anterior thalamic radiation 
L, R body of the corpus callosum 
L, R cingulum 
L corticospinal tract
L forceps major
L, R forceps minor
L, R genu of the corpus callosum
L, R inferior fronto-occipital fasciculus
L inferior longitudinal fasciculus
L posterior corona radiata
L splenium of the corpus callosum 
L, R superior corona radiata
L, R superior longitudinal fasciculus
L, R uncinate fasciculus
1691 R cingulum
R  corticospinal tract
R forceps major
R inferior fronto-occipital fasciculus
R inferior longitudinal fasciculus   
R posterior corona radiata
R splenium of the corpus callosum
R superior longitudinal fasciculus
1469 R cingulum
R forceps major
R inferior fronto-occipital fasciculus
R inferior longitudinal fasciculus
1313 L anterior thalamic radiation
L cingulum
L forceps major
L  inferior fronto-occipital fasciculus
L inferior longitudinal fasciculus
L splenium of the corpus callosum
L superior longitudinal fasciculus
92 L forceps major
L splenium of the corpus callosum
51 R superior longitudinal fasciculus
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Supplemental table 4. Post-hoc two sample t-test for FA investigating bvFTD < controls (n=20; 
p
corrected
<0.05; k=50). k = voxel; L = left; R = right. 
Cluster size (k) White matter tracts within cluster
55201 L, R anterior corona radiata
L, R anterior thalamic radiation
L, R body of the corpus callosum
L, R cingulum
L, R corticospinal tract
L, R Genu of the corpus callosum
L, R forceps major
L, R forceps minor
L, R inferior fronto-occipital fasciculus
L, R inferior longitudinal fasciculus
L, R splenium of the corpus callosum
L, R superior corona radiata
L, R superior longitudinal fasciculus
691 R anterior thalamic radiation
R inferior fronto-occipital fasciculus
204 R anterior corona radiata
161 L superior longitudinal fasciculus
105 L forceps major
L inferior fronto-occipital fasciculus
L inferior longitudinal fasciculus
93 L forceps major
L inferior fronto-occipital fasciculus
L inferior longitudinal fasciculus
59 R inferior fronto-occipital fasciculus
R inferior longitudinal fasciculus
55 R  corticospinal tract
52 L forceps major
L inferior fronto-occipital fasciculus
L inferior longitudinal fasciculus
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Supplemental table 5. Post-hoc two sample t-test for FA investigating bvFTD < AD (n=27; 
p
corrected
<0.05; k=50). k = voxel; L = left; R = right.
Cluster size (k) White matter tracts within cluster
36853 L, R anterior corona radiata
L, R anterior thalamic radiation
L, R body of the corpus callosum
L, R cingulum
L, R corticospinal tract
L, R Genu of the corpus callosum
R forceps major
L, R forceps minor
L, R inferior fronto-occipital fasciculus
L, R inferior longitudinal fasciculus
R splenium of the corpus callosum
R superior corona radiata
L, R superior longitudinal fasciculus
L, R Uncinate fasciculus
1488 L cingulum
L forceps major
L posterior corona radiata
L splenium of the corpus callosum
854 R cingulum
R splenium of the corpus callosum
683 L superior longitudinal fasciculus
280 R corticospinal tract
146 L inferior longitudinal fasciculus
136 L posterior thalamic radiation
L inferior longitudinal fasciculus
121 R anterior thalamic radiation
117 R cingulum
R forceps major
102 L superior longitudinal fasciculus
100 L corticospinal tract
95 R cingulum
95 R superior longitudinal fasciculus
85 L superior longitudinal fasciculus
61 L superior longitudinal fasciculus
53 L superior longitudinal fasciculus
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Supplemental table 8. Within-group correlations between WM microstructure and nGM volume 
or cCBF exceeding rho≥0.6 for either AD, bvFTD or controls. Significant correlations are printed in 
bold.
WM tract GM region
WM-GM correlation coefficient
Controls BvFtD AD
R ATR FA R HF nGM volume 0.150 0.142 0.694
R ATR MD R HF nGM volume 0.127 -0.335 -0.607
R CGc FA R ACC/subcallosal area cCBF -0.077 0.283 0.648
R CGc FA R precuneus/PCC cCBF 0.257 0.750 0.527
L CGc MD L ACC/subcallosal area nGM volume -0.006 -0.683 0.009
R CGc MD R precuneus/PCC cCBF -0.178 -0.867 -0.648
R CGh FA R precuneus/PCC cCBF -0.003 0.933 -0.382
L CGh MD L HF/ATL nGM volume 0.216 -0.517 -0.645
R CGh MD R HF/ATL nGM volume -0.001 -0.767 -0.445
L CGh MD L precuneus/PCC cCBF -0.394 -0.050 -0.600
R CGh MD R precuneus/PCC cCBF 0.323 -0.650 -0.091
R FMa FA R occipital cCBF 0.100 -0.617 -0.164
R IFOF FA R occipital cCBF -0.104 0.400 0.636
L IFOF MD L occipital cCBF 0.023 -0.350 -0.748
R IFOF MD R occipital cCBF -0.020 -0.600 -0.438
R IFOF MD R occipital nGM volume -0.765 -0.200 -0.137
L IFOF MD L OFG/IFG nGM volume -0.200 -0.717 -0.273
R IFOF MD R OFG/IFG nGM volume -0.546 -0.517 -0.761
R ILF MD R occipital nGM volume -0.765 -0.617 -0.318
R ILF MD R ITG/STG/ATL nGM volume -0.577 -0.767 -0.827
R SLF MD R ITG/PTL nGM volume -0.182 -0.683 -0.182
L SLF MD L precentral/IFG nGM volume -1.000 -1.000 -1.000
R SLF MD R precentral/IFG nGM volume -0.452 -0.700 -0.582
L UF MD L IFG/OFG cCBF 0.026 0.533 -0.624
L UF MD L IFG/OFG nGM volume -0.189 -0.733 -0.027
L UF MD L STG/ATL nGM volume -0.219 -0.750 -0.227
WM = white matter; nGM = normalised grey matter, cCBF = corrected cerebral blood flow; 
bvFTD = behavioural variant frontotemporal dementia; AD = Alzheimer’s disease; FA = fractional 
anisotropy; L = left; R = right; MD = mean diffusivity; ATR = anterior thalamic radiation;  CGc = 
cingulum (cingulate gyrus); CGh = cingulum (hippocampus); FMa = forceps major; IFOF = inferior 
fronto-occipital fasciculus; ILF = inferior longitudinal fasciculus; SLF = superior longitudinal 
fasciculus; UF = uncinate fasciculus; HF = hippocampal formation; = OFG = orbitofrontal gyrus; 
IFG = inferior frontal gyrus; ACC = anterior cingulate cortex; PCC = posterior cingulate cortex; ATL 
= anterior temporal lobe; ITG = inferior temporal gyrus; STG = superior temporal gyrus; PTL = 
posterior temporal lobe.
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abstract
White matter (WM) microstructure has been associated with abnormal and 
normal cognitive functioning. In behavioural variant frontotemporal dementia 
(bvFTD) and Alzheimer’s disease (AD) abnormalities of WM microstructure are 
observed. It can be postulated that specific symptomatology in bvFTD and AD 
is related to specific abnormalities of WM microstructure. This is of interest in 
early-stage bvFTD and AD, when symptoms may still be mild or unspecific, and 
microstructural WM abnormalities are already present. We investigated associa-
tions between cognition and WM microstructure in early-stage AD and bvFTD, to 
assess whether different WM tracts play a role in early-stage symptomatology of 
AD and bvFTD.
Eleven AD and 12 bvFTD early-stage patients, and 18 controls underwent 
diffusion tensor imaging at 3T. WM tract diffusivity measures and cognitive scores 
were established, and compared between groups. Correlations between diffu-
sion and cognition were calculated for both AD and bvFTD. 
We observed that attention and executive deficits were associated with WM 
microstructure abnormalities of several WM tracts in bvFTD, and to a lesser ex-
tent in AD. Language deficits were associated with WM microstructure abnormal-
ity in AD, and to a lesser extent normal language functioning was associated with 
WM microstructure in bvFTD. Additionally, normal memory functioning in bvFTD, 
as well as normal visuoconstructive functioning in AD was associated with WM 
microstructure abnormality. Evident memory deficits were not associated with 
any WM tract abnormalities in AD. 
In conclusion, there is an association between cognitive functioning and WM 
microstructure of specific WM tracts in early-stage AD and bvFTD patients. This 
suggests that specific WM tracts play an important role in cognitive functioning, 
and are not universally involved in all affected cognitive domains in early-stage 
AD and bvFTD.
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3.1
1. IntroDUCtIon
Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer’s disease 
(AD) are two common diseases underlying presenile dementia (age<65 years). 
BvFTD is mainly characterised by behavioural symptoms: disinhibition, apathy, 
loss of sympathy or empathy, stereotypical behaviour and hyperorality [1]. Ad-
ditionally, these patients present with cognitive abnormalities in executive func-
tioning [1], and, although not a core characteristic, they may also present with 
memory deficits [2,3]. AD is mainly characterised by cognitive abnormalities, par-
ticularly in the domain of learning and retrieving new information. Other cogni-
tive difficulties in AD include impaired reasoning and handling of complex tasks, 
visuospatial deficits and impaired language functioning. Additionally, some AD 
patients may present with behavioural changes such as mood fluctuations, social 
withdrawal and impaired motivation [4].
Brain abnormalities are thought to underlie the specific bvFTD and AD 
symptomatology, such as frontotemporal grey matter (GM) atrophy in bvFTD and 
temporoparietal GM atrophy in AD [1,4,5]. White matter (WM) microstructure 
changes are also observed in both bvFTD and AD, in frontal, temporal and parietal 
WM tracts [6–9] and have been associated with symptomatology in dementia 
[6,10]. WM microstructure is also associated with normal cognitive functioning 
(e.g. executive functioning, language, memory and visuoconstructive function-
ing) [11]. The superior longitudinal fasciculus for instance is well-known for its 
role in language functioning [12], and the uncinate fasciculus for its role in behav-
ioural functioning [10,13–15].
Given the functional association of white matter tracts with major cognitive 
domains it can be postulated that the specific symptomatology in AD and bvFTD 
is related to specific abnormalities of WM microstructure. This is of particular 
interest for the early stages of bvFTD and AD, when symptoms may still be mild 
or unspecific [16], and microstructural WM abnormalities are already present. 
As such, WM microstructure changes may aid diagnosis of early-stage AD and 
bvFTD. In this study we investigated the functional associations between early-
stage cognition and WM microstructure in both bvFTD and AD, to assess whether 
different WM tracts play a role in early-stage symptomatology of AD and bvFTD.
Microstructural WM and cognition in bvFTD and AD
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2. MethoDS
2.1 Participants
Patients were recruited in the Alzheimer Centre Southwest Netherlands. Inclu-
sion criteria were an age between 40 and 70 years, suspected diagnosis of early 
AD [4] or bvFTD [1], and a Mini-Mental State Examination [17] (MMSE) score of ≥ 
20. Exclusion criteria were contraindications for MRI, an expected loss to follow-
up within one year; other neurological disorders, a different cause of dementia, 
alternative psychiatric diagnosis, and past or current substance abuse. Patients 
were followed for at least one year after initial diagnosis to determine diagnosis 
certainty of AD or bvFTD. Patients underwent the MMSE as part of their routine 
clinical diagnostic work-up.
Healthy controls, matched for age and gender, and without neurological or 
psychiatric history, were recruited through advertisement. Controls underwent 
neuropsychological testing and the MMSE as part of this study.
The study was approved by the local medical ethics committee. All partici-
pants gave written informed consent.
2.2 Image acquisition
An MRI protocol including structural scans was performed on a 3T GE Discovery 
MR750 system (GE Healthcare, Milwaukee, WI, US). DTI scans with full coverage 
of the supratentorial brain were acquired using a spin echo echo planar imaging 
sequence. Acquisition parameters consisted of: 28 total volumes with 59 axial 
slices each, 3 non-diffusion weighted volumes, 25 diffusion-weighted directions, 
scan duration 3.50 min, field of view 240mm, echo time (TE) set to minimum with 
mean 84.6ms (range: 81.9-90.8ms), repetition time 7930ms, array spatial sensi-
tivity encoding technique acceleration factor 2, flip angle 90°, acquisition matrix 
128x128mm, slice thickness 2.5mm, and maximum b-value 1000 s/mm2.
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2.3 Neuropsychological data acquisition
Patients underwent a neuropsychological examination performed by an experi-
enced neuropsychologist at the Alzheimer Centre Southwest Netherlands. Cogni-
tive domains assessed were language, memory, attention and executive function-
ing, and visuoconstructive functioning (Table 1).
2.4 Post-processing and statistical analysis
2.4.1 Demographical analysis
Between-group differences in age were tested using a one-way ANOVA. Between-
group differences in MMSE scores were tested using a Welch-ANOVA and post-hoc 
Games-Howell t-tests, due to unequal variance across groups. Gender was com-
pared across groups using chi-square tests. Analyses were done using IBM SPSS 
Statistics (version 21.0, New York, USA) with a significance threshold of p<0.05.
2.4.2 Microstructural white matter (WM) post-processing
Data were analysed using FMRIB Software Library (FSL5, Oxford, UK) [27–29]. 
Data were corrected for motion and eddy currents using Eddy Correct and then 
skull-stripped using BET [30]. 
table 1. Cognitive domains and their specific neuropsychological tests used to assess cognitive 
functioning in patients and controls.
Cognitive domain neuropsychological test
Language Boston Naming Test (60 items)[18]
Memory 15 Words Test[19]
Digit Span of the Wechsler Adult Intelligence Scale third 
edition (WAIS-III)[20]
Mini-Mental State Examination (MMSE) orientation ques-
tions[17]
Attention / executive functions Trail Making Test A and B (TMT)[21]
Stroop colour-word task[22]
Categorical and letter fluency test[23]
Modified Wisconsin Card Sorting test (WCST)[24]
Letter Digit Substitution Test (LDST)[25]
Visuoconstructive functioning Clock drawing[26]
Microstructural WM and cognition in bvFTD and AD
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Tracts known to be associated with cognitive functioning were selected for 
tractography: anterior thalamic radiation [31,32], cingulum [10], forceps major 
[31,33], forceps minor [15,31,34], inferior fronto-occipital fasciculus [35–37], in-
ferior longitudinal fasciculus [35,38], superior longitudinal fasciculus [38,39] and 
uncinate fasciculus [10,15,37]. The genu and splenium of the corpus callosum 
were represented by respectively the forceps minor and major.
Automated probabilistic tractography (AutoPtx) [40] was used to apply 
a tensor fit with DTIFIT [41], followed by a FNIRT registration and a BEDPOSTX 
probabilistic model fit for each participant. PROBTRACKX [41,42] was then run for 
all selected WM tracts using default space seed, target, stop and exclusion masks 
available in AutoPtx [40], resulting in a participant-specific tract density image. 
Tract density images were normalised by dividing them by the number of fibres 
included in the tract, and then binarised for WM tract segmentation, based on 
the best-fit segmentation thresholds established by De Groot et al. (2015) [71] 
(see supplemental Table 1 for thresholds). 
Tensor-fit images were masked with thresholded tract images using FSLstats, 
to acquire median fractional anisotropy (FA) and mean diffusivity (MD)for each 
tract. 
2.4.3 Neuropsychological post-processing
Neuropsychological test scores were corrected for age and education level us-
ing a generalised linear model and then transformed to z-scores based on the 
average of all groups together. Z-scores were averaged for the tests assessing 
memory, and attention and executive functioning to establish one score per cog-
nitive domain (a composite score) for each participant (SPSS21.0, New York, USA). 
2.4.4 Analysis of cognitive and microstructural WM abnormalities 
Effect of age on FA and MD was investigated using linear regression analysis and 
corrected for if necessary (SPSS21.0, New York, USA). To establish cognitive and 
microstructural WM abnormalities in patients, cognitive domain scores and WM 
microstructural values were compared between AD patients and controls, and 
bvFTD patients and controls. Due to unequal variance across groups, independent 
non-parametric Mann-Whitney U tests were used with a Bonferroni correction 
for multiple comparisons (SPSS21.0, New York, USA). Bonferroni threshold was 
established by dividing the significance level of p=0.05 by the number of com-
parisons being done: 4 for cognition and 32 for WM (p
WM
<0.002; p
cognition
<0.0125).
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2.4.5 Correlational analysis
FA and MD values uncorrected for age, and z-scores (based on the average of all 
groups together) uncorrected for age and education were used for correlational 
analysis. For each left and right WM tract, correlations between the two diffusion 
values (FA and MD) and z-scores for the four cognitive domains were calculated. 
Correlational analysis was performed using a non-parametric partial correlation 
analysis, correcting for age and education level (SPSS21.0, New York, USA). Cor-
relations - uncorrected for multiple comparisons due to low study power - with 
p<0.05 and r>0.7 were considered. 
3. reSULtS
3.1 Participant and disease characteristics 
Eleven AD patients, 12 bvFTD patients and 21 controls were included in the study. 
Three controls were excluded due to incidental structural imaging findings and 
one control due to missing neuropsychological data. Two bvFTD patients and 
one AD patient were excluded from the analyses due to missing cognitive data 
as their neuropsychological exams were performed elsewhere as part of their 
routine clinical work-up and could not be repeated for this study. Data from 10 
AD patients, 10 bvFTD patients and 17 controls were used for analysis (Table 2). 
Participants did not differ in age at (F(2,34) = .689, p>0.05) or gender at 
(χ2(2,34) = 1.409, p>0.05). MMSE score was different between AD and controls 
only (F(2,34) = 16.123, p<0.001).
table 2. Demographic characteristics.
Group n Mean age (SD) Mean MMSe (SD)
BvFTD 10 (6 male) 59.5(8.2) 27.4 (2.1)
AD 10 (7 male) 62.8 (5.0) 25.2 (2.0)
Controls 17 (8 male) 60.5 (6.2) 29.1 (1.0)
BvFTD = behavioural variant frontotemporal dementia, AD = Alzheimer’s disease, N = sample size.. 
SD = standard deviation. MMSE = Mini-Mental State Examination.
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3.2 Cognitive and microstructural WM abnormalities
In comparison with controls, attention and executive functioning was affected in 
bvFTD and AD, and language and memory in AD only (Table 3).
In bvFTD in comparison with controls (Table 4), decreased FA and increased 
MD was observed in all WM tracts bilaterally, except for the left anterior tha-
lamic radiation and the forceps major where FA was normal. In AD in comparison 
with controls (Table 4), decreased FA was observed in the right inferior longi-
tudinal and superior longitudinal fasciculus, bilateral hippocampal and cingulate 
cingulum and inferior fronto-occipital fasciculus, forceps major and minor. In 
AD in comparison with controls, increased MD was observed in nearly all WM 
tracts, except for the bilateral cingulate cingulum and superior longitudinal fas-
ciculus.
3.3 Correlations between cognition and microstructural WM
In bvFTD (Table 5, Figure 1), normal language functioning correlated with normal 
FA in the left anterior thalamic radiation. Attention and executive deficits corre-
lated with FA abnormalities in the right cingulate cingulum, right inferior fronto-
occipital fasciculus, right inferior and superior longitudinal fasciculus, and with 
MD abnormalities in the left cingulate cingulum, left hippocampal cingulum, left 
inferior fronto-occipital fasciculus and forceps minor, and with both abnormal FA 
and MD in the left uncinate fasciculus. Normal memory functioning correlated 
with abnormal MD in the left cingulate cingulum. 
bvFTD = behavioural variant frontotemporal dementia , AD=Alzheimer’s disease.
Vs controls, p
bonferroni
<0.0125
table 3. Mean cognitive domain z-scores for bvFTD, AD and controls. Scores are corrected for age 
and education level.
BvFtD AD Controls
Language -0.22 -0.64 0.60
Attention and executive functioning -0.42 -0.46 0.50
Memory -0.13 -0.65 0.57
Visuoconstructive functioning -0.48 -0.09 0.43
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table 4. Mean FA (x10-3 ), and MD (x10-3 ) for bvFTD, AD and controls for WM tracts associated 
with cognition.
Wm 
tract
L/r fa MD
BvFtD AD Controls BvFtD AD Controls
ATR
L 324.29 330.01 326.80 0.90* 0.83* 0.82
R 317.96* 319.82 321.64 0.94* 0.84* 0.82
CGC
L 395.61* 421.47* 435.99 0.87* 0.80 0.81
R 349.37* 381.22* 402.68 0.88* 0.81 0.81
CGH
L 225.18* 258.71* 265.98 0.96* 0.88* 0.85
R 214.96* 250.00* 267.64 1.04* 0.87* 0.84
IFOF
L 378.17* 406.50* 413.75 0.89* 0.83* 0.83
R 378.87* 407.13* 423.97 0.90* 0.84* 0.82
ILF
L 371.79* 386.73 386.45 0.87* 0.83* 0.83
R 383.24* 391.74* 402.46 0.87* 0.83* 0.82
SLF
L 309.20* 324.83 329.22 0.84* 0.80 0.80
R 309.07* 325.62* 330.37 0.85* 0.79 0.80
UF
L 289.85* 330.61 354.94 0.96* 0.84* 0.82
R 275.48* 325.35 336.64 1.01* 0.85* 0.84
FMi n/a 311.75* 386.05* 418.34 0.98* 0.85* 0.82
FMa n/a 381.67 380.62* 397.56 0.83* 0.82* 0.81
FA = fractional anisotropy, MD = mean diffusivity, WM=white matter, bvFTD = behavioural variant 
frontotemporal dementia , AD=Alzheimer’s disease, ATR = anterior thalamic radiation, CGC = 
cingulum (cingulate), CGH = cingulum (hippocampal), IFOF = inferior fronto-occipital fasciculus, ILF 
= inferior longitudinal fasciculus, SLF = superior longitudinal fasciculus, UF = uncinate fasciculus, 
FMi = forceps minor, FMa = forceps major, L= left, R=right.
*Vs controls, p
bonferroni
<0.002
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In AD (Table 5, Figure 1), language deficits correlated with FA abnormalities in the 
right inferior fronto-occipital fasciculus, and with MD abnormalities in the right 
hippocampal cingulum. Language deficits also correlated with FA in the uncinate 
fasciculus, where FA was normal. Attention and executive deficits correlated with 
normal MD in the right cingulate cingulum and superior longitudinal fasciculus, 
and with MD abnormalities in the left uncinate and inferior longitudinal fascicu-
lus. Visuoconstructive functioning in AD correlated with abnormal MD in the for-
ceps major. 
Figure 1. Functional associations between white matter (WM) microstructure and cognitive 
domains in Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD).
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4. DISCUSSIon
In this study we investigated functional associations between WM microstruc-
ture and cognitive domains in bvFTD and AD separately to assess whether differ-
ent WM tracts play a role in early-stage symptomatology of bvFTD and AD. We 
observed that attention and executive deficits were associated with WM micro-
structure of several WM tracts in bvFTD, and to a lesser extent in AD. WM micro-
structure was associated with language deficits in AD, and to a lesser extent with 
language functioning in bvFTD. Additionally, WM microstructure was associated 
with memory functioning in bvFTD, as well as with visuoconstructive functioning 
in AD. 
WM microstructure was abnormal in all WM tracts in both early-stage AD 
and bvFTD but with more diffusion measures being affected in bvFTD than in AD. 
Among the least affected tracts were the forceps major and anterior thalamic 
radiation in bvFTD, and the superior longitudinal fasciculus in AD. On a neurocog-
nitive level, we observed that attention and executive functioning was abnormal 
in both early-stage bvFTD and AD, and language and memory in early-stage AD. 
Of all domains, attention and executive functioning shows most functional associa-
tions with WM microstructure. More associations were observed in bvFTD than in 
AD, which may be explained by this domain being severely affected in bvFTD , per-
haps in combination with the more pronounced WM microstructure abnormali-
ties in bvFTD than in AD [7]. In bvFTD, attention and executive functioning deficits 
were associated with microstructural abnormalities of the cingulate cingulum, left 
hippocampal cingulum, forceps minor, inferior fronto-occipital, right superior and 
inferior longitudinal fasciculus and left uncinate fasciculus. This is in line with pre-
vious findings linking attention and executive functioning to these particular WM 
tracts in various disease and/or healthy populations [10,13–15,43–52].
In AD, attention and executive deficits were associated with microstructural 
abnormalities of the left uncinate fasciculus and with normal WM microstructure 
in the right cingulate cingulum, and the left inferior and superior longitudinal fas-
ciculus. The observed functional associations between these WM tracts and at-
tention and executive functioning have been previously suggested in other popu-
lations [47,52–59]. Interestingly, a strong association was observed between WM 
microstructure not different from controls and attention and executive deficits. 
A possible explanation is that changes in these diffusion measures are too subtle 
and variable to be detected on a group level [7], but are nonetheless functionally 
associated with attention and executive deficits.
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Language – as assessed with an object naming task - showed several functional 
associations with WM microstructure in AD, whereas in bvFTD only one func-
tional association was observed. This is in line with the language deficits found in 
AD and not in bvFTD.
 Language deficits in AD were associated with normal WM microstructure 
in the uncinate fasciculus and abnormal WM microstructure in the right inferior 
fronto-occipital fasciculus and right hippocampal cingulum in AD. The inferior 
fronto-occipital and uncinate fasciculi are known for their role in semantic pro-
cessing [12,60,61]. However, to our knowledge, the hippocampal cingulum has 
not specifically been implicated with language functioning. One study has report-
ed cingulum involvement in a syndrome with altered language functioning [62], 
but evident hippocampal cingulum involvement in language functioning has not 
been reported previously.
Normal language functioning in bvFTD was associated with WM microstruc-
ture in the left anterior thalamic radiation. Previous research has observed a simi-
lar functional relationship between the left anterior thalamic radiation and sev-
eral semantic language tasks, including an object naming task [63]. It is unclear 
why the anterior thalamic radiation plays a role in language functioning in bvFTD 
specifically, but these results may suggest that the anterior thalamic radiation 
may be important for early language deficits in bvFTD.
Visuoconstructive functioning in AD was associated with microstructural abnor-
malities of the forceps major. Such a functional association has been previously re-
ported in patients with a lesion in the forceps major/splenium [64–67]. Other WM 
tracts that have been previously associated with the visuoconstructive domain, for 
instance the superior longitudinal and inferior fronto-occipital fasciculus, were not 
found to be significantly associated with visuoconstructive deficits in AD [68]. This 
suggests that in this early stage of AD particularly microstructural abnormalities of 
the forceps major play an important role in visuoconstructive functioning.
Although memory is a prominently affected domain in AD [4], it was not associ-
ated with any WM tract abnormalities. This may suggest that known GM abnor-
malities, such as of the hippocampus, are more involved in memory than those of 
WM microstructure. On the other hand, when exploring the correlations without 
regard for significance, it was observed that most WM tracts have moderate cor-
relations with memory, although this was more evident for bvFTD than for AD. 
This suggests that WM tracts may be involved in memory processes, which may 
become apparent in a larger sample with greater statistical power. Alternatively, 
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the use of composite scores may have obscured specific memory processes and 
their associations with WM tracts.
In bvFTD, the memory domain was not affected, but did show an association 
with abnormal WM microstructure of the left cingulate cingulum. This suggests 
a role for the affected cingulum in memory functioning in bvFTD. Such an asso-
ciation is supported by similar observations in previous literature, for instance in 
traumatic brain injury and healthy elderly [69,70]. 
This study knows some limitations. First, visuoconstructive functioning and lan-
guage were assessed with a single neuropsychological test, which may not be 
representative for all aspects of these domains. However, these are validated 
tests, which are routinely used in clinic practice to assess these domains. Memory 
and attention and executive functioning were assessed with several neuropsy-
chological tests and individual scores were transformed to one composite score 
for each domain. Here it could be argued that smaller and more specific effects 
may have become obscured, but that the cognitive domain overall is better rep-
resented. Second, sample sizes of patients were small. This is not desirable, but 
unfortunately inherent to clinical studies where patients are carefully selected for 
inclusion to establish clinically homogenous groups. Due to this underpowered 
sample, results were not corrected for multiple comparisons to avoid the risk 
of false negative results. Consequently the risk of false positives is present, but 
somewhat reduced by only reporting strong correlations (r > 0.7). 
In conclusion, we found an association between cognitive deficits and specific 
WM microstructure abnormalities in early-stage AD and bvFTD patients. This sug-
gests that specific WM tracts play an important role in cognitive functioning, and 
are not universally involved in all affected cognitive domains in AD and bvFTD.
Microstructural WM and cognition in bvFTD and AD
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SUPPLeMent
White matter tract tractography threshold
Anterior thalamic radiation (ATR) 0.016
Cingulum (cingulate gyrus) 0.08
Cingulum (parahippocampal region) 0.16
Forceps major (FMa) 0.04
Forceps minor (FMi) 0.08
Inferior fronto-occipital fasciculus (IFOF) 0.08
Inferior longitudinal fasciculus (ILF) 0.04
Superior longitudinal fasciculus (SLF) 0.008
Uncinate fasciculus (UF) 0.08
Supplemental table 1. Tractography tract thresholds based on De Groot et al. (2015), but 
multiplied with a factor of eight due to the resolution difference.
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abstract
Semantic dementia (SD) and behavioural variant frontotemporal dementia 
(bvFTD), subtypes of FTD, are characterised by distinct clinical symptoms and dis-
tinct neuroimaging features, with predominant left temporal grey matter (GM) 
atrophy in SD and bilateral or right frontal GM atrophy in bvFTD. Such different 
hemispheric predilection may also be reflected by other neuroimaging features, 
such as in brain connectivity. This study investigated white matter (WM) micro-
structure and functional connectivity differences between SD and bvFTD, specifi-
cally focusing on the hemispheric predilection of these differences.
Eight SD and 12 bvFTD early-stage patients, and 17 controls underwent dif-
fusion tensor imaging and resting state functional magnetic resonance imaging 
at 3T. Whole-brain WM microstructure was assessed to determine distinct WM 
tracts affected in SD and bvFTD. For these WM tracts, diffusivity measures and 
lateralization indices were calculated. Functional connectivity was established for 
grey matter (GM) regions affected in early stage SD or bvFTD. 
Whole-brain WM microstructure abnormalities were more pronounced in 
the left hemisphere in SD and in the right hemisphere in bvFTD. Lateralisation 
of tract-specific WM abnormalities was seen in SD only, towards the left hemi-
sphere. Functional connectivity of disease-specific regions was mainly decreased 
in both hemispheres in SD and in the right hemisphere in bvFTD.
In conclusion, SD and bvFTD show WM microstructural and functional 
connectivity abnormalities in different brain regions, that are overall more pro-
nounced in the left hemisphere in SD and in the right hemisphere in bvFTD. This 
indicates a hemispheric dissociation of abnormalities in brain connectivity be-
tween SD and bvFTD.
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1. IntroDUCtIon 
Frontotemporal dementia (FTD) is a common cause of dementia in relatively 
young patients (<65 years). FTD is the umbrella term for several dementia sub-
types affecting the frontal and/or temporal lobes. Two main subtypes of FTD are 
semantic dementia (SD) and behavioural variant FTD (bvFTD) [1]. Although both 
SD and bvFTD affect the frontotemporal regions, they are clinically different. SD 
is characterised by a language disorder, with core features of impaired confronta-
tion naming and impaired single-word comprehension, and shows predominantly 
left anterior temporal lobe (ATL) atrophy [2–4]. In contrast, bvFTD is characterised 
by behavioural symptoms, such as apathy and disinhibition, and shows predomi-
nantly bilateral or right frontal lobe atrophy [3–5]. As the left hemisphere is im-
portant for language functioning [6] and the bilateral frontal lobes for behaviour 
[7,8], the left lateralised atrophy pattern in SD and the right-lateralised/bilateral 
atrophy pattern in bvFTD are likely to underlie the differences in symptomatology. 
It can be hypothesised that other brain abnormalities, such as brain connectivity, 
may also be differentially lateralised between SD and bvFTD. 
Brain connectivity changes in frontotemporal networks have been suggested 
to play an important role in both bvFTD and language variants of dementia [9,10]. 
Brain connectivity can be assessed in terms of WM microstructure and functional 
connectivity, which have been suggested to be interrelated [11–13]. Both have 
been found to be abnormal in SD and bvFTD. Previous studies have observed WM 
microstructure abnormalities in SD mainly in the uncinate, arcuate and inferior 
longitudinal fasciculus - more pronounced in the left hemisphere  [14–19] -, and 
in bvFTD mainly in the bilateral uncinate fasciculus, cingulum and forceps minor/
genu of the corpus callosum [20,21]. Only a few studies looked at WM microstruc-
tural differences between SD and bvFTD [15,22,23], and mainly indicated severe 
left inferior longitudinal fasciculus abnormalities in SD, and increased forceps mi-
nor abnormalities in bvFTD. To the best of our knowledge none of these studies 
looked specifically at differences in lateralisation towards a particular hemisphere.
Similarly, functional connectivity changes have been observed in both SD 
and bvFTD within known functional networks and within regions implicated in 
SD and bvFTD [9,24–29], but only one study [26] reported functional network 
differences between SD and bvFTD in the default-mode, executive and salience 
network. Other functional connectivity differences between SD and bvFTD, such 
as in regions that are affected early in the disease process or between regions 
connected by affected WM tracts, and importantly the possible hemispheric pre-
dilection of these abnormalities, remain non-investigated. 
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As differences in brain connectivity - and in particular their hemispheric lateralisa-
tion - between SD and bvFTD are not yet clarified, this study investigates differ-
ences in WM microstructure and functional connectivity between SD and bvFTD, 
specifically focusing on the hemispheric predilection of these differences. 
2. MethoDS
2.1 Participants
Patients were recruited in the Alzheimer Centre Southwest Netherlands. Inclu-
sion criteria were: age between 40 and 70 years; diagnosis of SD [2] or bvFTD 
[30]; a Mini-Mental State Examination [31] (MMSE) score of ≥ 20. Exclusion crite-
ria were contraindications for MRI; other neurological disorders; a different cause 
of dementia; alternative psychiatric diagnosis; past or current substance abuse. 
SD patients were classified as left or right variant SD patients.
Healthy controls, matched for age and gender, and without neurological or 
psychiatric diagnosis, were recruited through advertisement. 
The study was approved by the local medical ethics committee. All partici-
pants gave written informed consent.
2.2 Image acquisition
Scanning was performed on a 3T GE Discovery MR750 system (GE Healthcare, 
Milwaukee, WI, US). See Table 1 for acquisition parameters.
A high-resolution three-dimensional (3D) inversion recovery (IR) fast spoiled 
gradient echo (FSPGR) T1-weighted (T1w) image was acquired for anatomical ref-
erence. DTI scans with a spin echo echo planar imaging (EPI) sequence and func-
tional scans with a gradient echo EPI sequence were acquired with full coverage 
of the supratentorial brain. For functional scans participants were instructed to 
focus on a fixation cross, to think of nothing in particular and to remain awake.
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2.3 Demographical analysis
Age was compared across groups using a one-way ANOVA, and gender differ-
ences using chi-square tests. Variance of MMSE scores was not equal across 
groups, hence between-group differences in MMSE score were tested using a 
Welch-ANOVA and post-hoc Games-Howell t-tests. Analyses were done using 
SPSS Statistics, version 21.0 (New York, USA) with the threshold for significance 
set at p<0.05.
T1w = T1-weighted, fMRI = functional magnetic resonance imaging, DTI = diffusion tensor 
imaging,  FOV= field of view,  TE = echo time, TR = repetition time,  ASSET = array spatial  
sensitivity encoding technique, TI = inversion time.
table I. Acquisition parameters.
t1w fmrI DtI
foV (mm) 240 240 240
te (ms) 3.06 30 84.7
tr (ms) 7904 3000 7.93
ASSet factor 2 2 2
flip angle 12° 90° 90°
Acquisition matrix 240x240 96x96 128x128
Slice thickness (mm) 1 3 2.5
Volumes (slices per volume) 1 (176) 200 (44) 28 (59)
Duration (min) 4.41 10.00 3.50
Diffusion-weighted directions n/a n/a 25
Maximum b-value (s/ mm2) n/a n/a 1000
tI (ms) 450 n/a n/a
Hemispheric dissociation of connectivity abnormalities in SD and bvFTD
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2.4 Grey matter (GM) volume analysis 
Whole-brain GM volumes were calculated according to the methods described 
in Bron et al. (2014) [32]. GM volumes were obtained from the T1w image using 
the unified tissue segmentation method of SPM8 (Statistical Parametric Mapping, 
London, UK), and divided by intracranial volume (ICV) to correct for head size. 
This normalised GM volume (nGM) was compared between all groups using a 
one-way ANOVA and post-hoc Bonferroni tests (IBM SPSS Statistics, version 21.0, 
New York, USA).
2.5 Microstructural white matter (WM) analysis 
Data were analysed using FMRIB Software Library (FSL5, Oxford, UK) [33–35]. 
Data were corrected for motion and eddy currents using Eddy Correct and then 
skull-stripped using BET [36]. 
2.5.1 Tract-Based Spatial Statistics (TBSS)
Diffusion tensors were reconstructed using DTIFIT [37], resulting in participant 
images for fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AxD), 
and the second and third eigenvalues. The latter were averaged using FSLmaths 
to calculate radial diffusivity (RD) images. 
Using TBSS [38], registration of DTI images was performed and participant-
specific skeletons for each of the diffusivity measures were created.
For all diffusivity measures, group differences were tested with Randomise 
[39] using 5000 nonparametric permutations and threshold-free cluster en-
hancement (TFCE) [40]. Using the General Linear Model (GLM) toolbox, a one-
way ANOVA design was defined with three groups (SD≠bvFTD≠controls) and six t-
contrasts (SD>controls, SD<controls, bvFTD>controls, bvFTD<controls, SD>bvFTD, 
SD<bvFTD) assessing post-hoc between-group differences. Results were family 
wise error (FWE) corrected for multiple comparisons.
Post-hoc t-tests results (p
FWE_corrected
<0.05) were identified within the bounda-
ries of the f-test results using FSLmaths. First, for the f-test and all t-tests a binary 
mask was created (p
threshold
=0.95). Second, each t-test binary mask was multiplied 
with the f-test binary mask, resulting in a common binary mask for every t-test. 
Clusters were extracted for each t-test using the Cluster toolbox (p
threshold
=0.95; k 
(cluster size)≥50).
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Results (p
FWE_corrected
<0.05; k=50) were visualised and anatomically identified in 
FSLview with the implemented JHU White-Matter Tractography Atlas and the JHU 
ICBM-DTI-81 White-Matter labels. 
WM tracts showing diffusivity abnormalities between patient groups were 
selected for further tractography analysis. 
2.5.2 Tractography
Median diffusivity values were extracted from those WM tracts that were 
different between SD and bvFTD. First, automated probabilistic tractography 
(AutoPtx) [41] was used to apply a tensor fit with DTIFIT [37], followed by FNIRT 
registration and a BEDPOSTX probabilistic model fit for each participant. Sec-
ond, PROBTRACKX [37,42] was run for all selected WM tracts using default space 
seed, target, stop and exclusion masks available in AutoPtx [41], resulting in a 
participant-specific tract density image. Tract density images were normalised by 
dividing them by the number of fibres included in the tract-image and then bina-
rised for WM tract segmentation, based on the best-fit segmentation thresholds 
established by De Groot et al. (2015) [43] (see supplemental (suppl) Table 1 for 
thresholds). 
Tensor-fit established diffusivity images were masked with thresholded tract 
images using FSLstats, to acquire median FA, MD, RD and AxD values for each 
tract. For each diffusivity measure a lateralisation index was calculated in each 
tract that differed between SD and bvFTD, except for the forceps minor, being a 
midline structure. The following formula was used:
 (1) Lateralisation index=(L−R)/(L+R).
Left lateralisation of abnormalities is indicated by a negative lateralisation 
index for FA, and a positive lateralisation index for MD, RD and AxD. Lateralisation 
indices were corrected – if necessary - for age and TE using linear regression. 
Between-group differences for all lateralisation indices were compared using a 
one-way ANOVA. Analyses were done using SPSS Statistics, version 21.0 (New 
York, USA).
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2.6 Functional connectivity analysis 
2.6.2 Hypothesis driven method
The anterior temporal lobe (ATL) and medial posterior orbitofrontal cortex (OFC), 
known to be affected in SD and bvFTD respectively, were selected as seed regions 
of interest (ROIs) for analysis. Left and right were assessed separately. 
Data were analysed using FMRIB Software Library (FSL5, Oxford, UK) [33–35]. 
Anatomical images were reoriented to establish standard template orientation 
and then skull-stripped using the Brain Extraction Tool (BET) [36]. Preprocessing 
was done using the FMRI Expert Analysis Tool (FEAT) with a high pass filter set to 
120s, MCFLIRT [44] motion correction to correct for linear motion, and spatial 
smoothing with a Gaussian kernel of 5 FWHM. Functional data were then linearly 
registered (normal search, 7 degrees of freedom (DOF)) to the corresponding 
T1w images, followed by both linear (full search, 12 DOF) and nonlinear registra-
tion (10mm warp resolution) to a standard MNI152 1mm brain template.
The medial, lateral and posterior orbital gyrus (left and right), and the medial 
and lateral anterior temporal lobe (left and right) were taken from the Hammers 
atlas [45]. Using FSLmaths, these individual ROIs were merged to construct four 
ROIs, namely the left and right ATL, and left and right OFC. Timeseries for each ROI 
were extracted using FSLmeans. Additionally, timeseries were extracted for sub-
ject-specific WM and cerebral spinal fluid (CSF) using predefined templates[46], 
and for a subject-specific brain mask.
Within-subject analysis was performed using a first-level FEAT with a lenient 
threshold (p
uncorrected
<0.05) in order to establish functional connectivity of each 
ROI with the remainder of the brain. Motion parameters and timeseries of WM, 
CSF and global brain signal were considered confound regressors. 
Between-group functional connectivity differences for each ROI were estab-
lished using a higher-level FEAT. Modelling and estimation of functional connectivity 
was done using FEATs Bayesian statistics tool, FMRIBs local analysis of mixed ef-
fects 1 (FLAME1). With the Bayesian statistics model correction for multiple com-
parisons is not required [47]. An ANCOVA GLM was then defined with three groups 
(SD≠bvFTD≠controls), and six t-contrasts (SD>controls, SD<controls, bvFTD>controls, 
bvFTD<controls, SD>bvFTD, SD<bvFTD) assessing post-hoc between-group differ-
ences, with GM volume added as covariate. Both the f-test and all t-tests were as-
sessed with FEAT Cluster thresholding (p<0.05, z=2.3) after which all t-tests were 
masked with f-test results to investigate within f-test boundaries results only. 
Results were visualised in FSLview and anatomically identified using the Har-
vard-Oxford structural cortical and subcortic alatlases implemented in FSLview.
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2.6.1 Exploratory method
Functional connectivity between GM regions on either end of the WM tracts that 
were different between SD and bvFTD was assessed in an exploratory analysis, 
using functional connectivity methods previously described in Ebisch et al. (2011) 
[48] and Verly et al. (2014) [49]. This was done to observe whether affected WM 
tracts were related to functional connectivity of adjoining GM regions and as dif-
ferent WM tracts may be affected between groups, whether this was also differ-
ent between groups.
Between-group differences were however not observed.
3. reSULtS
3.1 Participant characteristics 
Eight SD patients, 12 bvFTD patients and 17 controls were included (Table 2). 
Seven SD patients were classified as left and one as a right variant SD. One SD 
patient and three bvFTD patients were excluded from the functional connectivity 
analysis due to missing rs-fMRI data. Age (F (2, 34) = .704, p>0.05) and gender 
(χ2 (2, 34) = 1.003, p>0.05) were not different between groups; this was also the 
case for the functional connectivity analysis. MMSE score was different across 
groups (F (2, 12.82) = 7.79, p < 0.05) and was lower in both SD (p=0.049) and 
bvFTD (p=0.025) patients than in controls, but was not different between SD and 
bvFTD patients (p>0.05). For the functional connectivity analysis MMSE score was 
different between groups (F (2,30) = 6.6, p<0.05), and was lower in bvFTD than in 
controls (p=0.046). 
SD = semantic dementia, BvFTD = behavioural frontotemporal dementia, N = sample size. Values 
given as Mean (standard deviation). MMSE = Mini-Mental State Examination.
Group n 
(male)
Mean age in years 
(Std dev)
mean mmse
 (Std Dev)
SD 8 (5) 62.9 (3.5) 25.6 (3.3)
BvFTD 12 (6) 60.3 (7.7) 26.6 (2.8)
Controls 17 (7) 59.5 (6.8) 29.1 (1.1)
table 2. Demographic characteristics of participants included in the diffusion tensor imaging 
analysis. 
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3.2 GM volume
The three groups showed a difference in whole-brain GM volume corrected for 
ICV (F(2, 34) = 15.92, p<0.05), with a mean of 0.32% (standard deviation (Std 
Dev)0.03) for SD, 0.30% (Std Dev 0.04) for bvFTD and 0.36% (Std Dev 0.03) for 
controls. Lower GM volume was observed in both SD patients (p<0.01) and bvFTD 
patients (p<0.001) than in controls. GM volume was not different between the 
patient groups.
3.3 Microstructural WM
3.3.1 Whole-brain WM abnormalities
SD and bvFTD patients in comparison with controls showed decreased FA and 
increased MD, RD and AxD in the bilateral forceps minor and major, corpus cal-
Figure 1. White matter microstructure abnormalities for semantic dementia (SD) compared with 
controls (SD<controls for FA; SD>controls for MD, RD and AxD).. FA = fractional anisotropy, MD = 
mean diffusivity, RD = radial diffusivity, AxD = axial diffusivity.
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losum, inferior fronto-occipital fasciculus, anterior thalamic radiation, cingulum, 
uncinate fasciculus, and inferior and superior longitudinal fasciculi (Figures 1 and 
2, suppl Tables 2A-D).
Direct comparison between SD and bvFTD patients showed WM microstruc-
ture abnormalities in the left hemisphere in SD patients, and mostly in the right 
hemisphere in bvFTD patients. Specifically, SD patients compared with bvFTD pa-
tients (Figure 3, suppl Tables 2B-D) showed increased MD, RD and AxD in the left 
inferior fronto-occipital fasciculus, uncinate fasciculus, and inferior longitudinal 
fasciculus. Additionally, increased MD and RD, but not AxD, was observed in the 
left superior longitudinal fasciculus. Decreased FA was not observed. On the oth-
er hand, bvFTD patients compared with SD patients (Figure 4, suppl Tables 2A-D) 
showed decreased FA in the forceps minor and cingulum, and in the right inferior 
fronto-occipital fasciculus, anterior thalamic radiation, and uncinate fasciculus. In 
the latter three WM tracts AxD was also found to be increased. Increased MD and 
RD were observed in these tracts bilaterally. 
Figure 2. White matter microstructure abnormalities for behavioural variant frontotemporal 
dementia (bvFTD) compared with controls (bvFTD<controls for FA; bvFTD>controls for MD, RD 
and AxD). FA = fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity, AxD = axial 
diffusivity.
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Figure 3. White matter microstructure abnormalities for semantic dementia (SD) in comparison 
with behavioural variant frontotemporal dementia (bvFTD) (SD>bvFTD). MD = mean diffusivity, RD 
= radial diffusivity, AxD = axial diffusivity.
Figure 4. White matter microstructure abnormalities for behavioural variant frontotemporal 
dementia (bvFTD) in comparison with semantic dementia (SD) (bvFTD<SD for FA; bvFTD>SD for 
MD, RD and AxD). FA = fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity, AxD = 
axial diffusivity.
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3.3.2 Lateralisation of WM abnormalities 
Lateralisation of WM abnormalities was investigated for the anterior thalamic ra-
diation, hippocampal and cingulate part of the cingulum, inferior fronto-occipital, 
inferior and superior longitudinal and uncinate fasciculus (Table 3). 
Significantly different lateralisation indices showed a left-ward lateralisation 
in SD patients compared with controls for MD and RD in the uncinate and inferior 
fronto-occipital fasciculus, for MD and AxD in the hippocampal cingulum, for RD 
and FA in the superior longitudinal fasciculus, and for AxD in the uncinate fascicu-
lus, inferior longitudinal fasciculus and anterior thalamic radiation.
Lateralisation indices of diffusivity measures were not significantly different 
between bvFTD patients and controls.
Significantly different lateralisation indices between SD and bvFTD showed a 
left-ward lateralisation in SD patients and a right-ward lateralisation in bvFTD pa-
tients for MD, RD and AxD in the hippocampal cingulum and uncinate fasciculus, 
for MD in the superior longitudinal fasciculus, for RD in the inferior fronto-occip-
ital fasciculus, and for AxD in the inferior longitudinal fasciculus. These lateralisa-
tion differences were likely induced by SD lateralisation and not by bvFTD
3.4 Functional connectivity
3.4.1 Left anterior temporal lobe (ATL) 
SD patients in comparison with controls showed increased functional connectivi-
ty between the left ATL and the left hippocampus, amygdala, fusiform gyrus, para-
hippocampal gyrus, and inferior and middle temporal gyrus. SD patient compared 
both with controls and bvFTD patients showed decreased functional connectivity 
between the left ATL and the bilateral middle frontal gyrus, superior frontal gyrus 
and anterior cingulate cortex. 
BvFTD patients in comparison with controls showed increased connectivity 
between the left ATL and the bilateral cuneus, calcarine cortex, occipital pole and 
lateral occipital cortex. BvFTD patients in comparison with controls showed de-
creased functional connectivity between the left ATL and the right precentral gyrus, 
middle frontal gyrus, superior frontal gyrus and supplementary motor area. In com-
parison with SD patients there was decreased functional connectivity between the 
left ATL and the right precentral gyrus and left hippocampus, amygdala, fusiform 
gyrus, parahippocampal gyrus, inferior temporal gyrus and middle temporal gyrus.
Results are shown in figure 5 and supplemental table 3.
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3.4.2 Right anterior temporal lobe (ATL) 
Both SD and bvFTD patients in comparison with controls  showed decreased func-
tional connectivity between the right ATL and the left inferior temporal gyrus, 
middle temporal gyrus and superior temporal gyrus (Figure 6, suppl Table 3). No 
differences were observed between SD and bvFTD patients. 
Between-group differences for increased functional connectivity of the right 
ATL were not observed.
3.4.3 Left orbitofrontal cortex (OFC) 
SD patients in comparison with controls showed decreased functional connec-
tivity between the left OFC and the right posterior cingulate cortex and central 
Figure 5. Functional connectivity increase (red) and decrease (blue) of the left anterior temporal 
lobe (ATL). SD = semantic dementia, BvFTD = behavioural variant frontotemporal dementia.
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operculum, and bilateral postcentral gyrus and parietal operculum. SD patients 
in comparison with bvFTD patients showed decreased functional connectivity be-
tween the left OFC and the bilateral posterior cingulate cortex, central opercu-
lum, postcentral gyrus and parietal operculum.
Figure 7. Functional connectivity decrease of the left orbitofrontal cortex (OFC). SD = semantic 
dementia, BvFTD = behavioural variant frontotemporal dementia.
Figure 6. Functional connectivity decrease of the right anterior temporal lobe (ATL). SD = semantic 
dementia, BvFTD = behavioural variant frontotemporal dementia.
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BvFTD patients in comparison with both controls and SD patients showed de-
creased functional connectivity between the left OFC and the right lingual gyrus, 
occipital fusiform gyrus, lateral occipital lobe, inferior temporal gyrus and middle 
temporal gyrus.
Between-group differences for increased functional connectivity of the left 
OFC were not observed. Results are shown in figure 7 and supplemental table 3.
3.4.3 Right orbitofrontal cortex (OFC) 
Between-group differences were not observed for functional connectivity of the 
right OFC. 
4. DISCUSSIon 
This study observed a left-right differentiation of WM microstructure and func-
tional connectivity abnormalities in SD and bvFTD. Whole-brain WM microstruc-
ture abnormalities were more pronounced in the left hemisphere in SD and in the 
right hemisphere in bvFTD. Lateralisation of tract-specific WM abnormalities was 
seen in SD only, towards the left hemisphere. Functional connectivity of disease-
specific regions was mainly decreased with both hemispheres in SD and with the 
right hemisphere in bvFTD.
Differences in WM microstructure abnormalities were most prominent in the left 
temporal lobe in SD and in the right frontal lobe in bvFTD, and can be related to 
disease-specific symptoms, namely the language disorders in SD [2,6] and the 
behavioural disturbances in bvFTD [8,30]. 
In SD, changes of WM microstructure were observed in language-specific 
WM tracts that were lateralised toward the left hemisphere. These abnormalities 
(increased MD, RD and AxD) were most pronounced in the left ventral language 
stream (uncinate, inferior longitudinal and inferior fronto-occipital fasciculus) 
and only subtly in the dorsal language stream (superior longitudinal fascicu-
lus). The ventral stream is thought to be associated with semantic processing 
[50,51], and its predominant involvement in SD is in line with SD symptomatology, 
i.e. impaired single-word comprehension and confrontation naming [2]. Con-
versely, the relative sparing of the dorsal stream, which is associated with phono-
logical speech processing [51], is reflected by the preserved language production 
in SD. 
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In bvFTD, changes of WM microstructure were observed in behaviour-associated 
WM tracts in the bilateral – more pronounced in the right - frontal WM. These 
changes (mainly decreased FA and increased RD and MD) were most evident in 
the right inferior fronto-occipital and uncinate fasciculus, and in the right part 
of the forceps minor. Uncinate fasciculus abnormalities [52] have been associ-
ated with the typical bvFTD symptoms of behavioural dyscontrol [15], disinhibi-
ton [53,54], executive dysfunctioning [55], and apathy [54]. Implication of the 
inferior fronto-occipital fasciculus in bvFTD is not as clear, but an association with 
impaired emotion recognition in bvFTD [56] and involvement in emotional re-
sponses [57] and emotional prosody [58] has been suggested. The function of 
the forceps minor in relation to bvFTD has not been extensively studied, but its in-
volvement in disinhibition [53] and executive functioning [59] has been proposed.
Not all diffusivity measures were affected equally in both diseases, possi-
bly indicating specific neuropathological processes occurring at specific disease 
stages. In particular, AxD abnormalities (reflecting axonal injury or loss [60]) were 
less extensive in both SD and bvFTD than those of the other diffusivity measures. 
It may be that there was only mild axonal injury or loss at this early stage of SD 
and bvFTD, while myelin loss (reflected by changes in RD [61]) was already very 
prominent at this stage. Additionally, FA abnormalities (reflecting WM direction-
ality) were more or less equally distributed across the two hemispheres in both 
SD and bvFTD. A possible explanation may be that FA, being a composite meas-
ure of AxD and RD, has higher sensitivity to WM microstructural abnormalities. It 
can be hypothesised that FA changes are already present to such an extent that 
a hemispheric difference can no longer be appreciated. Interestingly, whereas 
more pronounced FA abnormalities seem to obscure hemispheric differences, 
these hemispheric differences become clear when looking at AxD abnormalities. 
This indicates that whereas a sensitive measure such as FA already shows diffuse 
abnormalities in early stage dementia, AxD may be specifically sensitive to  hemi-
spheric lateralization in regions typical for these early stages. 
A hemispheric dissociation between the two FTD subtypes was further indicated 
by functional connectivity abnormalities of the ATL and OFC, which were present 
in both hemispheres in SD (albeit more pronounced in the left hemisphere) and 
mainly in the right hemisphere in bvFTD.
The left ATL showed an extensive functional connectivity decrease in the 
bilateral frontal GM in SD in comparison with both healthy controls and bvFTD, 
whereas bvFTD showed a less widespread decrease in the right frontal GM. This 
more prominent role of the left ATL in SD is in line with known pronounced GM 
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atrophy of the left ATL [2] and may be explained by its role in semantic processing 
[62,63], a cognitive domain affected in SD but not in bvFTD. Despite a less obvious 
role of the left ATL in bvFTD than in SD, the literature does also report GM volume 
loss of the left ATL [64] in bvFTD, possibly explaining its less extensive decrease in 
functional connectivity observed here. Additionally, the involvement of the fron-
tal lobe may on the one hand be explained by the frontal lobe’s rich connections 
with the ATL [62], and on the other hand by its involvement in both SD and bvFTD 
pathology [64,65]. 
The left ATL also showed an increase in functional connectivity in SD with left 
temporal regions that are well-connected with the ATL [62,66] and are also impli-
cated in language processing [67,68]. Such increased functional connectivity has 
been suggested to be indicative of a compensatory mechanism [69,70], which 
may be highly important in the early stages of dementia to counteract the effects 
of inicipient neuronal dysfunctioning. In this study, increased functional connec-
tivity between the ATL and temporal regions may thus suggest an upregulation 
of the posterior part of the language network to compensate for the functional 
language deterioration of the left ATL. In bvFTD a similar mechanism was seen 
to be activated between the left ATL and the bilateral - but mainly left - medial 
occipital lobe. The temporal lobe and occipital lobe may be part of a functional 
network involving visual aspects of language [71], but why this network showed a 
compensatory process in bvFTD is unclear. 
Surprisingly, the right ATL showed a decrease in functional connectivity only 
with the left posterior temporal lobe (PTL) in both SD and bvFTD, and not with 
the frontal lobes. In general, the PTL has been suggested to be involved in naming 
[68,72], lexical and semantic processing [73], and also in memory processing [74], 
which possibly explains its involvement in SD. However, the nature of its connection 
with the right ATL, which is not necessarily involved in language, remains unclear. 
For bvFTD, as the left PTL is important for memory processing [74] and the right ATL 
for social knowledge [62], this finding may explain the social impairment typical of 
bvFTD, i.e. patients forget how to behave in a socially appropriate manner.
Functional connectivity changes of the OFC were limited to the left OFC in 
both SD and bvFTD. In SD, this finding is in line with its left-hemispheric predilec-
tion, leaving the right OFC functionally unaffected. In bvFTD however, right OFC 
abnormalities would have been expected. However, previous studies of bvFTD 
have also occasionally reported only left GM atrophy of the OFC [75], as well as 
only right [76], or bilateral involvement [53,75], all of which have been associated 
with behavioural dysfunctioning [53,75–77]. In SD, left OFC functional connectiv-
ity was decreased with the bilateral parietal lobe. Previous studies have asso-
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ciated parietal regions with theory of mind, memory functioning and language 
processing [78–83]; cognitive functions that are also affected in SD [2,84]. The 
relationship between the parietal lobe and OFC may be specifically explained by 
the role of the OFC in language processing [81]. 
In bvFTD, the left OFC showed decreased connectivity with the right temporal 
and occipital lobe. Together with these regions, the OFC has been shown to form 
a network that is involved in visual and socio-emotional functioning [76,77,85–
89]. It is possible that decreased functional connectivity in this network is related 
to the specific behavioural symptoms in bvFTD. Functional connectivity between 
the left OFC and right occipito-temporal regions was also decreased in bvFTD 
when compared with SD, again indicating that distinct functional connectivity dif-
ferences may underlie specific bvFTD behavioural symptomatology. 
Taken together, we find support for the hypothesis that changes of WM micro-
structure and functional connectivity are related [11–13]. Direct association 
between functional connectivity on either side of affected WM tracts was not 
observed, but regional overlap of WM microstructural and functional connec-
tivity abnormalities was present. We found WM microstructure abnormalities in 
temporal and frontal WM tracts, and functional connectivity abnormalities in the 
temporal and frontal lobes, as well as in adjacent GM regions connected by the 
affected WM tracts. Specifically, these concerned the left inferior longitudinal fas-
ciculus and uncinate fasciculus connecting frontal, temporal and parietal lobes in 
SD, and the right inferior fronto-occipital fasciculus and uncinate fasciculus con-
necting the frontal, temporal and occipital lobes in bvFTD. 
This study has some limitations. First, samples sizes of SD and bvFTD patients were 
small. This is unfortunate but inherent to research of relatively rare conditions in 
combination with well-defined inclusion criteria. Despite our small sample size 
we observed pronounced abnormalities, surviving stringent statistical threshold-
ing, that are in line with the current literature. Second, due to the small sample 
size we were not able to perform further rs-fMRI analyses, e.g. whole-brain analy-
sis, which may leave possible further differences unexplored. 
In conclusion, SD and bvFTD show WM microstructural and functional connec-
tivity abnormalities, affecting different structures, that were overall more pro-
nounced in the left hemisphere in SD and in the right hemisphere in bvFTD. This 
indicates a hemispheric dissociation of abnormalities in brain connectivity be-
tween SD and bvFTD.
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SUPPLeMent
Supplemental table 1. White matter tracts different between semantic dementia (SD) and 
behavioural variant frontotemporal dementia (bvFTD) based on the tract-based spatial statistics 
(TBSS) (p<0.05) analysis of diffusivity measures. Tractography tract thresholds are based on De 
Groot et al. (2015), but multiplied with a factor of eight due to the resolution difference.
White matter tract tractography threshold
Anterior thalamic radiation (ATR) 0.016
Cingulum (cingulate gyrus) 0.08
Cingulum (parahippocampal region) 0.16
Inferior fronto-occipital fasciculus (IFOF) 0.08
Inferior longitudinal fasciculus (ILF) 0.04
Superior longitudinal fasciculus (SLF) 0.008
Uncinate fasciculus (UF) 0.08
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Supplemental table 2A. Post-hoc two sample t-tests (p
corrected
<0.05; k≥50) for FA investigating 
group differences between SD, bvFTD and controls.  
FA = fractional anisotropy, SD = semantic dementia, bvFTD = behavioural variant frontotemporal 
dementia, L = left, R = right.
t-stat number 
of  
clusters
total 
number 
of voxels
number of 
voxels within 
largest cluster
Anatomical regions within  
largest cluster
SD<controls 16 41.147 38.759 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Splenium of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD<controls 11 48.453 47.210 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Splenium of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD<SD 2 5.550 4.968 L,R Forceps minor 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
R Inferior fronto-occipital fasciculus 
R Anterior thalamic radiation 
L,R Cingulum 
R Uncinate fasciculus 
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Supplemental table 2B. Post-hoc two sample t-tests (p
corrected
<0.05; k≥50) for MD investigating 
group differences between SD, bvFTD and controls.  
MD = mean diffusivity, SD = semantic dementia, bvFTD = behavioural variant frontotemporal 
dementia, L = left, R = right.
t-stat number 
of  
clusters
total 
number 
of voxels
number of 
voxels within 
largest cluster
Anatomical regions within  
largest cluster
SD>controls 9 59.192 58.050 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Splenium of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD>controls 8 62.862 61.229 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Splenium of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD>SD 1 12.229 12.229 L,R Forceps minor 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
SD>bvFTD 1 4.331 4.331 L Inferior fronto-occipital fasciculus 
L Uncinate fasciculus 
L Inferior longitudinal fasciculus 
L Superior longitudinal fasciculus 
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Supplemental table 2C. Post-hoc two sample t-tests (p
corrected
<0.05; k≥50) for RD investigating 
group differences between SD, bvFTD and controls.  
RD = radial diffusivity, SD = semantic dementia, bvFTD = behavioural variant frontotemporal 
dementia, L = left, R = right.
t-stat number 
of  
clusters
total 
number 
of voxels
number of 
voxels within 
largest cluster
Anatomical regions within  
largest cluster
SD>controls 8 59.248 55.938 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Splenium of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD>controls 4 66.140 65.518 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Splenium of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD>SD 1 13.120 13.120 L,R Forceps minor 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
SD>bvFTD 1 1.823 1.823 L Inferior fronto-occipital fasciculus 
L Uncinate fasciculus 
L Inferior longitudinal fasciculus 
L Superior longitudinal fasciculus 
Hemispheric dissociation of connectivity abnormalities in SD and bvFTD
146
Supplemental table 2D. Post-hoc two sample t-tests (p
corrected
<0.05; k≥50) for AxD investigating 
group differences between SD, bvFTD and controls.  
AxD = axial diffusivity, SD = semantic dementia, bvFTD = behavioural variant frontotemporal 
dementia, L = left, R = right.
t-stat number 
of  
clusters
total 
number 
of voxels
number of 
voxels within 
largest cluster
Anatomical regions within largest 
cluster
SD>controls 9 25.059 16.848 L Forceps minor 
L Forceps major 
L Genu of the corpus callosum 
L Body of the corpus callosum 
L Splenium of the corpus callosum 
L Inferior fronto-occipital fasciculus 
L Anterior thalamic radiation 
L Cingulum 
L Uncinate fasciculus 
L Inferior longitudinal fasciculus 
L Superior longitudinal fasciculus 
bvFTD>controls 5 30.230 26.332 L,R Forceps minor 
L,R Forceps major 
L,R Genu of the corpus callosum 
L,R Body of the corpus callosum 
L,R Inferior fronto-occipital fasciculus 
L,R Anterior thalamic radiation 
L,R Cingulum 
L,R Uncinate fasciculus 
L,R Inferior longitudinal fasciculus 
L,R Superior longitudinal fasciculus 
bvFTD>SD 2 557 347 R Inferior fronto-occipital fasciculus 
R Anterior thalamic radiation 
R Uncinate fasciculus 
SD>bvFTD 2 3.605 2.862 L Inferior fronto-occipital fasciculus 
L Uncinate fasciculus 
L Inferior longitudinal fasciculus 
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abstract
Phenocopy frontotemporal dementia (phFTD) is a rare and poorly understood 
clinical syndrome. PhFTD shows core behavioural variant FTD (bvFTD) symptoms, 
without associated cognitive deficits and brain abnormalities on conventional 
MRI, and without progression. In contrast with phFTD, functional connectivity and 
white matter (WM) microstructural abnormalities have been observed in bvFTD. 
We hypothesise that phFTD belongs to the same disease spectrum as bvFTD, and 
investigated whether functional connectivity and microstructural WM changes 
similar to bvFTD are present in phFTD. 
Seven phFTD patients without progression or alternative psychiatric diagno-
sis, twelve bvFTD patients and seventeen controls underwent resting state func-
tional MRI (rs-fMRI) and diffusion tensor imaging (DTI). Default mode network 
(DMN) connectivity and WM measures were compared between groups. 
PhFTD showed subtle increased DMN connectivity, and subtle microstruc-
tural changes in frontal WM tracts. BvFTD showed abnormalities in similar re-
gions as phFTD, but had lower increased DMN connectivity, and more extensive 
microstructural WM changes.
Our findings can be interpreted as neuropathological changes in phFTD and 
are in support of the hypothesis that phFTD and bvFTD may belong to the same 
disease spectrum. Advanced MRI techniques, objectively identifying brain abnor-
malities, would therefore be potentially suited to improve diagnosis of phFTD. 
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1. IntroDUCtIon
Phenocopy (or nonprogressive) frontotemporal dementia (phFTD) is a rare and 
poorly understood syndrome, which was only recently described by Davies et al. 
2006 [1] in a subgroup of behavioural variant FTD (bvFTD) patients who had a 
better prognosis than expected. 
PhFTD symptomatology is very similar to that of bvFTD, but some aspects of 
phFTD are essentially different. In phFTD, core bvFTD symptoms, such as apathy, 
behavioural disinhibition, and loss of insight[2], are generally not accompanied 
by cognitive and brain abnormalities as is the case in bvFTD. PhFTD patients show 
a cognitive profile that ranges from normal to suggesting FTD [3–6] and have 
a relatively intact performance of daily living activities (ADL)[2,6]. These clini-
cal features in phFTD appear stable over time, whereas in bvFTD patients rapid 
progression of cognitive deficits is evident [1,6–8]. On conventional (structural) 
magnetic resonance imaging (MRI), phFTD patients show no or only borderline 
abnormalities [1,8] in the frontal and temporal regions that are typically affected 
in bvFTD[9]. Positron emission tomography (PET) does not show the frontal hy-
pometabolism that is observed in bvFTD [10]. As bvFTD patients may initially also 
present without structural MRI abnormalities, early-stage distinction between 
phFTD and bvFTD may be difficult.
A pathophysiological explanation for phFTD symptomatology is currently una-
vailable. Patients often remain undiagnosed or receive an alternative psychiatric 
diagnosis. Additionally, they are occasionally found to be C9orf72 mutation carriers 
[11]. It is therefore of importance to investigate the presence of possible brain ab-
normalities underlying their symptoms using more advanced MRI techniques such 
as resting state functional MRI (rs-fMRI) and diffusion tensor imaging (DTI). These 
techniques measure subtle brain changes so far left unexplored, by looking at func-
tional connectivity and microstructural white matter (WM). A well-defined network 
showing functional abnormalities in bvFTD is the default mode network (DMN). In 
bvFTD, parietal regions of the DMN show increased connectivity [12,13]. Frontal 
DMN connectivity changes are more ambiguous, found to be either increased [14] 
or decreased [12]. Such functional changes are thought to precede grey matter 
atrophy appearing at the later stages of bvFTD [12,15]. WM abnormalities in bvFTD 
are found mainly in frontal and temporal areas such as the uncinate fasciculus (UF), 
cingulum and the genu of the corpus callosum (CC) [16]. Similar regions are found 
to be already affected in asymptomatic-FTD mutation-carriers [15].
As phFTD patients present with behavioural symptoms similar to bvFTD, we 
hypothesise that phFTD and bvFTD may belong to the same disease spectrum. 
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This study investigates whether phFTD patients have underlying brain abnormali-
ties that are similar to those seen in bvFTD patients: functional brain abnormali-
ties expressed as DMN connectivity changes and microstructural WM abnormali-
ties expressed as diffusion changes.
2. MethoDS
2.1 Participants
All patients were recruited in the Alzheimer Centre Southwest Netherlands. 
PhFTD patients (aged 40-75 years) with prominent behavioural changes interfer-
ing with social functioning, consisting of disinhibition and/or apathy and/or ste-
reotypy; no reported progression one year after initial routine diagnostic workup, 
and bvFTD patients (aged 45-70 years) with a diagnosis of bvFTD [17]; a clinical 
dementia rating scale score of ≤ 1; a Mini-Mental State Examination [18] (MMSE) 
score of ≥ 20, were included in the study.
Patients with other neurological disorders, past or current substance abuse 
or other psychiatric diagnosis were excluded. PhFTD patients with a diagnosis of 
dementia and missing heteroamnesis, and bvFTD patients with a different cause 
of dementia, were also excluded. 
Healthy controls (aged 60-70 years), without neurological or psychiatric his-
tory, were recruited through advertisement. They were matched for gender with 
phFTD patients and for age with all patients.
The study was approved by the local medical ethics committee. All partici-
pants gave written informed consent.
2.2 Psychiatric, neuropsychological and 
genetic mutation assessment
PhFTD patients underwent full psychiatric assessment as part of this study to ex-
clude alternative diagnoses. Additionally, their DNA was tested for the C9orf72 
mutation. 
All participants underwent a full neuropsychological assessment and an 
MMSE [18]. Six phFTD patients had a cognitive profile suggestive of FTD, but 
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showed no progression relative to previous neuropsychological testing consistent 
with the phFTD criteria. One phFTD patient had a normal cognitive profile. Mean 
interval between current and first neuropsychological testing was 36 months 
(range: 8-71 months). The cognitive profile was consistent with bvFTD for bvFTD 
patients and normal for controls.
2.3 Image acquisition
Scanning was performed on two 3T GE Discovery MR750 systems (GE Healthcare, 
Milwaukee, WI, US) with identical protocols. PhFTD patients and twelve controls 
were scanned on one, and bvFTD patients and eight controls on the other scan-
ner. All participants underwent a high-resolution three-dimensional (3D) inver-
sion recovery (IR) fast spoiled gradient echo (FSPGR) T1-weighted image for ana-
tomical reference, and a functional gradient echo echo planar imaging (EPI) and 
t1w fmrI DtI
foV (mm) 240 240 240
te (ms) 3.06 30 84.2*
tr (ms) 7.90 3000 7925
ASSet factor 2 2 2
flip angle 12° 90° 90°
Acquisition matrix 240x240 96x96 128x128
Slice thickness (mm) 1 3 2.5
Volumes (slices per volume) 1 (176) 200 (44) 28 (59)
Duration (min) 4.41 10.00 3.50
Diffusion-weighted directions n/a n/a 25
Maximum b-value (s/ mm2) n/a n/a 1000
tI (ms) 450 n/a n/a
T1w = T1-weighted, fMRI = functional magnetic resonance imaging, DTI = diffusion tensor 
imaging,  FOV= field of view,  TE = echo time, TR = repetition time,  ASSET = array spatial  
sensitivity encoding technique, TI = inversion time.
*TE for DTI was set to minimum. This number represents the average TE. The range  of TE was 
81.9-90.8 ms.
table 1. Acquisition parameters.
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DTI spin echo EPI with full coverage of the supratentorial brain (Table 1). During 
the functional scan participants were instructed to focus on a fixation cross, to 
think of nothing in particular, and to stay awake.
2.4 Structural MRI analysis
Whole brain grey matter (GM) volume was calculated for each participant according 
to the methods described in Bron et al. 2014 [19]. For each participant, whole brain 
GM volume was divided by their individual intracranial volume (ICV) to correct for 
head size (expressed as % ICV)[20–22], and referred to as normalised GM (nGM). 
These values (%ICV) were then averaged per group, resulting in a mean nGM vol-
ume expressed as %ICV.  These group means were then compared between groups 
using a one-way ANOVA and post-hoc Bonferroni tests (SPSS21, USA).
2.5 Rs-fMRI analysis
Rs-fMRI data were analysed using FMRIB Software library (FSL4.1.9, UK) (see sup-
plement section 1 for more detail). The brain was extracted using the Brain Extrac-
tion Tool (BET) [23]. Then, MELODIC independent component analysis was used for 
pre-processing of the functional data and establishing the DMN component. Due 
to small sample size, only one network of interest could be investigated. The DMN 
was chosen as it is a well-defined functional network showing functional abnor-
malities in bvFTD, allowing for meaningful comparison between phFTD and bvFTD. 
Hereafter, the participant-specific DMN was identified using Dual regression [24]. 
Subsequently, Randomise [25] was used to assess between-group DMN connectivi-
ty differences using a one-way ANCOVA  with three groups (phFTD≠bvFTD≠controls) 
and GM volume as covariate. Main effects were investigated and six t-contrasts 
(phFTD>HC, HC>phFTD, bvFTD>HC, HC>bvFTD, phFTD>bvFTD, bvFTD>phFTD) were 
constructed to assess post-hoc between-group differences.
Cluster was used to extract cluster information. Results (p
corrected
<0.05, cluster 
size (k) ≥1; p
uncorrected
 <0.05, k≥20) were visualised using FSLview. Structural atlases 
implemented in FSLView were used to anatomically identify the DMN regions. 
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2.6 DTI analysis
Data were corrected for motion, eddy currents and EPI distortions using ExploreD-
TI [26]. Further analyses were performed with FSL (5.0.2.2, UK) (see supplement 
section 1 for more detail). BET [23] was used to create skull-stripped binary-
masks, after which DTIFIT [27] was used to reconstruct diffusion tensors and to 
create subject images for all WM measures, i.e. fractional anisotropy (FA), mean 
diffusivity (MD), axial diffusivity (AxD) and radial diffusivity (RD). Then, registra-
tion was performed using Tract-Based Spatial Statistics (TBSS) [28], resulting in 
subject-specific WM skeletons for each WM measure. Subsequently, Randomise 
[25] was used to assess between-group WM measure differences using a one-
way ANOVA with the same groups and post-hoc t-tests as in the rs-fMRI analysis. 
Cluster was used to extract cluster information. Results (p
corrected
<0.05, k≥20) 
were visualised using FSLView. The WM atlases implemented in FSLView were 
used to anatomically identify the WM regions.
3. reSULtS
3.1 Participant and disease characteristics 
Data of 7 phFTD patients, 12 bvFTD patients (9 for rs-fMRI analysis) and 17 con-
trols were used for the current analyses (Table 2). In total, nine phFTD patients 
(all male), 12 bvFTD patients (seven male) and 20 healthy controls (all male) were 
originally included in the study. Two phFTD patients and three controls were ex-
cluded from the analysis (see supplement section 2). Three bvFTD patients had 
missing rs-fMRI data. One phFTD patient’s follow-up was just under one year 
(11 months), for logistical reasons. The clinical diagnosis phFTD was established 
based on the clinical profile and lack of disease progression. 
PhFTD = phenocopy FTD. BvFTD = behavioural FTD. N = sample size. Values given as Mean (SD). 
MMSE = Mini-Mental State Examination.
Group n mean age mean mmse
PhFTD 7 (all male) 63.4 (4.8) 26.6 (1.4)
BvFTD 12 (7 male) 60.2 (7.6) 26.6 (2.8)
Controls 17 (all male) 64.1 (3.3) 28.2 (1.5)
table 2. Demographic characteristics.
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Age (H (2) = 2,23 p>0.05, Table 2) and MMSE score did not differ between groups 
(H (2) = 5,93, p>0.05, Table 2). 
None of the phFTD patients received an alternative psychiatric diagnosis that 
could explain their behavioural symptoms. Additionally, none carried the C9orf72 mu-
tation.
3.2 Structural MRI
The three groups showed a difference in nGM (H (2) = 16.38, p<0.05), with a mean 
of 0.32 %ICV (SD 0.02) for phFTD, 0.29 %ICV (SD 0.04) for bvFTD, and 0.35 %ICV 
(SD 0.02) for controls. Compared with controls, both phFTD patients (p=0.013) 
and bvFTD patients (p<0.001) had lower nGM volume. nGM volume was not dif-
ferent between phFTD and bvFTD patients (p=0.359). 
3.3 Functional connectivity
PhFTD and bvFTD patients (Figure 1, supplement Table 1A) showed connectivity 
in all regions of the DMN. Controls showed connectivity in all DMN regions except 
the right lateral temporal cortex (LTC) (Figure 1, supplement Table 1A). 
PhFTD patients compared with controls showed increased DMN connectiv-
ity in the bilateral medial prefrontal cortex (mPFC), LTC, and inferior parietal lob-
ule (IPL), and in the left posterior cingulate cortex (PCC)/precuneus (Figure 2, 
supplement Table 1B).
BvFTD patients compared with controls showed increased DMN connectivity 
in the bilateral mPFC, and right LTC and IPL (Figure 2, supplement Table 1B), and 
decreased DMN connectivity in the more posterior right IPL.
PhFTD patients compared with bvFTD patients showed increased DMN con-
nectivity in the bilateral mPFC and LTC, and right IPL (Figure 2, supplement Table 
1B). 
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Figure 1. Mean  default mode network (DMN) connectivity (p<0.05, not corrected for multiple 
comparisons, but Bonferroni corrected (p<0.05) for multiple contrasts; k≥20) in phenocopy 
frontotemporal dementia (phFTD), behavioural variant FTD (bvFTD) and controls.
Figure 2. Post-hoc t-test comparisons (phFTD>bvFTD, phFTD>controls, bvFTD>controls) showing 
between-group DMN connectivity differences (p<0.05, not corrected for multiple comparisons, 
but within the constraints of the omnibus f-test (p<0.05, Bonferroni corrected for multiple 
contrasts); k≥20). 
DMN = default mode network, phFTD = phenocopy frontotemporal dementia, bvFTD = 
behavioural variant FTD.
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3.4 Microstructural WM 
PhFTD and bvFTD patients compared with controls showed decreased FA and in-
creased RD and MD mainly in the frontal and temporoparietal WM (Figure 3, supple-
ment Tables 2A-C), such as the cingulum (both cingulate and hippocampus portion), 
inferior fronto-occipital fasciculus (IFOF), superior longitudinal fasciculus (SLF), cor-
pus callosum and uncinate fasciculus. In bvFTD patients in comparison with controls 
increased AxD was observed in these regions as well (Figure 3, supplement Table 2D).
BvFTD patients compared with phFTD patients showed decreased FA and in-
creased AxD in frontal WM, and increased MD and RD in frontotemporal WM, mainly 
in the cingulum (cingulate portion), IFOF, SLF, corpus callosum and uncinate fascicu-
lus (Figure 4, supplement Tables 2A-D). 
Figure 4. Post-hoc t-test microstructural white matter changes for bvFTD in comparison with 
phFTD (p
corrected
<0.05; k≥20). Lower FA and higher MD, RD and AxD in bvFTD are shown in blue.
PhFTD = phenocopy frontotemporal dementia, bvFTD = behavioural variant FTD, FA = fractional 
anisotropy, MD = mean diffusivity, RD = radial diffusivity, AxD = axial diffusivity. 
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Figure 3. Post-hoc t-test of microstructural white matter changes for phFTD (p
corrected
<0.05; k≥20) 
and bvFTD (p
corrected
<0.05; k≥20) in comparison with controls. Lower FA and higher MD, RD and AxD 
in comparison with controls is shown in phFTD in red and in bvFTD in blue. WM regions showing 
overlapping abnormalities in phFTD and bvFTD are shown in pink.
PhFTD = phenocopy frontotemporal dementia, bvFTD = behavioural variant frontotemporal 
dementia, FA = fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity, AxD = axial 
diffusivity.
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4. DISCUSSIon
To the best of our knowledge, this is the first study demonstrating functional con-
nectivity changes and microstructural WM abnormalities in phFTD. There was 
increased DMN connectivity in nearly all regions of the DMN, and abnormal mi-
crostructural WM in frontal and temporoparietal lobes. These changes were simi-
lar to the changes observed in bvFTD, supporting our hypothesis that phFTD may 
belong to the same disease spectrum as bvFTD. Specifically, bvFTD also showed 
higher connectivity in DMN regions, but to a lesser extent than in phFTD, and 
microstructural WM abnormalities in the frontal and temporoparietal lobes, but 
more pronounced than in phFTD.
DMN connectivity was increased, albeit to a moderate extent, in both phFTD 
and bvFTD. As there are overt behavioural symptoms in phFTD, as well as frequent 
neuropsychological abnormalities, it is not surprising to observe functional brain 
abnormalities. Increased functional connectivity reflects changes in neuronal 
activity becoming more congruent between regions. This may point to a brain 
mechanism compensating for early diminished neuronal functioning [29,30]. The 
degree of increased connectivity may reflect the brain’s remaining ability of com-
pensation, and in case of advanced neuronal dysfunctioning, this ability may no 
longer present, resulting in decreased connectivity. This theory may explain why 
we observe higher connectivity in phFTD than in bvFTD. As pronounced cortical 
atrophy is evident in bvFTD but not in phFTD [1,8,9,31], neuronal dysfunctioning is 
likely much more prominent in bvFTD. This means that more relatively preserved 
neurons in phFTD may be able to provide a better functioning compensational 
mechanism than in bvFTD. The observation that the inferior parietal lobule showed 
both increased and decreased (depending on its subregion) functional connectiv-
ity in bvFTD in comparison with controls, is in line with this view. It is plausible 
that the various subregions of the inferior parietal lobule are not affected to the 
same extent in bvFTD, resulting in decreased functional connectivity in the more 
affected subregion and in increased functional connectivity in the less affected 
subregion. Future studies consisting of a larger patient sample could shed further 
light on whether other resting state networks show similar functional connectiv-
ity changes to the DMN. A network of particular interest would be the salience 
network, which is a frontal functional network known to be affected in bvFTD [13]. 
This would allow for further meaningful comparisons between phFTD and bvFTD.
Frontotemporal and parietal microstructural WM abnormalities were ob-
served in both phFTD and bvFTD. In phFTD, FA was decreased (i.e. there was less 
directional diffusion) and RD and MD were increased (i.e. there was more diffu-
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sion, particularly perpendicular to the tract’s axis) in multiple WM tracts, includ-
ing the cingulum, UF, IFOF, genu of the CC and SLF. Damage to these WM tracts 
has been linked to the various cognitive functions typically affected in bvFTD. Loss 
of behavioural control (e.g. disinhibition) has been related to diffusion changes 
in the UF, forceps minor and cingulum [32,33]. Additionally, abnormalities in ex-
ecutive functioning, visuo-spatial attention, working memory and apathy have 
also been linked with diffusivity changes in the cingulum [34,35]. Interestingly, RD 
changes in these tracts were less pronounced than FA changes, which may be ex-
plained by FA being a composite measure of both RD and AxD (i.e. diffusion along 
the tract’s main axis), and therefore more sensitive to subtle myelin and/or axonal 
changes, reflected by changes in RD [36] and AxD [37] respectively. In phFTD, AxD 
abnormalities were not observed, which may be explained by myelin damage 
only, without axonal injury. In bvFTD, WM changes were more pronounced and 
widespread, with lower FA, and higher MD, RD and AxD than in phFTD. Hence, 
here we show an association in phFTD, similar to bvFTD, between symptomatol-
ogy and damage to the frontotemporal and parietal WM tracts. Additionally, we 
show differences possibly reflecting neuropathological changes between phFTD 
and bvFTD, with phFTD suggesting myelin damage only, and bvFTD showing more 
pronounced myelin and axonal damage. 
Previous literature has shown a relationship between microstructural WM 
changes and functional connectivity changes [38–40], and proposes that micro-
structural WM predicts, or is reflected by, functional connectivity [39,40]. For ex-
ample, the medial prefrontal cortex and posterior cingulate cortex, core regions 
of the DMN, are connected through the cingulum [39]. Cingulum abnormalities 
such as observed in this study may have – to a certain extent – disconnected 
these regions, reducing functional connectivity between anterior and posterior 
DMN regions. In support of this idea, there were more pronounced anterior 
WM abnormalities in bvFTD that extended more posteriorly than in phFTD, and 
both frontal and parietal functional connectivity were seen to be correspond-
ingly lower. A recent study by Weiler et al. (2014) [41] observed that higher RD in 
the cingulum and parahippocampal bundle (both connecting DMN regions) pre-
dicted reduced performance on measures related to DMN cognitive functions. 
We therefore hypothesise that more advanced abnormalities of WM tracts of the 
DMN may eventually lead to a functional decrease in the associated DMN areas 
and result in reduced cognitive functioning. As we did not aim to directly explore 
such a mechanism, our study design does not allow for any firm conclusions con-
cerning this mechanism.  A longitudinal design employing correlational analyses 
is needed to verify this hypothesis.
Functional connectivity and microstructural WM changes in phFTD
166
Overall, phFTD showed functional connectivity and subtle WM changes, whereas 
bvFTD showed fewer functional connectivity and more extensive WM changes. 
Lower overall cortical GM volume in phFTD patients was observed in this study 
using a quantitative method, but was not observed in the regular clinical diag-
nostic work-up. This suggests that GM volume loss is also present in phFTD pa-
tients, but at such a limited degree that it is not clinically detected. These findings 
are indicative of incipient degeneration in phFTD. In order to investigate phFTD 
without the interference of an alternative diagnosis we ruled out alternative psy-
chiatric disorders, neuropsychological progression and presence of the C9orf72 
mutation. The observed incipient brain changes in this well-defined population 
are in favour of the controversial notion that phFTD and bvFTD may belong to the 
same disease spectrum. PhFTD presents with behavioural, neuropsychological 
and, as shown here, also neurodegenerative changes that are all similar to those 
observed in bvFTD. 
This study has some limitations. First, we were only able to investigate a small 
number of phFTD and bvFTD patients, limiting statistical power. As a result, rs-fM-
RI effects, already expected to be subtle, were only detectable using a relatively 
lenient statistical threshold, and could only be investigated in one functional net-
work.The sample size is inherent to the rarity of the phFTD syndrome, together 
with the application of strict inclusion and exclusion criteria to avoid inadvertent 
inclusion of patients with bvFTD or alternative psychiatric disorders. Second, the 
bvFTD group was not fully matched for gender with the phFTD and control group. 
There is no conclusive evidence on gender differences in functional connectivity 
[42] or microstructural WM. Both higher and lower FA was measured in the cin-
gulum and in the WM underlying the frontal cortex in men and in women com-
pared with the opposite gender [43]. Given these findings it is not likely that the 
FA decreases observed in this study were driven by gender differences. Third, the 
bvFTD group and part of the control group were scanned on a different scanner, 
although of identical type and field strength, and with identical protocols. While 
a scanner effect cannot be excluded, both rs-fMRI and DTI have been shown to 
be highly reproducible in terms of DMN functional connectivity and TBSS respec-
tively, even across different scanner platforms and vendors [44,45]. Moreover, 
the fact that our findings in bvFTD are consistent with the previous literature sug-
gest that the effect of scanner is likely to be minimal.
In conclusion, our findings are in support of the hypothesis that phFTD and 
bvFTD may belong to the same disease spectrum. In phFTD, there are changes in 
functional connectivity and microstructural WM that are similar to those found in 
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bvFTD. Advanced MRI techniques, such as rs-fMRI and DTI, are therefore poten-
tially suited to improve diagnosis of phFTD by identifying such incipient changes. 
Naturally, the hypothesis that phFTD and bvFTD may belong to the same disease 
spectrum would require confirmation with other diagnostic tools, such as histo-
pathology. Also, further assessment in a longitudinal study to assess changes over 
time would be required, at which our future efforts are aimed. Our findings could 
provide a direction for further development of MR - or other - diagnostic tools. 
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SUPPLeMent
Supplement section 1 
Rs-fMRI analysis
Resting state data were analysed using FMRIB Software library (FSL4.1.9, Oxford, 
UK)[1–3]. T1w images were first reoriented to ensure the same orientation as the 
standard template T1 images. The skull was stripped using the Brain Extraction 
Tool (BET)[4].
The Multivariate Exploratory Linear Optimised Decomposition into Inde-
pendent Components (MELODIC) toolbox was used to preprocess the data and 
to perform independent component analysis (ICA). Preprocessing consisted of 
several steps. First the high pass filter was set to remove low-frequency drifts 
(cut-off 120s). Then MCFLIRT[5] motion correction was applied to correct for 
linear motion followed by spatial smoothing performed with a Gaussian kernel 
of 5 FWHM. During registration, functional data were first linearly registered to 
the corresponding T1w images (full search, 7 degrees of freedom (DOF)). This 
was followed by both linear and nonlinear registration to a standard template 
brain (full search, 12 DOF) with a warp resolution of 10mm and a resampling 
resolution of 4mm. Resting state networks were identified by performing a multi-
session temporal concatenation ICA. Component output was limited to 30. Dual 
regression[6] was used to identify the group components in the functional data 
of each participant. The component representing the DMN was identified. The 
DMN was chosen because it is an anatomically clearly defined network and shows 
pronounced abnormalities in bvFTD patients [7,8]. Only one network was inves-
tigated because of the small sample size of the study and thus reduced statistical 
power. FSLcc was used to identify the component showing the highest correlation 
between a DMN template[9] and ICA output. 
The Randomise[10] tool was used to assess between-group differ-
ences in DMN network connectivity. The design was constructed using the 
general linear model (GLM) toolbox. A one-way ANCOVA with three groups 
(phFTD≠bvFTD≠controls) was performed to assess which regions showed dif-
ferent connectivity between groups. Effects per group were investigated and 
six t-contrasts (phFTD>HC, HC>phFTD, bvFTD>HC, HC>bvFTD, phFTD>bvFTD, 
bvFTD>phFTD) were constructed to assess post-hoc between-group differences. 
Grey matter volume was added as covariate to account for grey matter atrophy. 
Threshold-free cluster enhancement (TFCE) [11] and nonparametric permuta-
tion testing with 5000 permutations was applied. Results were not family-wise 
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error corrected for multiple comparisons on a voxel level. However, the f-test 
resulting from the one-way ANOVA and the group effects (phFTD, bvFTD, con-
trols) were Bonferroni corrected for the number of contrasts, thus using an effec-
tive threshold of p<0.0125. Subsequent Bonferroni correction for the number of 
post-hoc t-tests was considered unnecessary as their results were assessed with-
in the constraints of the omnibus f-test. This was done by creating common bi-
nary masks to identify post-hoc t-tests results within the omnibus f-test positive 
connectivity regions. Using the FSLmaths tool, first binary masks were created for 
the f-test and for every t-test. Second, the binary mask of each t-test was multi-
plied with binary mask of the f-test, resulting in common binary masks for each 
t-test.
All t-test common binary masks (p<0.05, not corrected for multiple com-
parisons), the f-test and the three group effects (p<0.05, Bonferroni corrected for 
multiple contrasts) were evaluated using the Cluster tool to extract cluster size 
with a cluster threshold of k≥20 voxels.
Results were visualised using FSLview. The Harvard-Oxford Cortical Struc-
tural Atlas and the Harvard-Oxford Subcortical Structural Atlas implemented in 
FSLView were used to anatomically identify the DMN regions.
DTI analysis
Data were corrected for motion, eddy currents and EPI distortions using 
ExploreDTI[12]. Further analyses were performed with FSL (5.0.2.2, Oxford, UK)
[1–3]. BET[4] was used to create skull-stripped binary-masks. Using DTIFIT, as 
implemented in FMRIB’s Diffusion Toolbox (FDT)[13], the diffusion tensors were 
reconstructed. Then DTIFIT created subject images for fractional anisotropy (FA), 
mean diffusivity (MD), the first eigenvalue/axial diffusivity (AxD) and the second 
and third eigenvalues. FSLmaths was used to calculate subject radial diffusivity 
(RD) images by averaging the second and third eigenvalue images.
Registration of diffusivity measure images was executed by Tract-Based Spa-
tial Statistics (TBSS) [14]. First, subject FA image outliers from DTIFIT were exclud-
ed by removing brain-end artefacts and end slices. Second, non-linear registra-
tion of all subject FA images to the FMRIB58 FA template was performed. Third, 
all subject FA images were normalised to the Montreal Neurological Institute 
(MNI) template. Then the mean of all normalised subject FA images was taken to 
create a mean FA skeleton. Fifth, the mean FA skeleton was binarised. Then each 
subject’s FA image was projected onto this binary FA skeleton. TBSS was repeated 
for AxD, MD and RD images. FA nonlinear registration parameters were applied to 
subject AxD, MD and RD images creating nonlinearly registered images for each 
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of them. For each measure all subject images were projected onto the FA skel-
eton, creating a new skeleton for each diffusivity measure. 
Randomise[10] was run to test for between-group differences in all de-
scribed diffusivity measures. TFCE[11] nonparametric permutation testing with 
5000 permutations was applied. Results were family-wise error (FWE) corrected 
for multiple comparisons.
WM microstructure differences between phFTD, bvFTD and controls were 
assessed using the same design defined for the rs-fMRI analysis, but now only the 
f-test and subsequent post-hoc t-tests were investigated. As group effects were 
not investigated, additional Bonferroni correction for the number of contrast was 
unnecessary. Again, common binary masks were created to assess t-test results 
within the constraints of the omnibus f-test results by multiplying binary masks 
of each t-test with the binary mask of the f-test. All t-test common binary masks 
(p<0.05, FWE corrected for multiple comparisons) were evaluated using Cluster 
to extract cluster size with a cluster threshold of k≥20.
Results were visualised using FSLView. The JHU White-Matter Tractography 
Atlas and the JHU ICBM-DTI-81 White-Matter labels implemented in FSLView 
were used to anatomically identify the white matter regions.
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Supplement section 2 – Participant exclusion after inclusion
Nine phFTD patients (all male), 12 bvFTD patients (seven male) and 20 healthy 
controls (all male) were included in the study. Two phFTD patients were excluded 
from the analysis: one refused neuropsychological testing and one showed dis-
ease progression on neuropsychological testing. One phFTD patient showed a 
cortical infarct in the right parietal lobe on the structural MRI scan, but reported 
no residual clinical symptoms and his neuropsychological profile was rated as 
normal; he was therefore retained in the analysis. Three controls were excluded 
from the analysis: one due to a below average score on a neuropsychological do-
main typically affected in FTD; the second due to an incidental scanner artefact 
observed in the MR images; the third because of missing DTI data. Three bvFTD 
patients had missing rs-fMRI data. 
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Supplement table 1A. Group effects (p<0.05, not corrected for multiple comparisons, but 
Bonferroni corrected (p<0.05) for multiple contrasts; k≥20) of DMN connectivity in phFTD, bvFTD 
and controls.
DMN = default mode network, phFTD = phenocopy frontotemporal dementia, bvFTD = 
behavioural variant frontotemporal dementia, HC = healthy controls, L = left, R = right.
Supplement table 1B. Post-hoc two sample t-tests (p<0.05, not corrected for multiple 
comparisons, but within the constraints of the omnibus f-test (p<0.05, Bonferroni corrected for 
multiple contrasts); k≥20) of group differences in DMN connectivity between phFTD, bvFTD and 
controls.
DMN = default mode network, phFTD = phenocopy frontotemporal dementia, bvFTD = 
behavioural variant frontotemporal dementia, HC = healthy controls, L = left, R = right.
t-stat number 
of DMn 
clusters
total 
number 
of voxels
number of voxels 
within largest 
DMn cluster
Anatomical regions within  
largest DMn cluster
phFTD>HC 7 635 162 Lateral temporal cortex R
Inferior parietal lobule R
bvFTD>HC 3 104 43 Lateral temporal cortex R
Inferior parietal lobule R
HC>bvFTD 1 44 44 Inferior parietal lobule R
phFTD>bvFTD 7 852 374 Lateral temporal cortex L
Subcortical and cerebellar regions L
Group 
effect
number 
of DMn 
clusters
total 
number 
of voxels
number of voxels 
within largest 
DMn cluster
Anatomical regions within  
largest DMn cluster
phFTD 2 7,852 7,827 Medial prefrontal cortex L, R
Lateral temporal cortex L, R
Inferior parietal lobule L, R
Precuneus/posterior cingulate cortex L, R
bvFTD 2 4,848 4,458 Lateral temporal cortex L, R
Inferior parietal lobule L, R
Precuneus/posterior cingulate cortex L, R
HC 5 1,635 1,015 Inferior parietal lobule R
Precuneus/posterior cingulate cortex L, R
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FA = fractional anisotropy, phFTD = phenocopy frontotemporal dementia, bvFTD = behavioural 
variant frontotemporal dementia, HC = healthy controls, L = left, R = right.
Supplement table 2A. Post-hoc two sample t-tests (p
corrected
<0.05; k≥20) of group differences in FA 
between phFTD, bvFTD and controls.
t-stat number 
of  
clusters
total 
number 
of voxels
number of voxels 
within largest 
cluster
Anatomical regions within  
largest cluster
phFTD<HC 28 14,084 4,644 Forceps minor
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
bvFTD<HC 12 31,220 29,598 Forceps minor
Forceps major
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Splenium of the corpus callosum 
L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
Inferior longitudinal fasciculus L, R
Superior longitudinal fasciculus L, R
bvFTD<phFTD 4 8,025 7,777 Forceps minor
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
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Supplement table 2B. Post-hoc two sample t-tests (p
corrected
<0.05; k≥20) of group differences in 
MD between phFTD, bvFTD and controls.
MD = mean diffusivity, phFTD = phenocopy frontotemporal dementia, bvFTD = behavioural variant 
frontotemporal dementia, HC = healthy controls, L = left, R = right.
t-stat number 
of  
clusters
total 
number 
of voxels
number of voxels 
within largest 
cluster
Anatomical regions within  
largest cluster
phFTD>HC 5 1,686 883 Anterior thalamic radiation L, R
Inferio fronto-occipital fasciculus 
L, R
Superior longitudinal fasciculus L, R
bvFTD>HC 14 39,036 37,066 Forceps minor
Forceps major
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Splenium of the corpus callosum 
L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
Inferior longitudinal fasciculus L, R
Superior longitudinal fasciculus L, R
bvFTD>phFTD 4 19,769 19,586 Forceps minor
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
Inferior longitudinal fasciculus L
Superior longitudinal fasciculus L, R
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Supplement table 2C. Post-hoc two sample t-tests (p
corrected
<0.05; k≥20) of group differences in RD 
between phFTD, bvFTD and controls. 
t-stat number 
of  
clusters
total 
number 
of voxels
number of voxels 
within largest 
cluster
Anatomical regions within  
largest cluster
phFTD>HC 9 7,963 6,137 Forceps minor
Forceps major
Inferior fronto-occipital fasciculus 
R
Anterior thalamic radiation R
Cingulum R
Uncinate fasciculus R
Inferior longitudinal fasciculus R
Superior longitudinal fasciculus R
bvFTD>HC 16 46,485 45,111 Forceps minor
Forceps major
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Splenium of the corpus callosum 
L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
Inferior longitudinal fasciculus L, R
Superior longitudinal fasciculus L, R
bvFTD>phFTD 6 22,230 21,946 Forceps minor
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L, R
Uncinate fasciculus L, R
Inferior longitudinal fasciculus L, R
Superior longitudinal fasciculus L, R
RD = radial diffusivity, phFTD = phenocopy frontotemporal dementia, bvFTD = behavioural variant 
frontotemporal dementia, HC = healthy controls, L = left, R = right.
181
4.1
Supplement table 2D. Post-hoc two sample t-tests (p
corrected
<0.05; k≥20)  of group differences in 
AxD between phFTD, bvFTD and controls. 
AxD = axial diffusivity, phFTD = phenocopy frontotemporal dementia, bvFTD = behavioural variant 
frontotemporal dementia, HC = healthy controls, L = left, R = right.
t-stat number 
of  
clusters
total 
number 
of voxels
number of voxels 
within largest 
cluster
Anatomical regions within  
largest cluster
phFTD>HC 0 n/a n/a n/a
bvFTD>HC 3 18,269 17,552 Forceps minor
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Cingulum L
Uncinate fasciculus L, R
Superior longitudinal fasciculus L, R
bvFTD>phFTD 8 11,202 10,396 Forceps minor
Genu of the corpus callosum L, R
Body of the corpus callosum L, R
Inferior fronto-occipital fasciculus 
L, R
Anterior thalamic radiation L, R
Uncinate fasciculus L, R
Superior longitudinal fasciculus L, R
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abstract 
‘Phenocopy’ frontotemporal dementia (phFTD) patients may clinically mimic the 
behavioural variant of FTD (bvFTD), but do not show functional decline or abnor-
malities upon visual inspection of routine neuroimaging. We aimed to identify 
abnormalities in grey matter (GM) volume and perfusion in phFTD and to assess 
whether phFTD belongs to the FTD spectrum. We compared phFTD patients with 
both healthy controls and bvFTD patients.
Seven phFTD and 11 bvFTD patients, and 20 age-matched controls under-
went structural T1-weighted magnetic resonance imaging (MRI) and 3D pseudo-
continuous arterial spin labelling (pCASL) at 3T. Normalised GM (nGM) volumes 
and perfusion, corrected for partial volume effects, were quantified regionally as 
well as in the entire supratentorial cortex, and compared between groups taking 
into account potential confounding effects of gender and scanner. 
PhFTD patients showed cortical atrophy, most prominently in the right tem-
poral lobe. Regional GM volume was otherwise generally not different from either 
controls or from bvFTD, despite the fact that bvFTD showed extensive frontotem-
poral atrophy. Perfusion was increased in the left prefrontal cortex compared to 
bvFTD and to a lesser extent to controls.
PhFTD and bvFTD show overlapping cortical structural abnormalities indicat-
ing a continuum of changes especially in the frontotemporal regions. Together 
with functional changes suggestive of a compensatory response to incipient pa-
thology in the left prefrontal regions, these findings are the first to support a 
possible neuropathological aetiology of phFTD and suggest that phFTD may be a 
neurodegenerative disease on the FTD spectrum.
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1. IntroDUCtIon
FTD is a presenile neurodegenerative disorder affecting the frontal and temporal 
lobes, with the behavioural variant (bvFTD) as its most common subtype. BvFTD 
is characterised by progressive deterioration in social and personal conduct [1]. 
Core clinical features are behavioural disinhibition, apathy, loss of empathy, and 
perseverative, stereotypical or compulsive behaviour. In addition to these symp-
toms, the diagnosis of probable bvFTD requires frontotemporal changes on neu-
roimaging and a gradual decline in functional abilities [2]. A subset (reports range 
from 7% up to 37% [3,4]) of predominantly male patients presents with behav-
ioural changes characteristic of bvFTD, but without abnormalities on structural 
magnetic resonance imaging (MRI) or fluorodeoxyglucose-positron emission to-
mography (FDG-PET) [5-8]. In addition, these patients have a more benign dis-
ease course [7] and do not show a decline in activities of daily living [9]. This 
clinical syndrome is referred to as ‘phenocopy’ FTD (phFTD) [10]. 
Because normal neuroimaging features and no cognitive decline over time 
are reported in these patients, a neurodegenerative aetiology is disputed. Au-
topsy findings are sparse, but have not shown features of neurodegeneration 
[11,12], Very recently, repeat expansion in the C9ORF72 gene has been associ-
ated with very slowly progressive FTD, resembling phFTD. Some patients with this 
mutation have initially been diagnosed with phFTD [3,13], but currently, phFTD 
is still defined as a clinical syndrome. An alternative notion is that phFTD patients 
might have a pre-existent psychiatric disorder and decompensate during mid-life 
[14-16].
In the present study we used advanced quantitative MRI techniques and 
analyses to investigate both structural and functional abnormalities in phFTD in 
more detail, as the typical behavioural changes in phFTD imply neurophysiologi-
cal changes which may be detected with these advanced methods [3]. We used 
arterial spin labelling (ASL)-MRI to quantify brain perfusion with higher spatial 
resolution than thus far achieved with PET [17]. Focal atrophy can be detected 
by regional quantification of grey matter volume on structural imaging. Grey mat-
ter volume and perfusion in phFTD patients were compared with both healthy 
controls and bvFTD patients in order to assess whether phFTD belongs to the FTD 
spectrum.
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2.1 Participant selection
PhFTD and bvFTD patients were recruited from the Alzheimer Centre Southwest 
Netherlands at Erasmus MC, Rotterdam, The Netherlands, which is a tertiary 
referral centre with special focus on FTD. Exclusion criteria for both phFTD and 
bvFTD patients were contraindications for MR imaging and lack of hetero-anam-
nestic information. In addition, phFTD patients were excluded when there was a 
diagnosis of dementia, or when other neurological or psychiatric disorders were 
suspected.
Of the fifteen patients that fulfilled the criteria for phFTD, i.e. behavioural 
features but no imaging findings consistent with bvFTD, and no progression for 
at least one year after initial diagnostic work-up, six patients declined to partici-
pate; one was excluded due to refusal of neuropsychological assessment; and 
one eventually showed progressive cognitive impairment at neuropsychological 
follow-up, resulting in the analysis of seven phFTD patients. One patient showing 
an asymptomatic cortical infarct in the right parietal lobe on MRI was retained in 
the analyses, as no residual clinical symptoms were reported and the infarct was 
not in a region of interest for FTD. Image processing results were visually checked 
and did not show any effect of the infarct on segmentation or registration proce-
dures. All phFTD patients were screened for the presence of the repeat expansion 
of the C9ORF72 gene.
Twelve bvFTD patients with possible bvFTD [2] with an onset before 65 years 
and a Mini Mental State Examination (MMSE) score ≥ 20 were prospectively re-
cruited as part of a larger ongoing study on advanced MR neuroimaging in the 
early stage of presenile dementia. If the diagnosis at the initial visit was uncertain, 
definitive diagnosis was confirmed after sufficient follow-up. One patient was ex-
cluded from analysis due to poor perfusion data quality, resulting in the analysis 
of 11 bvFTD patients.
Healthy age-matched controls were recruited through advertisement and 
from the patients’ peers. They were matched for gender with the phFTD patients. 
Exclusion criteria were history of neurological or psychiatric disorders and con-
traindications for MRI. Of the twenty-three controls, two were excluded due to 
missing data and one because of below-average scores on neuropsychological 
assessment, resulting in the analysis of twenty healthy controls.
The study was approved by the medical ethics committee of Erasmus MC. All 
participants gave written informed consent.
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2.2 Neuropsychological and psychiatric assessment
All participants underwent extensive neuropsychological examination as part of 
routine diagnostic work-up, assessing language and speech, attention and men-
tal processing speed, executive functions, memory, and social cognition. PhFTD 
patients had an additional assessment to verify whether they fulfilled the crite-
rion of no progression for at least one year. Additionally, they were assessed by 
an experienced psychiatrist to rule out major psychiatric disorders other than 
dementia. Psychiatric assessment was based on interviews with the patients and 
their caregivers, the Brief Psychiatric Rating Scale (BPRS [18]; Dutch translation 
[19]), and the psychiatrist’s observations.
2.3 Image acquisition
Patients underwent MR imaging on two identical 3T scanners (Discovery MR750 
system GE Healthcare, USA) with identical protocols. Seven healthy controls and 
all phFTD patients were scanned on one, and 13 healthy controls and all bvFTD 
patients on the other scanner. 
2.3.1 Structural imaging
For grey matter volumetric assessment and anatomical reference, a high-reso-
lution three-dimensional (3D) inversion recovery (IR) fast spoiled gradient-echo 
(FSPGR) T1-weighted (T1w) image was acquired (inversion time (TI) 450ms, echo 
time (TE) 3.06ms, repetition time (TR) 7.904s, flip angle 12°, ASSET factor 2, iso-
tropic resolution 1mm3 in a 240mm field of view (FOV), 176 sagittal slices, total 
acquisition time 4.41 min).
2.3.2 Perfusion imaging
Perfusion images were acquired using whole brain 3D pseudo-continuous ASL (p-
CASL), currently the recommended sequence for clinical use [20] (interleaved fast 
spin-echo stack-of-spiral readout of 512 sampling points on 8 spirals, background 
suppressed, post labelling delay 1525ms, labelling duration 1450ms, TE 10.5ms, 
TR 4632ms, isotropic resolution 3.3mm3 in a 240mm FOV, 36 axial slices, number 
of excitations (NEX) 3, total acquisition time 4.29 min). The labelling plane was 
positioned 9 cm below the anterior commissure – posterior commissure line.
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2.4 Image data processing 
We processed imaging data according to the methods described in detail by Bron 
et al., 2014 [21].
2.4.1 Tissue segmentation
Using the unified tissue segmentation method in SPM8 (Statistical Parametric 
Mapping, London, UK), we segmented T1w images into grey matter (GM), white 
matter and cerebrospinal fluid maps. The GM maps were subsequently used to 
derive GM volumes and cerebral blood flow (CBF). 
2.4.2 ASL post-processing
The ASL data consisted of a difference image and a control image. GM maps were 
rigidly registered with the difference image (Elastix registration software [22]) and 
registrations were checked visually. Tissue maps were transformed to ASL image 
space to perform partial volume (PV) correction, and PV effects in ASL difference 
and control images were subsequently corrected using local linear regression 
within a 3D kernel based on tissue maps [23]. We quantified PV-corrected ASL 
images as CBF maps using the single-compartment model [20]. CBF maps were 
transformed to T1w image space for further analysis.
2.4.3 ROI labelling
We defined regions of interest (ROIs) for each participant using a multi- 
atlas approach. This involved registration of 30 labelled T1w images, each 
containing 83 cortical and subcortical ROIs [24,25], to the participants’ T1w im-
ages. The labels of the 30 atlas images were fused by means of majority vot-
ing to obtain a final ROI labelling [26]. Rigid, affine, and non-rigid B-spline 
transformation models were applied successively for registration to the partici-
pants’ nonuniformity-corrected T1w images [27]. Both the participants’ and the 
labelled T1w images were masked for this registration using the Brain Extraction 
Tool [28].
2.4.4 ROI analysis
For all ROIs, we derived GM volumes and mean GM CBF values. The subcorti-
cal ROIs, cerebellum, brainstem, ventricles and white matter were excluded from 
analysis. ROIs that parcellated gyri in multiple sections were combined to consti-
tute entire gyri (supplementary table 1). GM volumes and mean GM CBF values 
were subsequently obtained for the left and right hemisphere separately. Region-
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al GM volumes were divided by the total intracranial volume to correct for head 
size and are referred to as normalised GM (nGM) volumes.
 
2.5 Data analysis
Using SPSS Statistics, version 20.0 (New York, USA) we first analysed differences in 
gender and scanner across groups with Fisher’s exact test. As these were signifi-
cantly different between groups (p<0.05), we then used hierarchical regression 
to sequentially assess the effects of scanner, gender, and group on nGM and CBF. 
Only the nGM and regional CBF ROIs that showed a significant effect of group 
but did not show significant effects of scanner and/or gender were further tested 
for differences between groups. This was done using a nonparametric Kruskal-
Wallis test with Dunn-Bonferroni correction for multiple comparisons as nGM, 
CBF, age and MMSE were not normally distributed across groups (Shapiro-Wilk 
test p<0.05). The findings were visually represented in boxplots of nGM and CBF 
for each of the brain lobes. Statistical thresholds were set at p<0.05.
3. reSULtS
3.1 Participant characteristics
Age was not different between groups (H(2) = 1.129, p>.05, Kruskal-Wallis test) 
(table 1). MMSE was significantly different between groups (F(2) = 10.182, p<.05, 
Kruskal-Wallis test): both phFTD and bvFTD patients had significantly lower MMSE 
scores than controls. 
Controls phFTD bvFTD
N (male) 20 (20) 7 (7) 11 (5)
Median age in years (25th-75th %ile) 64 (62-66) 61 (60-70) 63 (57-66)
Median MMSE (25th-75th %ile) 28 (28-30) 27 (26-28) 27 (24-28)
table 1: participant characteristics
bvFTD = behavioural variant frontotemporal dementia; IQR = interquartile range; MMSE = Mini 
Mental State Examination; phFTD = phenocopy frontotemporal dementia; SD = standard deviation
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None of the phFTD patients had a C9ORF72 mutation, nor could their behavioural 
disturbances be attributed to an underlying psychiatric disorder. Neuropsycho-
logical assessment was normal in one and suggestive of FTD in six phFTD patients, 
but did not demonstrate progressive decline.
Median follow-up to establish definitive diagnosis of bvFTD was 1.4 years 
(range 1.7 months - 2.4 years).
3.2 Grey matter volumetric changes
There were significant differences in nGM volume between groups mostly in fron-
tal and temporal regions (Figure 1A, Table 2). PhFTD patients had lower supraten-
torial nGM volume than controls which was most pronounced in the right pos-
terior temporal lobe, right superior temporal gyrus and bilateral fusiform gyrus. 
BvFTD showed extensive bilateral frontotemporal nGM volume loss compared 
to controls. Compared to phFTD, bvFTD showed lower nGM volume in the right 
hippocampal formation and the right amygdala. Other nGM volumes were not 
significantly different between bvFTD and phFTD. This spectrum of findings, with 
mean nGM volumes being highest in controls, lowest in bvFTD and in-between in 
phFTD, was particularly apparent in the frontal and temporal lobes (Figure 2A). 
3.3 Perfusion changes in the grey matter
There were significant differences in CBF between groups in frontal regions (Fig-
ure 1B, Table 3). CBF in the bilateral subcallosal area was higher in phFTD than 
both in bvFTD and controls, as illustrated in Figure 2B. CBF in bvFTD was lower 
than in phFTD in the left superior and inferior frontal gyrus, the left orbitofrontal 
gyrus, and in the bilateral straight gyrus. bvFTD showed lower CBF than controls 
in the left inferior frontal and straight gyrus, and the left orbitofrontal gyrus.
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Figure 1. Schematic overview of cortical regions showing (A) normalised GM volume and (B) 
perfusion abnormalities. Figure 1A shows in red regional nGM atrophy present in both phFTD and 
bvFTD; in blue regional nGM volume loss in bvFTD compared to both phFTD and controls; and 
in yellow regional nGM volume loss in in bvFTD when compared to controls, but not compared 
to phFTD. Figure 1B shows in cyan hyperperfusion in phFTD compared to bvFTD in regions that 
show hypoperfusion in bvFTD compared to controls; in green regional hyperperfusion in phFTD 
compared to both bvFTD and controls; and in violet regional hyperperfusion in phFTD compared 
to bvFTD. 
HC = healthy controls; phFTD = phenocopy frontotemporal dementia; bvFTD = behavioural variant 
frontotemporal dementia; nGM = normalised grey matter.
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4.2
4. DISCUSSIon
To the best of our knowledge, our study is the first to show cortical brain ab-
normalities in phFTD. We found cortical atrophy in phFTD, most prominently in 
the right superior and posterior temporal lobe, and the fusiform gyrus bilaterally. 
Furthermore, we found left frontal hyperperfusion in phFTD compared to bvFTD 
and to a lesser extent to controls, which may reflect functional compensation for 
incipient pathology.
Regional right temporal atrophy was not only seen in phFTD but also present 
in bvFTD, suggesting similar underlying pathophysiology. Atrophy in right tem-
poral regions has been linked to impaired emotion recognition and empathy in 
neurodegenerative disease [29,30], and more specifically to emotional blunting 
in bvFTD [31]. In addition, frontotemporal atrophy lateralised to the right hemi-
sphere is more often associated with socially undesirable behaviour in FTD than 
Figure 2. A) Normalised GM (% ICV) and B) CBF (ml/100g GM/min) in the different lobes for 
healthy controls (HC), phFTD (PH) and bvFTD (BV) patients. The central box represents values from 
lower to upper quartile (25-75th percentile), the middle line represents the median, and vertical 
bars extend from minimum to maximum value. Spheres outside the bars indicate extreme values 
(value ≥ 1.5 x interquartile range). Note that GM volumes in phFTD are generally in-between those 
of HC and bvFTD, and that perfusion in phFTD is generally higher than in bvFTD and controls. 
HC = healthy controls; phFTD = phenocopy frontotemporal dementia; bvFTD = behavioural variant 
frontotemporal dementia; nGM = normalised grey matter; ICV = intracranial volume; CBF = 
cerebral blood flow.
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when lateralised to the left [32]. The fact that we found atrophy in this specific 
region may explain why symptoms in phFTD patients are mostly isolated to the 
behavioural domain, in contrast to bvFTD patients who show a more widespread 
frontotemporal atrophy and additional cognitive and functional decline.
Our findings are in contrast to previous studies, in which no atrophy in phFTD 
was found using semi-quantitative ratings [7,33]. One possible explanation might 
be that such semi-quantitative rating was not sufficiently sensitive. However, 
other studies using the potentially more sensitive VBM method did not show 
any abnormalities either [5,34], except for one case study reporting non-specific 
parieto-occipital, thalamic and subtle frontoinsular atrophy [3]. The discrepancy 
with the present study may lie in the fact that we used highly specific patient se-
lection criteria, i.e. behavioural features consistent with bvFTD, without progres-
sion for at least one year, without psychiatric disorders and without C9ORF72 mu-
tations. It may also be due to methodological differences between voxel-wise and 
ROI analyses. ROI analysis circumvents the problem of inter-individual anatomical 
variability, as well as subsequent corrections for such variability that may compro-
mise resolution (such as smoothing). Additionally, statistical power of ROI analysis 
is hampered less by corrections for multiple comparisons than voxel-wise testing. 
Apart from the focal right temporal atrophy, nGM volumes in phFTD were 
generally not different from neither bvFTD nor from controls. Only the right hip-
pocampal formation and amygdala showed more atrophy in bvFTD compared 
with phFTD, suggesting preservation of those regions in phFTD, whereas these 
were severely affected in bvFTD [35]. Of note is that otherwise, nGM volumes 
were similar between phFTD and bvFTD, despite widespread GM loss in bvFTD 
compared to controls. These findings suggest that there is a continuum in nGM 
volumes ranging from normal on the one end to clearly abnormal in bvFTD on 
the other, with phFTD in-between. Together with the overlapping finding in both 
phFTD and bvFTD of right temporal lobe atrophy, this suggests that phFTD may be 
a disease on the FTD spectrum.
Our study was the first to use ASL-MRI in phFTD to assess perfusion. ASL is 
tightly coupled to brain metabolism and function as measured with FDG-PET, but 
previous PET studies failed to find any abnormalities in phFTD [5,8]. We found 
higher perfusion in phFTD in the bilateral straight gyrus and left superior, inferior 
and orbital frontal gyrus compared to bvFTD, and to a lesser extent compared to 
controls. Some of these regions, i.e. in the left inferior frontal gyrus, correspond to 
those showing hypoperfusion in bvFTD compared to controls. Such hyperperfu-
sion in phFTD relative to bvFTD may reflect a compensatory process of increased 
activity to compensate for incipient pathology in regions affected in bvFTD [36]. A 
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similar pattern could be observed in the right straight gyrus, where perfusion was 
increased in phFTD compared to bvFTD, while there was a trend (p=0.06) towards 
hypoperfusion in bvFTD compared to controls. The other hyperperfused regions 
in phFTD relative to bvFTD, namely the superior frontal gyrus and subcallosal re-
gion, did not show hypoperfusion in bvFTD. Although not observed in our bvFTD 
sample, left superior frontal hypoperfusion has been found in FTD in previous ASL 
studies [37-39]. Similarly, PET studies have reported subcallosal hypometabolism 
in FTD [40-42]. Therefore, a compensatory process may still be hypothesised.
Taken together, our findings in phFTD suggest functional compensation as 
well as focal structural abnormalities overlapping with those found in bvFTD. 
Overlapping focal cortical atrophy was limited to the right temporal lobe, consist-
ent with the disease-specific prominent behavioural changes of phFTD, while cor-
tical volumes in the remaining frontotemporal regions were in-between normal 
and those in bvFTD. These findings support the idea that phFTD is a disease of 
the FTD spectrum. One could even wonder whether phFTD is not simply an early 
manifestation of bvFTD. The notion of phFTD as a neurodegenerative disease is 
however still disputed due to the absence of disease progression in these pa-
tients. Psychiatric disorders have been proposed as an alternative or contributory 
aetiology [14-16,43]. In support of this view, imaging findings show substantial 
overlap between FTD and disorders such as schizophrenia [44,45] and depression 
[46,47]. In addition, phFTD patients may carry a C9ORF72 mutation [3,13] which 
is not only associated with bvFTD, but also with psychotic symptoms [48]. Yet in 
our patients, alternative psychiatric diagnoses were ruled out, which renders in-
terpretation in the context of neurodegenerative disease more likely. In addition, 
none of the phFTD patients had a mutation of the C9ORF72 gene. Therefore, as 
of yet, phFTD still seems to be described best as a clinical syndrome. As such, our 
phFTD population comprised patients with a distinct clinical profile: behavioural 
features consistent with bvFTD, without progression for at least one year, with-
out psychiatric disorders and without the C9ORF72 mutation. This well-defined 
clinical profile may have enabled a first link between the typical behavioural 
changes in phFTD and potential neurophysiological changes as detected with im-
aging.
The present study has some limitations. Firstly, the sample size was small. 
This is inherent to phFTD being a rare disease, with only 17 documented cases in 
a large tertiary referral centre as ours. Nevertheless, we studied a very well-de-
fined phFTD sample, by strictly controlling for disease progression and alternative 
psychiatric aetiology. One patient did have an asymptomatic cortical infarct in the 
right parietal lobe, but as this did not affect image processing results we expect 
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it did not influence our findings. Secondly, groups were not fully gender-matched 
and were scanned on two - albeit identical - scanners. We used hierarchical re-
gression analysis to account for potential confounding effects of gender and 
scanner. Although this stringent analysis limited the number of regions that were 
eventually analysed between groups and carries the risk of false negative results, 
it decreased the probability of false positives, and as such strengthens the valid-
ity of our findings. Finally, despite a one year follow-up to ensure the absence of 
progression, longer follow-up in a longitudinal study will be even better suited to 
assess whether patients show no or very slow progression. Therefore, follow-up 
of our phFTD sample is currently ongoing. Ultimately, post-mortem examination 
is essential to determine whether neuropathology is present and if so, what type. 
Hence, studies investigating both neurodegenerative aetiology and neuropsychi-
atric presentation of behavioural changes later in life [49] may further elucidate 
the relationship between behaviour and neurophysiology.
In conclusion, in addition to overlapping focal right temporal lobe atrophy in 
phFTD and bvFTD, we found a continuum of frontotemporal cortical volumes 
ranging from normal on the one end to clearly abnormal in bvFTD on the other, 
with phFTD in-between. Furthermore, we observed left frontal hyperperfusion in 
phFTD, suggestive of a compensatory process in response to incipient pathology 
in regions affected in FTD. To the best of our knowledge, our findings are the first 
evidence of a neuropathological substrate of phFTD and to possibly place it in an 
FTD spectrum. This may serve as the basis for further assessment in larger patient 
samples with longitudinal clinical and pathological follow-up.
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SUPPLeMent
Supplementary table 1. regions of interest (ROIs) 
Regions of interest (ROIs) assessed for grey matter volume and cerebral flood flow. Parcellated gyri 
(according to [24,25], right column) were combined (middle column) for analysis.
Lobe Gyrus Consisting of:
Frontal
Superior frontal gyrus
Middle frontal gyrus
Inferior frontal gyrus
Straight gyrus
Orbitofrontal gyrus
Anterior orbital gyrus
Medial orbital gyrus
Lateral orbital gyrus
Posterior orbital gyrus
Subcallosal area
Anterior cingulate gyrus
Insula
Precentral gyrus
Temporal
Anterior temporal lobe
Medial anterior temporal lobe
Lateral anterior temporal lobe
Posterior temporal lobe
Amygdala
Hippocampal formation
Hippocampus
Parahippocampal gyrus
Superior temporal gyrus
Inferior temporal gyrus
Fusiform gyrus
Parietal
Postcentral gyrus
Posterior cingulate gyrus
Precuneus
Remainder of parietal lobe
Occipital
Lingual gyrus
Cuneus
Lateral remainder of occipital lobe
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abstract
Phenocopy frontotemporal dementia (phFTD) is a syndrome of much debate, as 
it shares core characteristics with bvFTD yet without associated cognitive defi-
cits and brain abnormalities on conventional magnetic resonance imaging (MRI), 
and without progression. Using advanced MRI techniques, subtle structural and 
functional brain changes in phFTD similar to bvFTD were recently observed, and 
it was hypothesised that phFTD and bvFTD may belong to the same disease spec-
trum. The aim of the current study was to gain more insight into longitudinal 
brain changes in phFTD.
Six (5 for MRI) phFTD patients at 3-year follow-up were qualitatively com-
pared with baseline measures, and with 9 bvFTD patients and 17 controls. Quali-
tative comparison was performed for measures of cognition, grey matter volume, 
cerebral blood flow and fractional anisotropy. Additionally,  the clinical profile at 
follow-up for each phFTD case was described.
PhFTD patients showed symptomatology similar to bvFTD, but with a rela-
tively stable clinical profile. Qualitative comparison showed progression of lan-
guage and memory deficits and a stable pattern of structural brain abnormalities, 
with cognitive scores and structural values generally in between the normal and 
bvFTD, and functional changes in the sense of increased perfusion.
These findings are still in support of the notion that phFTD and bvFTD may 
belong to the same disease spectrum. These findings may be used as motivation 
and a basis for further longitudinal studies in phFTD, specifically exploring the 
structural versus functional brain changes.
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1. IntroDUCtIon
The clinical syndrome phenocopy frontotemporal dementia (phFTD) is the sub-
ject of much debate. It shares behavioural changes as core features with bvFTD 
but does not follow the same disease course. Apathy, behavioural disinhibition, 
and loss of insight occur in both phFTD and bvFTD [1]. However, phFTD does 
not show the cognitive and brain abnormalities that are typical for bvFTD. Their 
cognitive profile may range from normal to suggesting bvFTD [2–5] but they ap-
pear stable over time, whereas in bvFTD rapid progression of cognitive deficits is 
evident [5–8]. On conventional (structural) magnetic resonance imaging (MRI), 
phFTD shows no or only mild abnormalities [6,8] in the frontotemporal brain re-
gions typically affected in bvFTD [9].  Consequently, as a pathophysiological expla-
nation is not yet available, phFTD patients often remain undiagnosed or may re-
ceive an uncertain psychiatric diagnosis. Additionally, C9orf72 repeat expansions 
may occasionally mimic phFTD, as cognitive deficits remain stable over years [10]. 
In our recent work [11,12] we aimed to address this diagnostic concern and lack 
of neurological explanation by using advanced MRI techniques to investigate the 
possible presence of more subtle brain abnormalities. 
Using diffusion tensor imaging (DTI) we observed white matter (WM) micro-
structure abnormalities in the frontal and temporoparietal lobes in phFTD simi-
lar to bvFTD, but less pronounced than in bvFTD [11]. Using an advanced post-
processing method of structural imaging to explore grey matter (GM) volumes, 
we observed loss of GM volume in the right temporal lobe [12]. Additionally, we 
observed a continuum  with - especially - frontotemporal GM volumes ranging 
from the normal in healthy to abnormal in bvFTD, and phFTD in between with 
scores not significantly different from either [12].  Using resting state functional 
MRI (rs-fMRI) we observed increased default mode network (DMN) functional 
connectivity in phFTD in nearly all regions of the DMN, similar to bvFTD but more 
pronounced [11]. Using arterial spin labelling (ASL) we observed left frontal hy-
perperfusion [12]. 
These findings indicate that more subtle brain abnormalities are evident in 
phFTD. As these abnormalities are similar to bvFTD - in addition to their similar 
symptomatology - we concluded with the notion that phFTD and bvFTD may be-
long to the same disease spectrum. In the current study we aimed to gain more 
insight into longitudinal brain changes in phFTD by means of a case series ex-
ploring advanced MRI and neuropsychological examination in phFTD patients at 
3-year follow-up.
Longitudinal changes in phFTD: a case series
208
2. MethoDS
2.1 Participants
All patients were recruited in the Alzheimer Centre Southwest Netherlands. 
PhFTD patients (aged 40-75 years) with prominent behavioural changes inter-
fering with social functioning, consisting of disinhibition and/or apathy and/or 
stereotypy; without reported progression one year after initial routine diagnostic 
workup; and bvFTD patients (aged 45-70 years) with a diagnosis of bvFTD [13]; a 
clinical dementia rating scale score of ≤ 1; a Mini-Mental State Examination [14] 
(MMSE) score of ≥ 20, were included in the study.
Patients with other neurological disorders, past or current substance abuse 
or other psychiatric diagnosis were excluded. PhFTD patients with a diagnosis of 
dementia or missing heteroamnesis, and bvFTD patients with a different cause of 
dementia, were also excluded. 
Healthy controls (aged 60-70 years), without neurological or psychiatric his-
tory, were recruited through advertisement. They were matched for gender with 
phFTD patients and for age with all patients.
The study was approved by the local medical ethics committee. All partici-
pants gave written informed consent.
2.2 Participant assessment
PhFTD patients received an MRI scan, neuropsychological examination, MMSE, 
psychiatric assessment and genetic testing of the C9orf72 mutation at baseline. For 
convenience we will refer to this group as baseline phFTD. At 3-year follow-up, the 
phFTD patients received an MRI scan, neuropsychological examination and MMSE. 
BvFTD patients and controls underwent an MRI scan, neuropsychological ex-
amination and MMSE at baseline only. 
2.3 Image acquisition and assessment
Scanning was performed on two 3T GE Discovery MR750 systems (GE Healthcare, 
Milwaukee, WI, US) with identical protocols. PhFTD patients and nine controls 
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were scanned on one, and bvFTD patients and eight controls on the other scan-
ner. 
For clinical radiological assessment, GM volumetric assessment and ana-
tomical reference, a high-resolution three-dimensional (3D) inversion recovery 
(IR) fast spoiled gradient-echo (FSPGR) T1-weighted (T1w) scan was acquired. 
T1w parameters were a scan duration of 4.41 min, field of view (FOV) of 240mm, 
inversion time (TI) of 450ms, echo time (TE) of 3.06ms, repetition time (TR) of 
7904ms, array spatial sensitivity encoding technique acceleration (ASSET) factor 
of 2, a flip angle of 12°, an acquisition matrix of 240x240mm, and a slice thickness 
of 1mm.
DTI scans with full coverage of the supratentorial brain were acquired using a 
spin echo echo planar imaging (EPI) sequence. Acquisition parameters consisted 
of: 28 total volumes with 59 axial slices each, 3 non-diffusion weighted volumes, 
25 diffusion-weighted directions, scan duration 3.50 min, FOV 240mm, TE set to 
minimum with mean 84.04ms (range: 81.9-90.8ms; TE mean and range based on 
baseline scans), TR 7925ms, ASSET factor of 2, flip angle 90°, acquisition matrix 
128x128mm, slice thickness 2.5mm, and maximum b-value 1000 s/mm2. 
ASL scans were acquired using whole brain 3D pseudocontinuous ASL (p-
CASL), which is currently the recommended sequence for clinical use [15]. Perfu-
sion scans were acquired using the recommended parameters (interleaved fast 
spin-echo stackof-spiral readout of 512 sampling points on 8 spirals, background 
suppressed, labelling duration 1450 ms, TE 10.5 ms, TR 4632 ms, isotropic resolu-
tion 3.3 mm3, FOV 240 mm, 36 axial slices, number of excitations (NEX) 3, total 
acquisition time 4.29 min), with exception of the post labelling delay  which was 
1525 ms in the current study. The labelling plane was positioned 9 cm below the 
anterior commissure–posterior commissure line.
Structural (conventional) imaging at baseline and follow-up was clinically as-
sessed and reported upon by a neuroradiologist at Alzheimer Centre Southwest 
Netherlands. 
DTI scans (baseline and follow-up) were post-processed using Tractogra-
phy according to the methods previously described in Steketee & Meijboom et 
al. 2016 [16]. Median fractional anisotropy (FA) values were established for the 
following (bilateral) WM tracts: anterior thalamic radiation, cingulate and hip-
pocampal cingulum, inferior fronto-occipital fasciculus, inferior and superior lon-
gitudinal fasciculus, uncinate fasciculus, and forceps minor and major.
GM volumes and CBF (baseline and follow-up) were post-processed accord-
ing to the methods previously described in Steketee et al. 2016 [12]. Whole-brain 
GM volumes expressed as percentage of intracranial volume (%ICV), and whole-
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brain and regional mean CBF were established. For each brain lobe we then aver-
aged the appropriate regional CBF values to establish mean CBF for the frontal, 
temporal, parietal and occipital lobe.
2.4 Neuropsychological data acquisition and assessment
Patients received a neuropsychological examination performed by a neuropsy-
chologist at Alzheimer Centre Southwest Netherlands. Cognitive domains as-
sessed were attention and executive functioning, language, memory, and visuo-
constructive functioning (Table 1).
Baseline and follow-up neuropsychological scores were assessed and report-
ed upon by the neuropsychologist. 
Baseline and follow-up neuropsychological test scores were transformed to 
z-scores using the mean and standard deviation of controls as a reference. For the 
tests assessing attention and executive functioning, and memory, these z-scores 
were averaged to establish one score per cognitive domain (a composite score) 
for each participant (SPSS21.0, New York, USA).  
table 1. Cognitive domains and their specific neuropsychological tests used to assess cognitive 
functioning in patients and controls.
Cognitive domain neuropsychological test
Attention and concentration / 
executive functions
Trail Making Test (TMT)[17]
Stroop colour-word task[18]
Categorical and letter fluency test[19]
Modified Wisconsin Card Sorting test (WCST)[20]
Letter Digit Substitution Test (LDST)[21]
Language Boston Naming Test (60 items)[22]
Memory 15 Words Test[23]
Digit Span of the Wechsler Adult Intelligence Scale third 
edition (WAIS-III)[24]
Mini-Mental State Examination (MMSE) orientation ques-
tions[14]
Visuoconstructive functioning Clock drawing[25]
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2.5 Qualitative analysis 
Seven phFTD patients, 12 bvFTD patients and 17 controls were included in the 
study. One phFTD patient was excluded due to missing follow-up data. Six phFTD 
patients underwent follow-up assessment, one of whom did not undergo an MRI 
due to a pacemaker.  Only neuropsychological examination was performed in this 
patient. Three bvFTD patients were excluded due to incomplete data: two had 
missing neuropsychological data and one had ASL scans of unusable quality. Cog-
nitive, DTI, ASL and structural imaging data of 6 phFTD patients (5 for MRI data), 
9 bvFTD patients and all controls were used for qualitative comparisons (Table 2).
Age did not differ between groups (F (2) = 0,856 p>0.05; Welch-ANOVA test). 
The ANOVA test for MMSE score was significant (F (2) = 4.035, p=0.028); post-hoc 
between-group comparisons showed MMSE score was lower in phFTD than in 
controls (p=0.041) (SPSS21.0, New York, USA). See Table 2 for an overview of the 
demographics. For frequency of education levels per group see Table 3.
table 2. Demographic characteristics of reference groups
Group n mean age mean mmse
PhFTD 6 (6 male) 63.8 (5.1) 26.3 (1.4)
BvFTD 9 (4 male) 60.1 (8.4) 27.1 (2.0)
Controls 17 (17 male) 64.1 (3.3) 28.3 (1.4)
table 3. Education level frequencies per group
Education level PhFTD BvFTD Controls
1 0 0 0
2 0 0 0
3 1 2 0
4 4 3 1
5 1 1 9
6 1 3 4
7 0 0 3
PhFTD = phenocopy FTD, BvFTD = behavioural variant frontotemporal dementia, N = sample size. 
Values given as Mean (standard deviation). MMSE = Mini-Mental State Examination.
PhFTD = phenocopy FTD, BvFTD = behavioural variant frontotemporal dementia.
Education levels reported using the dutch Verhage education scale (1964): with a score of 1 
representing less than primary education and a score of 7 representing university education.
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None of the phFTD patients received an alternative psychiatric diagnosis that could 
explain their behavioural symptoms. Additionally, none carried the C9orf72 mutation.
For each group (phFTD baseline, phFTD follow-up, bvFTD and controls) cog-
nitive domain scores, WM tract FA, whole-brain GM volume (%ICV) and whole-
brain and regional CBF, were averaged (SPSS21.0, New York, USA).
3. reSULtS
3.1 Summary of qualitative comparison of advanced  
MRI measures 
Patients with phFTD generally performed worse on follow-up for language and 
memory in comparison with baseline, and similarly for visuoconstructive function-
ing and attention and executive functioning. Follow-up phFTD scores for all do-
mains were in between scores for bvFTD patients and controls (Figure 1, Table 1).
Whole-brain GM volume in phFTD upon follow-up was similar to baseline 
and in between volumes of bvFTD and controls (Figure 2, Table 2). Whole brain 
Figure 1. Cognitive domain z-scores for each group (bvFTD, baseline phFTD, follow-up phFTD). 
Z-scores are calculated using means of controls as a reference (i.e. control mean = 0). Domains 
assessed are language, attention and executive functioning, memory and visuoconstructive 
functioning.
bvFTD = behavioural variant frontotemporal dementia, phFTD = phenocopy frontotemporal 
dementia, BL = baseline, FU = follow-up.
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and regional perfusion in follow-up phFTD was increased in comparison with 
baseline phFTD (Figure 3, Table 3). WM tract FA in follow-up phFTD was similar to 
baseline phFTD (Figure 4, Table 4), and generally in between bvFTD and controls.
Cognitive test results , GM volume, CBF and FA values for each phFTD case 
at baseline and follow-up, are listed in Tables 1-4. 
Figure 2. Whole-brain grey matter (GM) volume expressed in intracranial volume (ICV) shown 
for each group (bvFTD, baseline phFTD, follow-up phFTD, controls). bvFTD = behavioural variant 
frontotemporal dementia, phFTD = phenocopy frontotemporal dementia, BL = baseline, FU = 
follow-up.
Figure 3. Whole-brain perfusion and brain-lobe perfusion shown for each group (bvFTD, baseline 
phFTD, follow-up phFTD, controls). bvFTD = behavioural variant frontotemporal dementia, phFTD 
= phenocopy frontotemporal dementia, BL = baseline,  FU = follow-up.
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Figure 4. White matter (WM) microstructure represented by fractional anisotropy (FA) per WM 
tract shown for each group (bvFTD, baseline phFTD, follow-up phFTD, controls). WM tracts 
included are the left and right anterior thalamic radiation (ATR_L and ATR_R), left and right 
cingulate cingulum (CGC_L and CGC_R), left and right hippocampal cingulum (CGH_L and CGH_R), 
forceps major (FMA), forceps minor (FMI), left and right inferior fronto-occipital fasciculus (IFOF_L 
and IFOF_R), left and right inferior longitudinal fasciculus (ILF_L and ILF_R), left and right superior 
longitudinal fasciculus (SLF_L and SLF_R), and left and right uncinate fasciculus (UF_L and UF_R).
bvFTD = behavioural variant frontotemporal dementia, phFTD = phenocopy frontotemporal 
dementia, BL = baseline, FU = follow-up.
table 1. Cognitive domain z-scores for phenocopy frontotemporal dementia (phFTD) cases at 
baseline and follow-up.
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Language Baseline -2.90 -8.33 -0.96 -2.12 -0.57 -1.73
Follow-up -5.62 -8.72 -1.73 -4.06 -2.12 -2.12
Attention and executive 
functioning
Baseline -1.80 -2.55 -0.92 -1.09 0.26 -2.28
Follow-up -1.64 -2.98 -0.68 -0.78 0.07 -3.22
Memory Baseline -0.88 0.35 -1.12 -0.87 -0.14 -3.01
Follow-up -1.77 -0.89 -1.60 -0.07 -0.56 -3.43
Visuoconstructive  
functioning
Baseline -0.54 -0.54 0.61 -0.54 -1.68 -2.83
Follow-up 0.61 -0.54 -0.54 0.61 -1.68 -5.11
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table 2. Whole brain grey matter (GM) volume (% intracranial volume) for phenocopy 
frontotemporal dementia (phFTD) cases at baseline and follow-up.
Case 1 Case 2 Case 3 Case 5 Case 6
Whole-brain GM volume (%ICV) Baseline 0.3491 0.2759 0.3368 0.3165 0.3083
Follow-up 0.3432 0.2589 0.3373 0.3215 0.3408
table 3. Whole brain and regional cerebral blood flow (CBF) for phenocopy frontotemporal 
dementia (phFTD) cases at baseline and follow-up.
Case 1 Case 2 Case 3 Case 5 Case 6
Whole-brain CBF Baseline 37.49 59.88 28.36 42.60 42.19
Follow-up 54.45 60.86 36.18 44.14 50.54
Frontal CBF Baseline 39.49 68.45 35.28 49.22 46.96
Follow-up 55.86 70.78 47.81 44.22 52.26
Temporal CBF Baseline 36.93 55.39 30.30 40.44 40.70
Follow-up 57.48 60.44 34.24 42.13 43.52
Parietal CBF Baseline 37.82 55.83 28.68 39.30 42.54
Follow-up 53.20 56.27 38.17 41.71 56.14
Occipital CBF Baseline 35.18 51.49 17.11 47.56 38.22
Follow-up 46.49 47.71 19.75 48.61 46.78
table 4. White matter (WM) tract fractional anisotropy (FA) for phenocopy frontotemporal 
dementia (phFTD) cases at baseline and follow-up. L= left, R=right.
Case 1 Case 2 Case 3 Case 5 Case 6
Anterior thalamic radiation L Baseline 0.3541 0.3201 0.3662 0.3465 0.3592
Follow-up 0.3407 0.3008 0.3641 0.3391 0.2965
Anterior thalamic radiation R Baseline 0.3336 0.3480 0.3803 0.3260 0.3428
Follow-up 0.3161 0.3223 0.3665 0.3407 0.3266
Cingulate cingulum L Baseline 0.5052 0.4491 0.4825 0.4090 0.5019
Follow-up 0.5179 0.4527 0.5384 0.4183 0.5214
Cingulate cingulum R Baseline 0.4420 0.3750 0.5104 0.3768 0.4958
Follow-up 0.4559 0.3885 0.5044 0.3824 0.4334
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Hippocampal cingulum L Baseline 0.4199 0.3505 0.3499 0.3573 0.3777
Follow-up 0.4318 0.3105 0.3825 0.3908 0.3995
Hippocampal cingulum R Baseline 0.4296 0.3619 0.4049 0.3985 0.4162
Follow-up 0.3975 0.3843 0.3976 0.4323 0.3712
Forceps major Baseline 0.5719 0.4507 0.6411 0.4990 0.4561
Follow-up 0.5214 0.4376 0.6366 0.4994 0.4947
Forceps minor Baseline 0.6663 0.5138 0.6446 0.5522 0.5117
Follow-up 0.6613 0.4763 0.6846 0.5605 0.5225
Inferior fronto-occipital  
fasciculus L
Baseline 0.4499 0.4099 0.5251 0.4643 0.4261
Follow-up 0.4630 0.3940 0.4632 0.4818 0.4028
Inferior fronto-occipital  
fasciculus R
Baseline 0.4735 0.4159 0.4733 0.4978 0.4154
Follow-up 0.4794 0.4105 0.4855 0.5242 0.4480
Inferior longitudinal fasciculus L Baseline 0.4526 0.3619 0.4910 0.4104 0.4052
Follow-up 0.4422 0.3593 0.4732 0.4164 0.3970
Inferior longitudinal fasciculus R Baseline 0.4718 0.3656 0.5011 0.4138 0.4113
Follow-up 0.4439 0.3778 0.5054 0.4316 0.4015
Superior longitudinal fasciculus L Baseline 0.3991 0.3126 0.4226 0.3709 0.3710
Follow-up 0.3912 0.3175 0.4218 0.3775 0.3657
Superior longitudinal fasciculus R Baseline 0.3948 0.3209 0.4297 0.3220 0.3573
Follow-up 0.3932 0.3204 0.4238 0.3208 0.3509
Uncinate fasciculus L Baseline 0.4561 0.3864 0.4923 0.3966 0.3794
Follow-up 0.4226 0.3883 0.4797 0.3691 0.3919
Uncinate fasciculus R Baseline 0.4266 0.3498 0.4217 0.3814 0.3642
Follow-up 0.4033 0.3545 0.4254 0.3900 0.4051
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3.2 Case descriptions
Case 1
Patient 1 was a 64 year old male who reported first noticing behavioural changes 
15 years previously. His major complaints involved loss of empathy, increased and 
uncontrolled anger, loss of initiative, compulsivity, irritability, increased talking 
and moving.
The neuropsychological report at follow-up stated disorders of language 
(naming), divided attention and social cognition. Additionally, mild abnormali-
ties in the executive functions and working memory/memory were observed. In 
comparison with the neuropsychological report at baseline the patient showed a 
very mild progression of language, memory and divided attention abnormalities. 
Although the clinical and neuropsychological profile suggested bvFTD, the pro-
tracted disease course and lack of evident progression of cognitive dysfunction-
ing did not support the clinical diagnosis of probable bvFTD.
The radiological report at follow-up stated that GM atrophy or WM abnor-
malities were not observed on conventional (structural) MRI.
Case 2
Patient 2 was a 73 year old male who reported first noticing behavioural changes 
at least 12 years previously. His major complaints included increased dependency 
on his partner, loss of initiative, apathy, increase of food intake, and the inability 
to cope with changes.
The neuropsychological report at follow-up stated disorders of naming, task-
switching, visuo-associative memory and emotion recognition. In comparison 
with baseline neuropsychological examination there was a decrease in memory 
functioning and inhibition. 
The radiological report of conventional (structural) imaging at follow-up stat-
ed a mild increase of global GM atrophy (global cortical atrophy scale 1 (GCA)), 
and no regional GM atrophy. Additionally, it stated that already known WM le-
sions were observed (Fazekas 3), which were most likely of vascular origin. 
Case 3
Patient 3 was a 74 year old male who reported first noticing behavioural changes 
at least 8 years previously. Major complaints included angry and aggressive be-
haviour, impulsivity, decreased empathy, sexual disinhibition, speech disinhibi-
tion, compulsive information gathering, and no symptom insight. 
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The neuropsychological report at follow-up stated weak scores on verbal memory 
and emotion recognition. Other domains showed average or just-below average 
scores. In comparison with baseline neuropsychological examination, emotion 
recognition was more abnormal, but in contrast, scores for a complex executive 
task were higher. Scores on the other domains showed no changes.
The radiological report of conventional (structural) imaging at follow-up stat-
ed no regional atrophy, and very mild global atrophy (GCA 1). No changes were 
observed in comparison with baseline MRI.
Case 4
Patient 4 was a 62 year old male who reported first noticing behavioural changes 
at least 10 years previously. His main complaints included severe forgetfulness, 
switching letters during speech, incorrect use of words, disinhibition in general, 
and disinhibition of speech specifically.  
The neuropsychological report at follow-up stated weak performance of di-
vided attention, and below-average performance on language, processing speed 
and working memory. The other domains, among which memory and social cog-
nition, were of average score. In comparison with baseline neuropsychological 
examination there was progression in one attention and one processing speed 
task, while other scores remained stable.
The patient did not receive a follow-up MRI due to placement of a pacemaker 
during follow-up. The radiological report of conventional (structural) imaging at 
baseline stated global atrophy (GCA 1), which was somewhat more pronounced 
in the parietal lobe. There were some WM lesions (Fazekas 1). Importantly, as 
the patient reported memory problems, the report stated that no hippocampal 
atrophy was observed.
Case 5
Patient 5 was a 67 year old male who reported first noticing behavioural changes 
10 years previously. Major complaints included loss of empathy, impulsive pur-
chases, increased intake of food, isolated behaviour, unhappiness, increased an-
ger triggered by minor events, loss of initiative, reduced vocabulary and forgetful-
ness. 
The neuropsychological report at follow-up stated average and above-aver-
age performance on cognitive domains, with the exception of weak performance 
on emotion recognition. The report concluded that no cognitive disorders were 
objectified, and that there were no changes in comparison with neuropsychologi-
cal examination at baseline. 
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The radiological report of conventional (structural) imaging at follow-up stated no 
cortical atrophy or WM lesions, other than known lacunar infarcts in the brain-
stem and a cortical infarct in the right parietal lobe. This profile was not different 
from MRI at baseline. 
Case 6
Patient 6 was a 63 year old male who reported first noticing behavioural changes 
20 years previously. Major complaints included short term memory loss, reduced 
personal hygiene, verbal aggressiveness, inappropriate, a.o. sexual, remarks, 
word finding problems, loss of control concerning drinking and eating. 
The neuropsychological report at follow-up stated disorders of executive 
functioning, attention and social cognition. Weak memory performance is ob-
served for encoding of new material, retaining and recall. Visuoconstruction and 
praxis were abnormal. There were no evident disorders of language and orienta-
tion. In comparison with baseline neuropsychological examination, minimal pro-
gression was observed for executive functioning, social cognition and processing 
speed. However, overall  the cognitive profile was stable in comparison with neu-
ropsychological examination performed in 2003. 
The radiological report of conventional (structural) imaging at follow-up 
stated minimal frontal atrophy, which did not show evident progression in com-
parison with baseline MRI.  Additionally, three microbleeds were observed, and a 
hypertensive origin was suggested. 
4. DISCUSSIon
The aim of this case series was a qualitative description of brain and cognitive 
changes in phFTD patients after a 3-year time period. No evident clinical pro-
gression was observed in phFTD cases with disease durations ranging from 8 to 
20 years. Neuropsychological examination showed that cognitive profiles may be 
normal, may be suggestive of bvFTD, and be stable or show some progression. 
Conventional (structural) MRI showed no or unspecific atrophy patterns, which 
did not or only mildly progressed. Qualitative comparison of cognitive perfor-
mance at baseline and follow-up showed some progression in the language and 
memory domains, yet all cognitive domain scores were still in between those of 
bvFTD and controls. Qualitative comparison of advanced MRI measures showed 
that structural brain abnormalities in phFTD showed no evident progression and 
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were generally in between bvFTD and controls. Additionally, it showed that func-
tional brain abnormalities, i.e. hyperperfusion, progressed over time and were 
more pronounced than in bvFTD and controls.
This case series illustrates that clinically phFTD does not show clear longitudinal 
changes, except for some progression in language and memory deficits; this may 
suggest that progression of these domains clinically may become apparent be-
fore that of other cognitive domains, although their scores were still in between 
bvFTD and controls.
 Importantly, this case series also suggests that structural abnormalities, 
such as GM volume and WM microstructure, appear to be both relatively sta-
ble and in between bvFTD and controls, whereas functional abnormalities show 
longitudinal changes. Higher perfusion was observed for the whole brain and for 
each lobe, which is in line with our previous findings [12]. Naturally, a firm con-
clusion cannot be drawn as we could not perform any formal comparisons with 
controls and baseline measurements due to the small study sample. However, we 
can speculate on this interesting finding, as previous literature has hypothesised 
that functional changes may be related to a mechanism compensating for subtle 
neuronal dysfunctioning [26,27]. Our hypothesis is that deterioration of neuronal 
functioning over time in phFTD is associated with compensatory changes in per-
fusion, in the absence of unchanged GM volume. 
This case series also points out the diversity of the clinical profile in phFTD cases 
and the difficulties with phFTD diagnosis. For instance, disease duration, behav-
ioural profiles, cognitive profiles and conventional (structural) MRI were similar 
amongst all cases, but were not the same. A specific example is case 2 who showed 
lower GM volumes, lower neuropsychological scores, higher perfusion and lower 
FA in WM tracts, in comparison with the other cases. Together with mild progres-
sion clinically, we could speculate that these findings suggest that this patient is 
in a slightly more advanced disease stage than the other cases. However, disease 
duration is 12 years, which is still highly unlike bvFTD. This emphasises the need 
for long-term follow-up with repeat assessments to understand disease develop-
ment in this particular case, and in phFTD in general. 
This study knows some limitations, specifically its qualitative nature and a small 
sample size. However, as phFTD is a rare and relatively unknown syndrome, more 
information is of great value for its understanding and diagnosis. This case series 
adds to the increasing knowledge of longitudinal changes in phFTD [1,4–6,28].
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In conclusion, phFTD patients assessed at 3-year follow-up show symptomatology 
similar to bvFTD, but with a relatively stable clinical profile. They show progression 
of language and memory deficits and a stable pattern of structural brain abnor-
malities, with cognitive scores and structural values generally in between normal 
and bvFTD, and functional changes in the sense of increased perfusion. Overall, 
these observations are still in support of the notion that phFTD and bvFTD may 
belong to the same disease spectrum. Despite the fact that a descriptive case 
series does not allow for strong conclusions, we may use these observations as 
motivation and a basis for further longitudinal studies in phFTD, specifically ex-
ploring the structural versus functional brain changes.
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In this thesis, I investigated the use of advanced magnetic resonance imaging 
(MRI) techniques, i.e. diffusion tensor imaging (DTI), resting state functional MRI 
(rs-fMRI) and arterial spin labelling (ASL), in underlying diseases of dementia: be-
havioural variant frontotemporal dementia (bvFTD), phenocopy frontotemporal 
dementia (phFTD), semantic dementia (SD) and Alzheimer’s disease (AD). I inves-
tigated the use of these techniques in identifying subtle brain abnormalities, as-
sociating subtle brain abnormalities with disease symptomatology and improving 
early (differential) diagnosis. In this section I will provide an overview of the main 
findings and discuss the methodological considerations, clinical implications and 
future perspectives. 
Main findings
Alzheimer’s disease (AD) and behavioural variant frontotemporal  
dementia (bvFTD)
BvFTD and AD are two of the most common underlying disorders of presenile 
dementia (age<65 years) [1]. BvFTD is mainly characterized by behavioural prob-
lems such as disinhibition and apathy [2]. In contrast, AD is mainly characterized 
by a memory disturbance for recently learned material as well as for learning 
new material [3]. This disease-specific clinical profile usually predominates in lat-
er stages of AD and bvFTD, but in earlier stages symptoms may still be mild and 
unspecific. This complicates differential diagnosis of AD and bvFTD and may lead 
to inconclusive diagnosis or misdiagnosed patients. With the use of conventional 
MRI, diagnosis of AD or bvFTD can be supported. However, in early disease stag-
es, conventional (structural) MRI may still appear normal or show diffuse brain 
abnormalities unspecific for AD or bvFTD [4–6]. More advanced MRI techniques, 
such as DTI, rs-fMRI and ASL can potentially aid the diagnostic process by looking 
at more subtle brain abnormalities: DTI assesses white matter (WM) microstruc-
ture, rs-fMRI assesses functional connectivity and ASL assesses grey matter (GM) 
perfusion. These techniques provide the following advantages over conventional 
imaging: quantification of subtle brain abnormalities (chapter 2.1) and combina-
tion of subtle brain abnormality measures (chapter 2.2). 
Early-stage and long-term clinical differentiation of AD and bvFTD may especially 
benefit from objective quantitative measures (chapter 2.1), because these allow 
for establishing reference values in a healthy population, with which patients can 
be compared. To this end, we explored the diagnostic utility of quantitative mea-
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sures of tract-specific WM microstructure and functional connectivity of the de-
fault mode network (DMN), using DTI and rs-fMRI respectively. Despite the DMN 
being a well-defined resting state network showing functional abnormalities in 
dementia, quantitative assessment of its functional connectivity did not aid differ-
ential diagnosis of AD and bvFTD. In contrast, measures of quantitative tract-spe-
cific WM microstructure indicated pronounced differences between early-stage 
AD and bvFTD, with WM microstructural abnormalities being widely observed 
in bvFTD, and only regionally in the hippocampal cingulum in AD.  The extent 
of these differences was smaller after 1-year follow-up, but WM microstructural 
abnormalities were still more pronounced in bvFTD than in AD, specifically in the 
cingulate cingulum and inferior fronto-occipital fasciculus. This indicates that dif-
ferential diagnosis of AD and bvFTD will benefit from using tract-specific WM mi-
crostructure, especially in the early stages, as diagnostic tool. 
An important advantage of these quantitative advanced MRI techniques, such as 
DTI and ASL, is that the measures they provide may also be used in combination 
(chapter 2.2). This combination provides the unique opportunity to gain insight 
into the relationship between WM microstructure (DTI) and GM perfusion (ASL) 
changes in AD and bvFTD. It should be noted that the use of structural MRI may be 
improved by quantifying GM volumes, and additionally, by combining these mea-
sures with WM microstructure and GM perfusion.  This combination allowed us 
to observe a disease-specific dissociation of structural and functional abnormali-
ties, with structural degeneration in bvFTD on the one hand and hypoperfusion in 
AD on the other hand. Importantly, we observed strong coherence between WM 
and GM changes in regions implicated in later stages of AD and bvFTD pathology, 
which indicates concurrent WM and GM degeneration in disease-specific net-
works. Additionally, as coherence was mostly absent in healthy elderly, and WM 
and GM measures that were not necessarily different between groups did show 
coherence in AD and bvFTD, the correlational methodology applied here allowed 
for detection of incipient abnormalities that would otherwise go undetected in 
conventional comparative group analyses. 
As advanced imaging not only allows us to quantify abnormalities, but is also 
more sensitive to detect more subtle abnormalities, it gives us the possibility to 
investigate relationships between subtle brain changes and clinical cognitive pro-
files in the early stages of AD and bvFTD (chapter 3.1). We observed that abnor-
malities of attention and executive deficits are related to microstructural WM 
changes in several WM tracts in bvFTD and to a lesser extent in AD. Such a rela-
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tionship was also observed for language deficits in AD, and to a lesser extent for 
normal language functioning and WM microstructure in bvFTD. Additionally, nor-
mal memory functioning in bvFTD, as well as normal visuoconstructive function-
ing in AD was associated with WM microstructure abnormality. Interestingly, no 
relationship with WM abnormalities was observed for evident memory deficits in 
AD. This suggests that only certain cognitive domains are functionally related to 
abnormalities of WM microstructure in AD and bvFTD, and that GM abnormali-
ties may play a more important role for deficits in other cognitive domains.
Frontotemporal dementia (FTD) variants
Frontotemporal dementia (FTD) is an umbrella term for several dementia variants 
affecting the frontal and temporal lobes, generally with an onset before the age 
of 65 years (presenile dementia)[7]. Well-known variants of FTD are the behav-
ioural variant (bvFTD), as well as language variants, such as SD [8]. PhFTD, a rare 
syndrome clinically similar to bvFTD, may also belong to this FTD spectrum. 
BvFTD is one of the most common variants, predominantly showing bilateral or 
right frontal lobe atrophy [2,8,9]. As described previously, it is mainly characterized 
by behavioural symptoms, and differential diagnosis with AD may be difficult in the 
early stage. Additionally, differential diagnosis of bvFTD and alternative psychiatric 
disorders may also be very challenging. This is due to resemblance between the 
behavioural disorder in bvFTD and psychiatric symptomatology such as psycho-
sis and late onset schizophrenia[10]. This specific differential diagnostic issue is 
especially applicable to phFTD, which is a poorly understood syndrome, clinically 
similar to bvFTD but without its typical disease course. PhFTD presents with core 
bvFTD symptoms, such as apathy and behavioural disinhibition [11], but without 
the associated cognitive deficits [12–15] and disease progression [5,15–17], and 
without (or with unspecific borderline) brain abnormalities on conventional (struc-
tural) MRI [5,16]. As phFTD presents with a behavioural syndrome without appar-
ent degeneration, its symptomatalogy may be attributed to alternative psychiatric 
disorders instead. However, in our studies investigating a carefully selected sample 
of phFTD patients, we established by means of psychiatric examination that phFTD 
symptomatology was not explained by an alternative psychiatric diagnosis. Instead, 
using advanced MRI techniques to investigate the more subtle brain changes, we 
observed brain abnormalities similar to bvFTD underlying phFTD symptomatology. 
Structurally, we observed abnormal WM microstructure in the frontal and tempo-
roparietal lobes in phFTD also similar to bvFTD but less extensive (chapter 4.1), 
and cortical atrophy in the right temporal lobe (chapter 4.2). Cortical atrophy over-
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lapped with bvFTD and frontotemporal GM volumes showed a continuum ranging 
from the normal to abnormal in bvFTD with phFTD in between. Functionally, we 
observed increased DMN functional connectivity in phFTD in nearly all regions of 
the DMN, similar to bvFTD but more pronounced (chapter 4.1), and left frontal 
hyperperfusion (chapter 4.2). Such functional increases are thought to reflect a 
mechanism compensating for incipient diminished neuronal functioning [18]. The 
ability of this mechanism to compensate is likely to decrease when the abnormali-
ties become more severe, such as in bvFTD.
We extended these findings by qualitatively comparing cognition, brain func-
tion and brain structure in phFTD at 3-year follow-up with baseline (chapter 4.3). 
We observed some progression of language and memory deficits and a stable 
pattern of structural brain abnormalities, with cognitive scores and structural val-
ues generally in between normal and those in bvFTD. Interestingly, higher perfu-
sion was observed for the whole brain and for each lobe, which is in line with the 
above described theory of compensation (chapter 4.1 and 4.2). Consequently, we 
hypothesized that deterioration of neuronal functioning over time in phFTD is as-
sociated with compensatory changes in perfusion, in the absence of unchanged 
GM volume.
Taken together, these findings suggest that phFTD may belong to the same 
disease spectrum as bvFTD, and may also indicate that advanced MRI techniques 
are potentially suited to detect subtle brain changes in phFTD that may improve 
diagnosis. Naturally, the hypothesis that phFTD may belong to the bvFTD disease 
spectrum requires confirmation with other diagnostic tools, such as histopathol-
ogy. The findings of our studies may provide a direction for further development 
of such diagnostic - MRI or other - tools. Additionally, the longitudinal findings 
may be used as motivation and a basis for further longitudinal studies in phFTD, 
specifically exploring the structural versus functional brain changes.
The SD variant of FTD, in contrast with bvFTD, is characterized by a language disor-
der and shows predominantly left anterior temporal lobe (ATL) atrophy [8,9,19]. 
In contrast, bvFTD affects the right or bilateral frontal lobe [2,8,9]. We observed 
a similar hemispheric dissociation between SD and bvFTD when looking at brain 
connectivity abnormalities (chapter 3.2). This was especially evident for micro-
structural abnormalities of WM tracts in the left hemisphere in SD, and functional 
connectivity in the right hemisphere in bvFTD. Microstructural WM abnormali-
ties were more pronounced in and lateralized towards the left hemisphere in SD 
compared with bvFTD, particularly in the uncinate, inferior longitudinal and infe-
rior fronto-occipital fasciculus. These WM tracts are part of the ventral language 
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stream, which is associated with semantic processing [20,21], a domain charac-
teristically affected in SD [19]. In bvFTD compared with SD, microstructural WM 
abnormalities were also more pronounced in one hemisphere - the right hemi-
sphere - but were less lateralized than in SD. They were most pronounced in WM 
tracts associated with behavioural symptoms [22–26] which are evident in bvFTD 
(e.g. executive and emotional functioning): right uncinate and inferior fronto-oc-
cipital fasciculus, and the forceps minor. Functional connectivity of disease-spe-
cific regions (ATL and orbitofrontal cortex (OFC)) was mainly decreased with both 
hemispheres in SD compared with bvFTD and with the right hemisphere in bvFTD 
compared with SD. Explanation of observed functional connectivity by relating 
it to symptomatology was less straightforward, but generally the observed func-
tional connectivity was found in GM regions previously observed to be associated 
with language in SD and behaviour in bvFTD. These findings indicate that SD and 
bvFTD show a hemispheric dissociation of brain connectivity in the frontotempo-
ral regions, which underlies their differential symptomatology.
In conclusion, findings from this thesis have several indications for the use of 
advanced MRI in AD, bvFTD, SD and phFTD. First, AD and bvFTD findings may indi-
cate that early-stage differential diagnosis of AD and bvFTD will benefit from using 
tract-specific WM microstructure as diagnostic tool (chapter 2.1); that there may 
be disease-specific concurrent degeneration of WM and GM structures in AD and 
bvFTD (chapter 2.2); that combining quantitative WM and GM measures may 
allow for detection of incipient abnormalities in AD and bvFTD that otherwise 
remain undetected (chapter 2.2); and that only certain cognitive domains may be 
functionally related to abnormalities of WM microstructure in AD and/or bvFTD 
(chapter 3.1). Second, SD and bvFTD findings are suggestive of a hemispheric 
dissociation of frontotemporal brain connectivity in SD and bvFTD, possibly ex-
plaining their  differences in symptomatology (chapter 3.2). Third, phFTD findings 
suggest that phFTD may belong to the same disease spectrum as bvFTD, and they 
may also indicate that advanced MRI techniques are potentially suited to detect 
subtle brain changes in phFTD that may improve diagnosis (section 4). 
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Methodological considerations
Small sample size 
The sample size of the studies presented in this thesis are small. A small sample is 
inherent to clinical studies investigating relatively rare syndromes, such as phFTD, 
bvFTD, SD and presenile AD. Rare and particularly controversial diseases (such as 
phFTD) warrant the application of strict inclusion and exclusion criteria to estab-
lish disease-homogenous samples allowing for meaningful between-group com-
parisons. For example, only 15 cases of phFTD were documented in our large 
referral centre in a five year period. Additionally, not all patients are willing to 
participate (e.g. only nine out of fifteen in this study) and importantly, clinical 
diagnosis may turn out to be incorrect upon follow-up. The latter is especially 
emphasized by our study on early-stage dementia. Overall, only 51 patients diag-
nosed with probable AD and/or FTD were included in a 3.5-year period. Due to an 
early disease stage – and therefore possible uncertain diagnosis - twelve patients 
received a final diagnosis other than dementia upon follow-up and were excluded 
from the study. Moreover, six patients received a diagnosis of primary progressive 
aphasia (PPA) without specification of underlying AD or bvFTD pathology, or SD 
diagnosis. Of the remaining 39 patients, a confirmed diagnosis was established 
for eleven AD patients, nine bvFTD patients and eight SD patients (the other five 
cancelled the appointment or terminated the MRI scan prematurely). Overall, 
this emphasizes the difficulties with sample size in clinical studies, and especially 
with clinical diagnostics in a rare and early-stage population. 
Effect of small sample size on study results
Small sample size limits statistical power and may thus influence our study results 
and interpretation. It may introduce false positives or lead to underestimation of 
group differences. Especially in the case of contradictory or unexpected findings 
caution with result interpretation is warranted. We have addressed the issue of 
false positives in our studies by applying corrections for multiple comparisons. 
In some analyses we were unable to apply such corrections and instead used al-
ternative approaches (e.g. higher cluster size threshold, lower p-value threshold, 
non-parametrical testing) to minimize the occurrence of false positives. As a re-
sult, we may have underestimated the group differences, but we have increased 
certainty about the differences observed.
Rs-fMRI turned out to be especially vulnerable to a low sample size in our stud-
ies. Low sample size allowed for investigating a single resting state network only: 
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the DMN, and the whole-brain DMN results we observed were only detectable 
using a relatively lenient threshold. Additionally, between-group differences of 
functional connectivity remained obscured in quantitative region of interest (ROI) 
analysis. This is worrisome for neuroscientific studies aiming to identify resting 
state networks in smaller populations. However, it also indicates that rs-fMRI is 
likely not a useful technique for clinical diagnostics. This indication may be used to 
guide future efforts of improving MRI diagnostics, which should rather be focused 
elsewhere, for example on DTI and ASL. Despite the fact that low sample size 
likely also had some influence on DTI and ASL findings, we observed both within-
group and between-group abnormalities that survived stringent statistical thresh-
olds and that were in accordance with previous literature, suggesting meaningful 
results and less sensitivity of DTI and ASL to small sample size.
Clinical implications and future directives
We observed differential brain abnormalities in AD and FTD subtypes using DTI, 
ASL and, to a much lesser extent, rs-fMRI, where conventional MRI techniques 
commonly fail. This indicates diagnostic utility for advanced MRI techniques in 
detecting more subtle brain abnormalities that may remain undiscovered using 
conventional (structural) imaging. 
For instance, differential diagnosis of AD and bvFTD can be aided by using 
tract-specific quantitative DTI to detect widespread WM microstructural abnor-
malities in bvFTD and only regionally in the hippocampal cingulum in AD. Moreo-
ver, differential diagnosis of AD and bvFTD may be aided by combining quantita-
tive measures of WM and GM. Correlating such quantitative measures allows for 
detection of incipient abnormalities that go undetected in regular group analysis. 
Additionally, diagnosis of phFTD may be aided by using advanced MRI to detect 
subtle brain changes in phFTD, similar to bvFTD, that have not been observed 
previously by using conventional MRI.
It should be noted that the findings observed in our studies are based on 
group analyses. Consequently, results are potentially not directly applicable to an 
individual patient level. Our work provides an indication of the utility of advanced 
MRI techniques in dementia and can aid future research focussing on individual 
patient assessment.   
The use of DTI and ASL may be very beneficial for clinical diagnosis of early-stage 
presenile dementia as both techniques can produce quantitative measures that 
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detect subtle brain abnormalities. Conventional (structural) MRI does not detect 
such subtle changes, but its use may be improved by quantifying GM volumes 
using advanced post-processing pipelines. On the other hand, the use of rs-fMRI 
for the purpose of clinical diagnosis is debatable. We did not detect functional 
DMN connectivity differences between a small sample of AD and bvFTD patients, 
using a quantitative approach.  As clinical use warrants sensitivity of measures 
at an individual patient level;  minor differences in  quantitative functional DMN 
connectivity in a small patient group does not seem to make rs-fMRI suitable for 
individual diagnostics. In contrast, both ASL and DTI were able to detect group-
specific differences in the same small samples. 
Our findings are especially indicative for the use of DTI as a diagnostic tool, 
and hence I will elaborate on this technique specifically. DTI has proven sensitive 
to detecting brain diffusion changes in patient groups where abnormalities are 
expected to be subtle. Furthermore, despite being established in small groups, 
these abnormalities are in line with previous research, suggesting sensitivity of 
DTI on an individual patient level. Additionally, quantification of DTI findings is 
possible, allowing for tract-specific measures of WM microstructure abnormali-
ties. Importantly, an even more detailed approach is possible by establishing 
mean diffusion values per WM tract segment rather than for the whole WM tract. 
Especially in long tracts, such as the inferior fronto-occipital fasciculus, one mean 
for the whole tract will obscure regional differences. Such regional differences 
are likely of reasonable extent in dementia, where for example in bvFTD mainly 
frontotemporal WM is affected. Importantly, as diffusion models are becoming 
more advanced using high angular resolution diffusion-weighted imaging (HARDI) 
approaches, diffusion measures will have improved accuracy, will likely have bet-
ter sensitivity to microstructural WM changes in neurodegeneration, and may 
become an even better diagnostic tool in the future.
In order to improve diagnostic utility of DTI, or recent diffusion approaches such 
as HARDI, it is important to investigate sensitivity and specificity of quantitative 
WM microstructure in larger samples and establish reference values in a healthy 
population. Reference values have recently been established for GM volume (Ver-
nooij et al., unpublished data) within the initiative of the Rotterdam Scan Study 
[27], indicating feasibility for establishing reference values for WM microstruc-
ture. 
Also of note is the contribution of quantitative DTI to computer-aided-diag-
nosis (CAD) in dementia. A recent CAD study has shown that fractional anisotropy 
(FA) values improve computer-aided differentiation between AD and bvFTD (Bron 
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et al., unpublished data). This is important as CAD will likely become more in-
volved as support tool in future radiological diagnosis. 
Conclusion
Advanced MRI techniques identify subtle brain abnormalities in dementia sub-
types not otherwise detected using conventional (structural) MR imaging. These 
subtle brain abnormalities aid to the understanding of brain processes in demen-
tia, and especially DTI and ASL may aid clinical diagnosis and differentiation of the 
dementia subtypes. Future research should especially focus on quantitative MRI 
by establishing reference values for MRI measures.
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Presenile dementia (occurring before 65 years of age) [1] is a neurodegenerative 
disorder affecting white matter (WM) and grey matter (GM) in different regions 
of the brain. The two most common underlying diseases of presenile dementia 
are Alzheimer’s disease (AD) and frontotemporal dementia (FTD) [2]. FTD is the 
umbrella term for several types of dementia, such as behavioural variant FTD 
(bvFTD) and semantic dementia (SD). Additionally, phenocopy frontotemporal 
dementia (phFTD), a rare syndrome clinically similar to bvFTD, may also belong to 
this FTD spectrum. In early-stages of these diseases, symptoms may still be mild 
or unspecific. Consequently, early-stage (differential) diagnosis can be difficult. 
Magnetic resonance imaging (MRI) of the brain supports diagnosis, but may still 
appear normal or show unspecific brain abnormalities in early stages of dementia 
[3–5]. More advanced MRI techniques, such as diffusion tensor imaging (DTI), 
resting state functional MRI (rs-fMRI) and arterial spin labelling (ASL) may aid dif-
ferential diagnosis by detecting subtle abnormalities that remain unrevealed us-
ing conventional (structural) MRI [6]. Also, we can quantify advanced MRI, which 
allows for comparing patients to reference values of the healthy population, and 
allows for combining WM and GM measures to investigate relations between 
subtle WM and GM changes in dementia.
The first and second technique, DTI and rs-fMRI, can be used to assess brain 
connectivity, in terms of respectively WM microstructure (e.g. fractional anisot-
ropy, mean diffusivity) and functional connectivity of resting state networks (e.g. 
default mode network (DMN)). The third technique, ASL, can be used to assess 
GM perfusion of the whole-brain or in regions of interest. Additionally, by apply-
ing advanced post-processing tools to conventional (structural) MRI we may be 
able identify smaller GM volume changes and combine these with the advanced 
MRI measures as mentioned above. 
In this thesis I investigate the use of these techniques in identifying subtle brain 
abnormalities, associating brain abnormalities with disease symptomatology, and 
improving early (differential) diagnosis in several diseases underlying presenile 
dementia.
Section 2 describes subtle brain abnormalities in early-stage AD and bvFTD using 
advanced MRI. In chapter 2.1, we investigated quantitative measures of tract-
specific WM microstructure and functional DMN connectivity to explore clinical 
applicability for early-stage and long-term differential diagnosis of AD and bvFTD. 
We observed that functional connectivity of the DMN was not different between 
groups neither at baseline nor at follow-up. Diffusion abnormalities were ob-
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served widely in bvFTD, and regionally in the hippocampal cingulum in AD. The 
extent of the differences between bvFTD and AD were diminished at follow-up 
yet abnormalities were still more pronounced in bvFTD, specifically in the cin-
gulate cingulum and inferior fronto-occipital fasciculus. The rate of change was 
very similar in bvFTD and AD. We concluded that quantitative tract-specific mi-
crostructural WM abnormalities, but not quantitative functional connectivity of 
the DMN, may aid early-stage and long-term differential diagnosis of bvFTD and 
AD. Specifically, pronounced microstructural WM changes in anterior WM tracts 
characterise bvFTD, whereas microstructural WM abnormalities of the hippo-
campal cingulum characterise AD. 
In chapter 2.2 we extended these findings by exploring a combination of 
quantitative tract-specific WM measures and regional GM volumes and perfu-
sion values. We investigated regional coherence between these measures in AD 
and bvFTD using a correlational approach. WM-GM coherence, compared with 
controls, was stronger between cingulum WM and frontotemporal GM in AD, and 
temporoparietal GM in bvFTD. In addition, in AD compared with controls, coher-
ence was stronger between inferior fronto-occipital fasciculus WM microstruc-
ture and occipital GM perfusion. We concluded that WM and GM changes show 
strong coherence between regions implicated in later stages of AD and bvFTD 
pathology, which indicates concurrent WM and GM degeneration in disease-spe-
cific networks. Additionally, our methodology allowed for the detection of incipi-
ent abnormalities that go undetected in conventional between-group analyses.
Section 3 explores subtle brain changes in dementia in relation to early-stage 
dementia symptomatology. In chapter 3.1 we investigated associations between 
cognition and WM microstructure in early-stage AD and bvFTD, to assess whether 
different WM tracts play a role in early-stage symptomatology of AD and bvFTD. 
WM microstructure has previously been associated with abnormal as well as 
normal cognitive functioning. As bvFTD and AD both show abnormalities of WM 
microstructure, it can be postulated that specific symptomatology in bvFTD and 
AD is related to specific abnormalities of WM microstructure. This is especially of 
interest in early-stage bvFTD and AD, when symptoms may still be mild or unspe-
cific, and microstructural WM abnormalities are already present. We observed 
that attention and executive deficits were associated with WM microstructure of 
several WM tracts in bvFTD, and to a lesser extent in AD. Language deficits were 
associated with WM microstructure abnormality in AD, and to a lesser extent, 
normal language functioning was associated with WM microstructure in bvFTD. 
Additionally, normal memory functioning in bvFTD, as well as normal visuocon-
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structive functioning in AD was associated with WM microstructure abnormality. 
Interestingly, evident memory deficits were not associated with any WM tract 
abnormalities in AD. We concluded that there is an association between cognitive 
functioning and WM microstructure of specific WM tracts in early-stage AD and 
bvFTD patients. This suggests that specific WM tracts play an important role in 
cognitive functioning, and are not universally involved in all cognitive domains in 
early-stage AD and bvFTD.
In chapter 3.2  we explored whether changes in brain connectivity are reflec-
tive of differential symptomatology in SD and bvFTD. Language deficits in SD are 
associated with left anterior temporal lobe atrophy [7–9], and behavioural defi-
cits in bvFTD are associated with right or bilateral frontal lobe atrophy [7,8,10]. 
We investigated whether WM microstructure and functional connectivity were 
also differentially lateralized in SD and bvFTD. Microstructural WM abnormalities 
were more pronounced in and lateralized towards the left hemisphere in SD in 
WM tracts associated with semantic processing. In bvFTD microstructural WM 
abnormalities were more pronounced in the right hemisphere, but were less lat-
eralized than in SD. They were most pronounced in WM tracts associated with be-
havioural symptoms. Functional connectivity of disease-specific regions (ATL and 
orbitofrontal cortex (OFC)) was mainly decreased with both hemispheres in SD, 
and with the right hemisphere in bvFTD. Here symptomatology associations were 
less straightforward, but generally functional connectivity was observed in GM 
regions associated with language and behaviour in SD and bvFTD respectively. 
We concluded that SD and bvFTD show a hemispheric dissociation of brain con-
nectivity in the frontotemporal regions, which underlies their differential symp-
tomatology.
Section 4 continues the discussion on the FTD spectrum of diseases by describing 
brain abnormalities in phFTD and discussing its relation with bvFTD. PhFTD is a 
syndrome of much debate, as it shares core characteristics with bvFTD yet with-
out associated cognitive deficits or brain abnormalities on conventional MRI, and 
without progression. We hypothesised that phFTD belongs to the same disease 
spectrum as bvFTD and investigated brain abnormalities in phFTD compared to 
bvFTD using sensitive MR imaging techniques. 
In chapter 4.1  we assessed WM microstructure and functional connectivity 
of the DMN. We observed that phFTD showed subtle microstructural changes in 
frontal WM tracts, and subtle increased DMN connectivity. BvFTD showed ab-
normalities in similar regions as phFTD, but had more extensive microstructural 
WM changes, and less increased DMN connectivity. In chapter 4.2 we assessed 
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regional GM volumes and perfusion. We observed cortical atrophy in the right 
temporal lobe in phFTD. Additionally, frontotemporal GM volumes were not dif-
ferent from either controls or bvFTD patients, and showed a continuum rang-
ing from the normal to abnormal in bvFTD, with phFTD in between. Perfusion 
changes were observed in the sense of hyperperfusion in the left frontal lobe. 
Taken together, findings of chapters 4.1 and 4.2 are in support of the hypothesis 
that phFTD and bvFTD may belong to the same disease spectrum and may also in-
dicate that advanced MRI techniques are potentially suited to detect subtle brain 
changes in phFTD that may improve diagnosis.
We extended these findings by qualitatively describing a subset of phFTD 
patients at 3-year follow-up in chapter 4.3. These patients were qualitatively 
compared with their baseline measures, and with bvFTD patients and controls. 
Qualitative comparison was performed for measures of cognition, GM volume, 
perfusion and WM microstructure. We observed a relatively stable clinical profile. 
Qualitative comparison showed some progression of language and memory defi-
cits and a stable pattern of structural brain abnormalities, with cognitive scores 
and structural values generally in between normal and those in bvFTD, and func-
tional changes in the sense of increased perfusion.
We concluded that these findings are still in support of the notion that 
phFTD and bvFTD may belong to the same disease spectrum. These findings may 
be used as motivation and a basis for further longitudinal studies in phFTD, spe-
cifically exploring the structural versus functional brain changes.
In section 5, I provide an overview of the main findings of this thesis and discuss 
the methodological considerations, clinical implications and future perspectives. 
In conclusion, advanced MRI techniques identify subtle brain abnormalities in 
dementia subtypes not otherwise detected using conventional (structural) MR 
imaging. These subtle brain abnormalities aid to the understanding of brain pro-
cesses in dementia, and especially DTI and ASL may aid clinical diagnosis and dif-
ferentiation of the dementia subtypes. Future research should especially focus on 
quantitative MRI by establishing reference values for MRI measures.
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Preseniele dementie (d.w.z. dementie optredend voor het 65 jarige levensjaar) 
[1] is een neurodegeneratieve ziekte die de witte en grijze stof aantast in ver-
schillende hersengebieden. De twee meest voorkomende onderliggende aan-
doeningen van preseniele dementie zijn de ziekte van Alzheimer (AD) en fronto-
temporale dementie (FTD) [2]. FTD is de overkoepelende term voor verschillende 
vormen van dementie, zoals de gedragsvariant van FTD (bvFTD) en semantische 
dementie (SD). Daarnaast is er een zeldzaam syndroom dat klinisch vergelijkbaar 
is met bvFTD, de zogenaamde phenocopy frontotemporale dementie (phFTD), 
dat mogelijk ook tot dit FTD spectrum behoort. In het vroege stadium van deze 
aandoeningen kunnen symptomen nog mild of aspecifiek zijn. Als gevolg hiervan 
kan het moeilijk zijn om de juiste diagnose te stellen. Beeldvorming met mag-
netic resonance imaging (MRI) draagt bij aan het stellen van de diagnose. In het 
vroege stadium van dementie kan de MRI scan echter nog normaal zijn of enkel 
aspecifieke hersenafwijkingen laten zien, waardoor ook deze niet altijd helpt bij 
het stellen van de diagnose [3-5].Meer geavanceerde MRI technieken, zoals dif-
fusion tensor imaging (DTI), resting state functionele MRI (rs-fMRI) en arterial 
spin labelling (ASL) kunnen mogelijk bijdragen aan het stellen van een differen-
tiaal diagnose door het detecteren van subtiele veranderingen in de hersenen 
die niet zichtbaar zijn op conventionele (structurele) MRI [6]. Daarnaast kunnen 
we geavanceerde MRI technieken kwantificeren waardoor we patiënten kunnen 
vergelijken met referentie waarden uit de gezonde populatie. Ook kunnen we 
maten voor witte en grijze stof combineren, zodat het mogelijk wordt om relaties 
tussen subtiele veranderingen in de witte en grijze stof bij dementie te bestu-
deren.
De eerste en tweede techniek, DTI en rs-fMRI, kunnen worden gebruikt om 
de connectiviteit van de hersenen te onderzoeken. Met DTI maten kunnen we 
de microstructuur van de witte stof in kaart brengen en met rs-fMRI kunnen we 
de functionele connectiviteit van resting state netwerken onderzoeken (bv. de-
fault mode network (DMN)). De derde techniek, ASL, kan worden gebruikt om 
doorbloeding van de grijze stof te meten, zowel in het hele brein als in speci-
fieke gebieden. Daarnaast is het mogelijk om veranderingen in het volume van 
de grijze stof te identificeren, door geavanceerde post-processing software toe 
te passen op conventionele (structurele) MRI beelden. Deze software kan dan 
gecombineerd worden met de geavanceerde MRI maten die hierboven genoemd 
werden.
In dit proefschrift onderzoek ik de toepassing van deze technieken voor het de-
tecteren van subtiele veranderingen in de hersenen, het associëren van hersen-
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veranderingen met ziekte symptomatologie, en het verbeteren van vroeg (differ-
entiaal) diagnostiek van de verschillende aandoeningen die onderliggend zijn aan 
preseniele dementie. 
Deel 2 beschrijft het detecteren van subtiele hersenveranderingen in het vroege 
stadium van AD en bvFTD door gebruik te maken van geavanceerde MRI. In 
hoofdstuk 2.1 hebben we gekeken naar de microstructuur van specifieke witte 
stof banen en functionele connectiviteit van het DMN. Dit hebben we gedaan om 
klinische toepasbaarheid te onderzoeken voor de differentiële diagnose tussen 
AD en bvFTD in zowel een vroeg stadium als op de langere termijn. We vonden 
dat functionele connectiviteit van het DMN niet verschillend was tussen groepen 
bij de eerste meting en ook niet bij de vervolg meting. Veranderingen in de mi-
crostructuur, gemeten met DTI, werden wijdverspreid geobserveerd bij bvFTD, en 
enkel regionaal in de hippocampale cingulum in AD. De verschillen tussen bvFTD 
en AD waren kleiner bij de vervolgmeting, alhoewel de afwijkingen nog steeds 
nadrukkelijker aanwezig waren in bvFTD, met name in de cingulate cingulum en 
de inferieure fronto-occipitale fasciculus. De mate van verandering over tijd was 
vergelijkbaar in bvFTD en AD. We concludeerden dat kwantitatieve microstruc-
turele veranderingen in specifieke witte stof banen, maar niet de kwantitatieve 
functionele connectiviteit van het DMN, kunnen helpen bij de differentiële diag-
nostiek tussen bvFTD en AD in een vroeg stadium en op de langere termijn. In het 
bijzonder zijn uitgesproken microstructurele veranderingen in de anterieure witte 
stof banen karakteristiek voor bvFTD, terwijl microstructurele veranderingen van 
het hippocampale cingulum karakteristiek zijn voor AD.
In hoofdstuk 2.2 hebben we deze bevindingen verder uitgebreid door kwan-
titatieve microstructurele maten voor specifieke witte stof banen te combineren 
met regionale metingen van volume en doorbloeding in de grijze stof. We onder-
zochten de samenhang tussen deze maten in zowel AD als bvFTD door middel 
van een correlationele methode. De samenhang tussen de witte en grijze stof, in 
vergelijking met controles, was sterker tussen de witte stof microstructuur van het 
cingulum en de frontotemporale grijze stof in AD, en de temporopariëtale grijze 
stof in bvFTD. Daarnaast was bij AD, in vergelijking met controles, de samenhang 
sterker tussen de microstructuur van de inferieure fronto-occipitale fasciculus en 
de doorbloeding in de grijze stof in de occipitaalkwab. We concludeerden dat 
veranderingen in de witte en grijze stof een sterke samenhang laten zien tussen 
regio’s die betrokken zijn in de ontwikkeling van pathologie zoals we die kennen 
in de latere stadia van AD en bvFTD. Dit wijst op een gelijktijdige degeneratie van 
de witte en grijze stof in ziekte-specifieke netwerken. Bovendien kunnen we met 
Samenvatting
252
onze correlationele methodologie beginnende afwijkingen detecteren die met 
conventionele groepsvergelijkingen onopgemerkt blijven.
Deel 3 onderzoekt subtiele hersenveranderingen in relatie tot de symptomatolo-
gie in het vroege stadium van dementie. In hoofdstuk 3.1 hebben we onderzocht 
of er associaties zijn tussen cognitie en de microstructuur van de witte stof in 
het vroege stadium van AD en bvFTD. Hierdoor konden we bekijken of meerdere 
witte stof banen een rol spelen in de symptomatologie in het vroege stadium 
van AD en bvFTD. Eerder onderzoek heeft aangetoond dat de microstructuur van 
de witte stof geassocieerd is met abnormaal en normaal cognitief functioneren. 
Aangezien zowel bvFTD als AD afwijkingen laten zien in de microstructuur van de 
witte stof, kan worden aangenomen dat specifieke symptomatologie van bvFTD 
en AD gerelateerd is aan specifieke afwijkingen van de microstructuur van de 
witte stof. Dit is met name interessant in het vroege stadium van bvFTD en AD, 
wanneer symptomen nog mild en aspecifiek kunnen zijn, en afwijkingen in de 
microstuur van de witte stof wel al aanwezig zijn. We vonden dat stoornissen in 
de aandacht en executieve functies geassocieerd waren met de microstructuur 
van de witte stof in verschillende witte stof banen bij bvFTD, en in mindere mate 
bij AD. Taal afwijkingen waren geassocieerd met afwijkingen in microstructuur 
van de witte stof bij AD, en in mindere mate was normaal taal functioneren geas-
socieerd met microstructuur van de witte stof bij bvFTD. Daarnaast was normaal 
functioneren van het geheugen bij bvFTD, en normaal functioneren van de visuo-
constructieve functies bij AD, geassocieerd met afwijkingen in de microstructuur 
van de witte stof. Interessant is dat evidente geheugen stoornissen niet geas-
socieerd waren met afwijkingen van de microstructuur van de witte stof bij AD. 
We concludeerden dat er een associatie is tussen cognitief functioneren en mi-
crostructuur van specifieke witte stof banen in het vroege stadium van AD en 
bvFTD. Dit suggereert dat specifieke witte stof banen een belangrijke rol spelen in 
het cognitief functioneren, en dat niet alle witte stof banen universeel betrokken 
zijn bij de cognitieve domeinen die in het vroege stadium van AD en bvFTD zijn 
aangedaan.
In hoofdstuk 3.2 hebben we onderzocht of veranderingen in de hersen-
connectiviteit de bestaande verschillen in symptomatologie tussen SD en bvFTD 
reflecteren. Taal afwijkingen bij SD zijn geassocieerd met grijze stof atrofie van 
de linker anterieure temporaalkwab [7-9], en gedragsafwijkingen bij bvFTD zijn 
geassocieerd met atrofie van de rechter of bilaterale frontaalkwab [7,8,10]. We 
onderzochten of microstructuur van de witte stof en functionele connectiviteit 
van specifieke regio’s ook verschillend gelateraliseerd zijn bij SD en bvFTD. Mi-
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crostructurele witte stof afwijkingen waren meer uitgesproken in, en gelaterali-
seerd naar, de linker hemisfeer bij SD. Dit was het geval voor witte stof banen 
die geassocieerd zijn met de semantische verwerking van taal. Bij bvFTD waren 
de microstructurele afwijkingen in de witte stof meer uitgesproken in de rechter 
hemisfeer, maar minder gelateraliseerd dan bij SD. Ze waren het meest uitgespro-
ken in de witte stof banen die geassocieerd zijn met gedragssymptomen. Func-
tionele connectiviteit van ziekte-specifeke regio’s (anterieure temporaal kwab 
en orbitofrontale cortex) was met name verminderd met beide hemisferen bij 
SD, en met de rechter hemisfeer bij bvFTD. Hier waren de symptomatologische 
associaties minder vanzelfsprekend, maar over het algemeen werd functionele 
connectiviteit geobserveerd in grijze stof gebieden die zijn geassocieerd met taal 
respectievelijk gedrag bij SD en bvFTD. We concludeerden dat er sprake is van een 
hemisferische dissociatie van hersenconnectiviteit in de frontotemporale regio’s 
tussen SD en bvFTD, wat onderliggend is aan hun verschillende symptomatologie.
Deel 4 zet de discussie over het FTD spectrum van aandoeningen voort door het 
beschrijven van hersenafwijkingen in phFTD en het exploreren van de relatie 
tussen phFTD en bvFTD. Het syndroom phFTD is onderwerp van veel debat 
aangezien phFTD kern eigenschappen van bvFTD laat zien zonder de bijkomende 
cognitieve afwijkingen of hersenafwijkingen zoals zichtbaar op conventionele 
MRI, en zonder dat er achteruitgang optreedt. We hypothetiseerden dat phFTD 
tot hetzelfde ziekte spectrum als bvFTD behoort en we onderzochten hersenaf-
wijkingen bij phFTD in vergelijking met bvFTD, door middel van geavanceerde MR 
beeldvorming. 
In hoofdstuk 4.1 hebben we gekeken naar de microstructuur van de witte 
stof en de functionele connectiviteit van het DMN. We observeerden dat phFTD 
subtiele microstructurele veranderingen in de frontale witte stof banen en sub-
tiele verhoogde DMN connectiviteit liet zien. BvFTD liet afwijkingen in vergelijk-
bare regio’s zien als phFTD, maar had uitgebreidere microstructurele verander-
ingen van de witte stof, en een minder sterke verhoging van DMN connectiviteit. 
In hoofdstuk 4.2 hebben we regionale grijze stof volumes en regionale grijze stof 
doorbloeding onderzocht. We observeerden corticale atrofie in de rechter tem-
poraal kwab in phFTD. Daarnaast vonden we dat frontotemporale grijze stof vol-
umes niet verschillend waren van zowel controles als bvFTD, en dat er sprake was 
van een continuüm variërend van normaal tot afwijkend in bvFTD, met phFTD 
ertussen in. Veranderingen in de doorbloeding werden geobserveerd in de vorm 
van verhoogde doorbloeding in de linker frontaalkwab. Samengenomen waren 
de bevindingen van hoofdstuk 4.1 en hoofdstuk 4.2 ondersteunend voor de hy-
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pothese dat phFTD en bvFTD mogelijk tot hetzelfde ziekte spectrum behoren. 
Daarnaast wijzen ze er op dat geavanceerde MRI technieken potentieel geschikt 
zijn voor het detecteren van subtiele hersenafwijkingen in phFTD en die daarmee 
het stellen van een diagnose mogelijk kunnen verbeteren. 
We breiden deze bevindingen in hoofdstuk 4.3 uit door middel van het 
kwalitatief beschrijven van een subgroep van phFTD patiënten die drie jaar na de 
eerste meting nogmaals onderzocht zijn. Deze patiënten hebben we kwalitatief 
vergeleken met hun eerste meting, en met zowel bvFTD patiënten als controles. 
Deze kwalitatieve vergelijking werd uitgevoerd voor cognitieve maten, grijze stof 
volumes en doorbloeding waarden, en de microstructuur van de witte stof. We 
observeerden een relatief stabiel klinisch profiel, zoals past bij phFTD. De kwalita-
tieve vergelijking liet enige achteruitgang van taal en geheugen zien en daarnaast 
een stabiel patroon van structurele hersenafwijkingen. Over het algemeen waren 
de cognitieve scores en de structurele waarden voor phFTD tussen normaal 
en bvFTD in, en waren er functionele veranderingen bij phFTD in de vorm van 
verhoogde doorbloeding. We concludeerden dat deze bevindingen nog steeds 
ondersteunend zijn voor het idee dat phFTD en bvFTD mogelijk tot hetzelfde 
ziektespectrum behoren. Deze bevindingen kunnen mogelijk gebruikt worden als 
motivatie en basis voor verdere longitudinale studies van phFTD, in het bijzonder 
voor het exploreren van structurele versus functionele hersenveranderingen.
In deel 5 geef ik een overzicht van de belangrijkste bevindingen van dit proef-
schrift en bediscussieer ik de methodologische overwegingen, klinische implica-
ties en toekomst perspectieven. Concluderend identificeren geavanceerde MRI 
technieken subtiele hersenafwijkingen bij verschillende aandoeningen onder-
liggend aan dementie die niet zichtbaar zijn met conventionele (structurele) MR 
beeldvorming. Deze subtiele hersenafwijkingen dragen bij aan het begrip van de 
hersenprocessen bij dementie, en daarnaast kunnen met name DTI en ASL mo-
gelijk bijdragen aan de klinische diagnose en differentiatie van de verschillende 
aandoeningen die aan dementie ten grondslag liggen. Toekomstig onderzoek zal 
zich vooral moeten richten op kwantitatieve MRI door het vaststellen van refer-
entie waarden voor MRI maten. 
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van mijn proefschrift mag bespreken. 
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all these years, even when you ate my food, or hid my chewing gum and left me 
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Dankwoord
262
Moira Henderson, for their help and making me feel welcome. Caroline, het was 
fijn om Belgische/Nederlandse onderonsjes te hebben :).
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